Rhode Island: drugs across all filers
Schedule G of each Rhode Island filing lists drugs, with an amount and a number of claims for each. This page sets the 2,364 rows of all 14 filings for calendar year 2025 side by side, by drug code. Every amount as filed links to its page of the filing.
The filings describe the Schedule G amounts in more than one way, so an amount added across filers may add figures that were not measured alike. How this page is put together
- 2,364drug rows in 14 filings
- 1,271drug codes (NDC) filed as one 11-digit code
- 501of those codes are on two or more filings
- 310rows show “fewer than 6” for claims. What this means
All 2,364 rows, by drug code
| Drug name and code | Amount as filed, added across filers | Claims as filed, added | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc.61958-2501-01Most often named Biktarvy 50 mg/200 mg/25 mg tab 30 in the filings | 16,904,736.90 | at least 5,771 | ||||||||||||||||||||||||||||
10 filers: the filed rows for Biktarvy | ||||||||||||||||||||||||||||||
| Descovyemtricitabine and tenofovir alafenamide200 mg; 25 mgtabletGilead Sciences, Inc.61958-2002-01Most often named Descovy 200-25 mg tab 30 in the filings | 1,476,625.19 | at least 1,394 | ||||||||||||||||||||||||||||
10 filers: the filed rows for Descovy | ||||||||||||||||||||||||||||||
| Ozempicsemaglutide1.34 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP00169-4130-13Most often named Ozempic inj 4 mg/3 mL in the filings | 1,743,475.08 | 4,664 | ||||||||||||||||||||||||||||
11 rows from 9 filers: the filed rows for Ozempic | ||||||||||||||||||||||||||||||
| Ozempicsemaglutide0.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP00169-4181-13Most often named Ozempic inj 2 mg/3 mL in the filings | 2,118,348.76 | 6,033 | ||||||||||||||||||||||||||||
11 rows from 9 filers: the filed rows for Ozempic | ||||||||||||||||||||||||||||||
| Ozempicsemaglutide2.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP00169-4772-12Most often named Ozempic inj 8 mg/3 mL in the filings | 1,754,657.03 | 5,385 | ||||||||||||||||||||||||||||
10 rows from 9 filers: the filed rows for Ozempic | ||||||||||||||||||||||||||||||
| Wegovysemaglutide2.4 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP00169-4524-14Most often named Wegovy inj 2.4 mg in the filings | 667,462.72 | 1,111 | ||||||||||||||||||||||||||||
10 rows from 9 filers: the filed rows for Wegovy | ||||||||||||||||||||||||||||||
| Basaglar KwikPeninsulin glargine100 IU/mLinjection, solutionEli Lilly and Company00002-7715-59Most often named Basaglar inj 100 units in the filings | 485,701.81 | 1,392 | ||||||||||||||||||||||||||||
8 filers: the filed rows for Basaglar KwikPen | ||||||||||||||||||||||||||||||
| Mounjarotirzepatide12.5 mg/0.5 mLinjection, solutionEli Lilly and Company00002-1460-80Most often named Mounjaro inj 12.5/0.5 in the filings | 416,308.09 | 420 | ||||||||||||||||||||||||||||
8 filers: the filed rows for Mounjaro | ||||||||||||||||||||||||||||||
| Mounjarotirzepatide7.5 mg/0.5 mLinjection, solutionEli Lilly and Company00002-1484-80Most often named Mounjaro inj 7.5/0.5 in the filings | 800,062.92 | 751 | ||||||||||||||||||||||||||||
8 filers: the filed rows for Mounjaro | ||||||||||||||||||||||||||||||
| Mounjarotirzepatide5 mg/0.5 mLinjection, solutionEli Lilly and Company00002-1495-80Most often named Mounjaro inj 5 mg/0.5 in the filings | 1,064,506.43 | 899 | ||||||||||||||||||||||||||||
8 filers: the filed rows for Mounjaro | ||||||||||||||||||||||||||||||
| Mounjarotirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company00002-1506-80Most often named Mounjaro inj 2.5/0.5 in the filings | 605,624.00 | 557 | ||||||||||||||||||||||||||||
8 filers: the filed rows for Mounjaro | ||||||||||||||||||||||||||||||
| Tivicaydolutegravir sodium50 mgtablet, film coatedViiV Healthcare Company49702-0228-13Most often named Tivicay 50 mg tab 30 in the filings | 621,249.05 | at least 600 | ||||||||||||||||||||||||||||
8 filers: the filed rows for Tivicay | ||||||||||||||||||||||||||||||
| Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate200 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC00173-0893-10Most often named Trelegy aer 200 mcg in the filings | 552,555.22 | 2,151 | ||||||||||||||||||||||||||||
8 filers: the filed rows for Trelegy Ellipta | ||||||||||||||||||||||||||||||
| Wegovysemaglutide1.7 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP00169-4517-14Most often named Wegovy inj 1.7 mg in the filings | 453,485.04 | 676 | ||||||||||||||||||||||||||||
9 rows from 8 filers: the filed rows for Wegovy | ||||||||||||||||||||||||||||||
| ApretudecabotegravirkitViiV Healthcare Company49702-0264-23Most often named Apretude 600 mg kit in the filings | 1,588,301.81 | at least 507 | ||||||||||||||||||||||||||||
8 rows from 7 filers: the filed rows for Apretude | ||||||||||||||||||||||||||||||
| Genvoyaelvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide150 mg; 150 mg; 200 mg; 10 mgtabletGilead Sciences, Inc.61958-1901-01Most often named Genvoya tab in the filings | 1,048,540.36 | at least 420 | ||||||||||||||||||||||||||||
7 filers: the filed rows for Genvoya | ||||||||||||||||||||||||||||||
| Mavyretglecaprevir and pibrentasvir40 mg; 100 mgtablet, film coatedAbbVie Inc.00074-2625-28Most often named Mavyret 100/40 mg tab 84 in the filings | 1,118,142.02 | at least 96 | ||||||||||||||||||||||||||||
7 filers: the filed rows for Mavyret | ||||||||||||||||||||||||||||||
| Mounjarotirzepatide15 mg/0.5 mLinjection, solutionEli Lilly and Company00002-1457-80Most often named Mounjaro inj 15 mg/0.5 in the filings | 591,713.56 | 568 | ||||||||||||||||||||||||||||
7 filers: the filed rows for Mounjaro | ||||||||||||||||||||||||||||||
| Mounjarotirzepatide10 mg/0.5 mLinjection, solutionEli Lilly and Company00002-1471-80Most often named Mounjaro inj 10 mg/0.5 in the filings | 677,491.80 | 606 | ||||||||||||||||||||||||||||
7 filers: the filed rows for Mounjaro | ||||||||||||||||||||||||||||||
| Trulicitydulaglutide0.75 mg/0.5 mLinjection, solutionEli Lilly and Company00002-1433-80Most often named Trulicity inj 0.75/0.5 in the filings | 280,148.26 | 685 | ||||||||||||||||||||||||||||
7 filers: the filed rows for Trulicity | ||||||||||||||||||||||||||||||
| Trulicitydulaglutide3 mg/0.5 mLinjection, solutionEli Lilly and Company00002-2236-80Most often named Trulicity inj 3/0.5 in the filings | 467,053.48 | 453 | ||||||||||||||||||||||||||||
7 filers: the filed rows for Trulicity | ||||||||||||||||||||||||||||||
| Wegovysemaglutide1 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP00169-4501-14Most often named Wegovy inj 1 mg in the filings | 316,020.09 | at least 524 | ||||||||||||||||||||||||||||
8 rows from 7 filers: the filed rows for Wegovy | ||||||||||||||||||||||||||||||
| Wegovysemaglutide0.5 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP00169-4505-14Most often named Wegovy inj 0.5 mg in the filings | 269,815.68 | 474 | ||||||||||||||||||||||||||||
8 rows from 7 filers: the filed rows for Wegovy | ||||||||||||||||||||||||||||||
| Wegovysemaglutide0.25 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP00169-4525-14Most often named Wegovy inj 0.25 mg in the filings | 284,005.58 | at least 471 | ||||||||||||||||||||||||||||
8 rows from 7 filers: the filed rows for Wegovy | ||||||||||||||||||||||||||||||
| Zepboundtirzepatide7.5 mg/0.5 mLinjection, solutionEli Lilly and Company00002-2484-80Most often named Zepbound inj 7.5/0.5 in the filings | 314,651.30 | 401 | ||||||||||||||||||||||||||||
7 filers: the filed rows for Zepbound | ||||||||||||||||||||||||||||||
| Zepboundtirzepatide5 mg/0.5 mLinjection, solutionEli Lilly and Company00002-2495-80Most often named Zepbound inj 5/0.5 mL in the filings | 401,993.46 | at least 380 | ||||||||||||||||||||||||||||
7 filers: the filed rows for Zepbound | ||||||||||||||||||||||||||||||
| Zepboundtirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company00002-2506-80Most often named Zepbound inj 2.5/0.5 in the filings | 303,326.02 | at least 276 | ||||||||||||||||||||||||||||
7 filers: the filed rows for Zepbound | ||||||||||||||||||||||||||||||
| Ajovyfremanezumab-vfrm225 mg/1.5 mLinjectionTeva Pharmaceuticals USA, Inc.51759-0202-10Most often named Ajovy inj 225/1.5 in the filings | 50,503.63 | 268 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Ajovy
| ||||||||||||||||||||||||||||||
| Entrestosacubitril and valsartan24 mg; 26 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0659-20Most often named Entresto tab 24-26 mg in the filings | 322,335.46 | 1,463 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Entresto
| ||||||||||||||||||||||||||||||
| HumiraadalimumabkitAbbVie Inc.00074-0554-02Most often named Humira pen inj 40/0.4 mL in the filings | 2,978,550.29 | 2,060 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Humira | ||||||||||||||||||||||||||||||
| Invega Sustennapaliperidone palmitate234 mg/1.5 mLinjectionJanssen Pharmaceuticals, Inc.50458-0564-01Most often named Invega SUST inj 234/1.5 in the filings | 1,260,680.78 | at least 1,016 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Invega Sustenna | ||||||||||||||||||||||||||||||
| Nurtec ODTrimegepant sulfate75 mgtablet, orally disintegratingPfizer Laboratories Div Pfizer Inc72618-3000-02Most often named Nurtec tab 75 mg ODT in the filings | 308,652.03 | 766 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Nurtec ODT
| ||||||||||||||||||||||||||||||
| Paxlovidnirmatrelvir and ritonavirkitPfizer Laboratories Div Pfizer Inc00069-5321-30Most often named Paxlovid new 300/100 mg T standard in the filings | 268,609.32 | 261 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Paxlovid | ||||||||||||||||||||||||||||||
| Skyrizirisankizumab-rzaa150 mg/mLinjectionAbbVie Inc.00074-2100-01Most often named Skyrizi 150 mg/mL pen in the filings | 3,502,402.49 | at least 299 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Skyrizi | ||||||||||||||||||||||||||||||
| Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate100 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC00173-0887-10Most often named Trelegy aer 100 mcg in the filings | 565,888.83 | 2,354 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Trelegy Ellipta | ||||||||||||||||||||||||||||||
| Tremfyaguselkumab100 mg/mLinjectionJanssen Biotech, Inc.57894-0640-11Most often named Tremfya inj 100 mg/mL in the filings | 1,004,212.74 | 236 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Tremfya
| ||||||||||||||||||||||||||||||
| Trulicitydulaglutide1.5 mg/0.5 mLinjection, solutionEli Lilly and Company00002-1434-80Most often named Trulicity inj 1.5/0.5 in the filings | 264,254.55 | 511 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Trulicity
| ||||||||||||||||||||||||||||||
| Trulicitydulaglutide4.5 mg/0.5 mLinjection, solutionEli Lilly and Company00002-3182-80Most often named Trulicity inj 4.5/0.5 in the filings | 276,360.72 | at least 199 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Trulicity | ||||||||||||||||||||||||||||||
| VivitrolnaltrexonekitAlkermes, Inc.65757-0300-01Most often named Vivitrol inj 380 mg in the filings | 510,836.04 | 693 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Vivitrol
| ||||||||||||||||||||||||||||||
| Vraylarcariprazine1.5 mgcapsule, gelatin coatedAllergan, Inc.61874-0115-30Most often named Vraylar cap 1.5 mg in the filings | 189,583.12 | at least 214 | ||||||||||||||||||||||||||||
6 filers: the filed rows for Vraylar
| ||||||||||||||||||||||||||||||
| BotoxonabotulinumtoxinA200 USP unitsinjection, powder, lyophilized, for solutionAllergan, Inc.00023-3921-02Most often named Botox 200 units inj, 1 vial in the filings | 261,917.41 | at least 136 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Botox
| ||||||||||||||||||||||||||||||
| Breo Elliptafluticasone furoate and vilanterol trifenatate100 mcg; 25 mcgpowderGlaxoSmithKline LLC00173-0859-10Most often named Breo Ellipta inh 100-25 in the filings | 66,850.93 | 687 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Breo Ellipta
| ||||||||||||||||||||||||||||||
| Budesonide and Formoterol Fumarate Dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP00310-7370-20Most often named Budesonide/FORM 160/4.5 mcg(120 inh) in the filings | 204,015.88 | 1,807 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Budesonide and Formoterol Fumarate Dihydrate
| ||||||||||||||||||||||||||||||
| Caplytalumateperone42 mgcapsuleIntra-Cellular Therapies, Inc72060-0142-40Most often named Caplyta cap 42 mg in the filings | 164,464.02 | 137 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Caplyta
| ||||||||||||||||||||||||||||||
| Dapagliflozin10 mgtablet, film coatedPrasco Laboratories66993-0457-30Most often named Dapagliflozin 10 mg tab 30 in the filings | 195,238.80 | 818 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Dapagliflozin
| ||||||||||||||||||||||||||||||
| Dovatodolutegravir sodium and lamivudine50 mg; 300 mgtablet, film coatedViiV Healthcare Company49702-0246-13Most often named Dovato 50 mg-300 mg tab 30 in the filings | 2,367,028.49 | at least 1,036 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Dovato
| ||||||||||||||||||||||||||||||
| Dupixentdupilumab300 mg/2 mLinjection, solutionSanofi-Aventis U.S. LLC00024-5915-02Most often named Dupixent 300 mg/2 mL pen in the filings | 4,993,902.52 | at least 1,605 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Dupixent
| ||||||||||||||||||||||||||||||
| Entrestosacubitril and valsartan97 mg; 103 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0696-20Most often named Entresto tab 97-103 mg in the filings | 115,476.80 | 353 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Entresto
| ||||||||||||||||||||||||||||||
| Entrestosacubitril and valsartan49 mg; 51 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0777-20Most often named Entresto tab 49-51 mg in the filings | 152,636.77 | 540 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Entresto
| ||||||||||||||||||||||||||||||
| Fasenrabenralizumab30 mg/mLinjection, solutionAstraZeneca Pharmaceuticals LP00310-1830-30Most often named Fasenra pen inj 30 mg/mL in the filings | 691,166.30 | at least 189 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Fasenra
| ||||||||||||||||||||||||||||||
| Gamunex-Cimmune globulin (human)10 g/100 mLinjectionGrifols USA, LLC13533-0800-24Most often named Gamunex-C 20 g/200 mL in the filings | 568,070.14 | 269 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Gamunex-C
| ||||||||||||||||||||||||||||||
| Incruse Elliptaumeclidinium62.5 mcgaerosol, powderGlaxoSmithKline LLC00173-0873-10Most often named Incruse Ellipta inh 30 in the filings | 135,000.77 | 1,320 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Incruse Ellipta
| ||||||||||||||||||||||||||||||
| Nucalamepolizumab100 mg/mLinjection, solutionGlaxoSmithKline LLC00173-0892-01Most often named Nucala inj 100 mg/mL in the filings | 928,932.85 | at least 145 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Nucala
| ||||||||||||||||||||||||||||||
| Ocrevusocrelizumab300 mg/10 mLinjectionGenentech, Inc.50242-0150-01Most often named Ocrevus 300 mg SDV 10 mL in the filings | 3,302,198.02 | at least 135 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Ocrevus
| ||||||||||||||||||||||||||||||
| Proliadenosumab60 mg/mLinjectionAmgen, Inc55513-0710-21Most often named Prolia inj 60 mg/mL in the filings | 1,390,743.58 | 1,494 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Prolia
| ||||||||||||||||||||||||||||||
| Rinvoqupadacitinib30 mgtablet, extended releaseAbbVie Inc.00074-2310-30Most often named Rinvoq tab 30 mg ER in the filings | 728,474.63 | at least 235 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Rinvoq
| ||||||||||||||||||||||||||||||
| Sofosbuvir and Velpatasvirvelpatasvir and sofosbuvir100 mg; 400 mgtablet, film coatedAsegua Therapeutics LLC72626-2701-01Most often named Sofosbuvir Velpatasvr 400 mg-100 mg tab 28 in the filings | 151,627.00 | at least 22 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Sofosbuvir and Velpatasvir | ||||||||||||||||||||||||||||||
| Stelaraustekinumab90 mg/mLinjection, solutionJanssen Biotech, Inc.57894-0061-03Most often named Stelara 90 mg/mL PFS in the filings | 5,314,471.57 | at least 505 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Stelara
| ||||||||||||||||||||||||||||||
| Sublocadebuprenorphine100 mgsolutionIndivior Inc.12496-0100-01Most often named Sublocade inj 100 mg/0.5 mL 1 in the filings | 366,156.08 | at least 247 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Sublocade
| ||||||||||||||||||||||||||||||
| Tresibainsulin degludec100 units/mLinjection, solutionNovo Nordisk00169-2660-15Most often named Tresiba Flex inj 100 units in the filings | 54,107.92 | 422 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Tresiba
| ||||||||||||||||||||||||||||||
| Xifaxanrifaximin550 mgtabletSalix Pharmaceuticals, Inc.65649-0303-02Most often named Xifaxan tab 550 mg in the filings | 163,687.58 | 188 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Xifaxan
| ||||||||||||||||||||||||||||||
| Xolairomalizumab300 mg/2 mLinjection, solutionGenentech, Inc.50242-0227-55Most often named Xolair inj 300/2 mL in the filings | 186,722.25 | at least 73 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Xolair
| ||||||||||||||||||||||||||||||
| Zepboundtirzepatide10 mg/0.5 mLinjection, solutionEli Lilly and Company00002-2471-80Most often named Zepbound inj 10/0.5 mL in the filings | 312,573.26 | 332 | ||||||||||||||||||||||||||||
5 filers: the filed rows for Zepbound
| ||||||||||||||||||||||||||||||
| Abilify MaintenaaripiprazolekitOtsuka America Pharmaceutical, Inc.59148-0245-12Most often named Abilify Maintena 400 mg kit in the filings | 495,479.07 | at least 316 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Abilify Maintena
| ||||||||||||||||||||||||||||||
| Adalimumabadalimumab-adaz40 mg/0.4 mLinjection, solutionSandoz Inc61314-0327-20Most often named Adalimu-adaz inj 40/0.4 mL in the filings | 403,650.04 | 621 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Adalimumab
| ||||||||||||||||||||||||||||||
| Adbrytralokinumab-ldrm300 mg/2 mLinjection, solutionLEO Pharma Inc.50222-0350-02Most often named Adbry inj 300/2 mL in the filings | 101,766.27 | at least 40 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Adbry
| ||||||||||||||||||||||||||||||
| Albuterol Sulfate HFA90 mcgaerosol, meteredPrasco Laboratories66993-0019-68Most often named Albuterol aer HFA in the filings | 140,192.50 | 6,243 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Albuterol Sulfate HFA
| ||||||||||||||||||||||||||||||
| Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc.61958-2501-03Most often named Biktarvy tab in the filings | 196,813.15 | at least 151 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Biktarvy
| ||||||||||||||||||||||||||||||
| BotoxonabotulinumtoxinA100 USP unitsinjection, powder, lyophilized, for solutionAllergan, Inc.00023-1145-01Most often named Botox 100 units vial in the filings | 2,046,261.70 | 2,497 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Botox
| ||||||||||||||||||||||||||||||
| Breztribudesonide, glycopyrrolate, and formoterol fumarate160 mcg; 9 mcg; 4.8 mcgaerosol, meteredAstraZeneca Pharmaceuticals LP00310-4616-12Most often named Breztri aero aer Sphere in the filings | 84,708.99 | 374 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Breztri
| ||||||||||||||||||||||||||||||
| Bridionsugammadex100 mg/mLinjection, solutionMerck Sharp & Dohme LLC00006-5423-12Most often named Bridion 200 mg/2 mL SOLN in the filings | 1,387,021.71 | 12,449 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Bridion
| ||||||||||||||||||||||||||||||
| Budesonide and Formoterol Fumarate Dihydrate80 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP00310-7372-20Most often named Budesonide/FORM 80/4.5 mcg (120 inh) in the filings | 117,949.11 | 1,227 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Budesonide and Formoterol Fumarate Dihydrate
| ||||||||||||||||||||||||||||||
| Cabenuvacabotegravir and rilpivirinekitViiV Healthcare Company49702-0240-15Most often named Cabenuva 600-900 mg sus kit in the filings | 4,382,192.45 | at least 844 | ||||||||||||||||||||||||||||
5 rows from 4 filers: the filed rows for Cabenuva
| ||||||||||||||||||||||||||||||
| Combivent Respimatipratropium bromide and albuterol20 mcg; 100 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc.00597-0024-02Most often named Combivent aer 20-100 in the filings | 72,037.72 | 251 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Combivent Respimat
| ||||||||||||||||||||||||||||||
| Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation00078-0639-41Most often named Cosentyx pen inj 300dose in the filings | 1,006,106.34 | 522 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Cosentyx
| ||||||||||||||||||||||||||||||
| Dapagliflozin5 mgtablet, film coatedPrasco Laboratories66993-0456-30Most often named Dapagliflozi tab 5 mg in the filings | 133,443.71 | 543 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Dapagliflozin
| ||||||||||||||||||||||||||||||
| Eliquisapixaban5 mgtablet, film coatedE.R. Squibb & Sons, L.L.C.00003-0894-21Most often named Eliquis 5 mg tab 60 in the filings | 179,594.32 | 5,506 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Eliquis
| ||||||||||||||||||||||||||||||
| Enhertufam-trastuzumab deruxtecan-nxki100 mg/5 mLinjection, powder, lyophilized, for solutionDaiichi Sankyo Inc.65597-0406-01Most often named Enhertu 100 mg SOLR in the filings | 6,764,203.17 | 1,461 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Enhertu
| ||||||||||||||||||||||||||||||
| Epclusavelpatasvir and sofosbuvir100 mg; 400 mgtablet, film coatedGilead Sciences, Inc.61958-2201-01Most often named Epclusa tab 400-100 in the filings | 119,887.44 | at least 17 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Epclusa
| ||||||||||||||||||||||||||||||
| Gamunex-Cimmune globulin (human)10 g/100 mLinjectionGrifols USA, LLC13533-0800-71Most often named MPB Gamunex-C 10 g/100 mL in the filings | 407,012.48 | 310 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Gamunex-C
| ||||||||||||||||||||||||||||||
| Gazyvaobinutuzumab1,000 mg/40 mLinjection, solution, concentrateGenentech, Inc.50242-0070-01Most often named Gazyva 1,000 mg VL 40 mL in the filings | 985,648.85 | at least 153 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Gazyva
| ||||||||||||||||||||||||||||||
| Gemtesavibegron75 mgtablet, film coatedSumitomo Pharma America, Inc.73336-0075-30Most often named Gemtesa tab 75 mg in the filings | 65,120.65 | 273 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Gemtesa
| ||||||||||||||||||||||||||||||
| Hadlimaadalimumab-bwwd40 mg/0.4 mLsolutionOrganon LLC78206-0187-01Most often named Hadlima push inj 40/0.4 mL in the filings | 1,016,866.48 | 1,362 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Hadlima
| ||||||||||||||||||||||||||||||
| Ilumyatildrakizumab-asmn100 mg/mLinjection, solutionSun Pharmaceutical Industries, Inc.47335-0177-95Most often named Ilumya inj 100 mg/mL in the filings | 741,549.53 | at least 58 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Ilumya
| ||||||||||||||||||||||||||||||
| Imfinzidurvalumab500 mg/10 mLinjection, solutionAstraZeneca Pharmaceuticals LP00310-4611-50Most often named Imfinzi 500 mg SDV 10 mL in the filings | 7,403,270.90 | 826 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Imfinzi
| ||||||||||||||||||||||||||||||
| Ingrezzavalbenazine80 mgcapsuleNeurocrine Biosciences, Inc.70370-1080-01Most often named Ingrezza cap 80 mg in the filings | 218,282.08 | at least 39 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Ingrezza
| ||||||||||||||||||||||||||||||
| Invega Trinzapaliperidone palmitate546 mg/1.75 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc50458-0608-01Most often named Invega Trinz inj 546 mg in the filings | 369,681.14 | at least 95 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Invega Trinza
| ||||||||||||||||||||||||||||||
| Julucadolutegravir sodium and rilpivirine hydrochloride50 mg; 25 mgtablet, film coatedViiV Healthcare Company49702-0242-13Most often named Juluca tab 50-25 mg in the filings | 676,384.28 | at least 267 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Juluca
| ||||||||||||||||||||||||||||||
| Kadcylaado-trastuzumab emtansine20 mg/mLinjection, powder, lyophilized, for solutionGenentech, Inc.50242-0088-01Most often named Kadcyla 100 mg SOLR in the filings | 1,366,926.42 | 304 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Kadcyla
| ||||||||||||||||||||||||||||||
| Keytrudapembrolizumab25 mg/mLinjection, solutionMerck Sharp & Dohme LLC00006-3026-02Most often named Keytruda 100 mg SDV 4 mL in the filings | 44,652,561.17 | 6,049 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Keytruda
| ||||||||||||||||||||||||||||||
| Kisqaliribociclib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0860-01Most often named Kisqali FCT tab 200 mg in the filings | 370,699.64 | 100 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Kisqali
| ||||||||||||||||||||||||||||||
| Lantus Solostarinsulin glargine100 IU/mLinjection, solutionsanofi-aventis U.S. LLC00088-2219-05Most often named Lantus Solos inj 100/mL in the filings | 66,999.01 | 3,351 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Lantus Solostar
| ||||||||||||||||||||||||||||||
| Lynparzaolaparib150 mgtablet, film coatedAstraZeneca Pharmaceuticals LP00310-0679-12Most often named Lynparza in the filings | 2,135,858.58 | at least 180 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Lynparza
| ||||||||||||||||||||||||||||||
| Mvasibevacizumab-awwb100 mg/4 mLinjection, solutionAmgen, Inc55513-0206-01Most often named Mvasi 100 mg SDV 4 mL in the filings | 355,649.11 | 1,663 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Mvasi
| ||||||||||||||||||||||||||||||
| Mvasibevacizumab-awwb400 mg/16 mLinjection, solutionAmgen, Inc55513-0207-01Most often named Mvasi 400 mg SDV 16 mL in the filings | 1,838,493.84 | 1,783 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Mvasi
| ||||||||||||||||||||||||||||||
| NeulastapegfilgrastimkitAmgen, Inc55513-0192-01Most often named Neulasta Onpro 6 mg/0.6 mL SOSY in the filings | 231,449.57 | 683 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Neulasta
| ||||||||||||||||||||||||||||||
| Novologinsulin aspart100 IU/mLinjection, solutionNovo Nordisk00169-6339-10Most often named Novolog inj Flexpen in the filings | 37,068.43 | 502 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Novolog
| ||||||||||||||||||||||||||||||
| Opdivonivolumab10 mg/mLinjectionE.R. Squibb & Sons, L.L.C.00003-3734-13Most often named Opdivo 240 mg VL 24 mL in the filings | 10,775,878.14 | 1,189 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Opdivo
| ||||||||||||||||||||||||||||||
| Paxlovidnirmatrelvir and ritonavirkitPfizer Laboratories Div Pfizer Inc00069-5045-30Most often named Paxlovid tab 300-100 in the filings | 100,960.16 | 98 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Paxlovid
| ||||||||||||||||||||||||||||||
| Polivypolatuzumab vedotin140 mg/7.52 mLinjection, powder, lyophilized, for solutionGenentech, Inc.50242-0105-01Most often named Polivy 140 mg SDV in the filings | 1,755,377.52 | at least 118 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Polivy
| ||||||||||||||||||||||||||||||
| Quliptaatogepant60 mgtabletAbbVie Inc.00074-7094-30Most often named Qulipta tab 60 mg in the filings | 123,843.63 | 277 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Qulipta
| ||||||||||||||||||||||||||||||
| Reblozylluspatercept25 mginjection, powder, lyophilized, for solutionCelgene Corporation59572-0711-01Most often named Reblozyl 25 mg SDV in the filings | 621,087.06 | at least 183 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Reblozyl
| ||||||||||||||||||||||||||||||
| Reblozylluspatercept75 mginjection, powder, lyophilized, for solutionCelgene Corporation59572-0775-01Most often named Reblozyl 75 mg SDV in the filings | 2,824,226.05 | 294 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Reblozyl
| ||||||||||||||||||||||||||||||
| Retacritepoetin alfa-epbx40,000 IU/mLinjection, solutionPfizer Laboratories Div Pfizer Inc00069-1309-04Most often named Retacrit 40,000 units/mL SOLN in the filings | 152,669.54 | 689 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Retacrit
| ||||||||||||||||||||||||||||||
| Rexultibrexpiprazole0.5 mgtabletOtsuka America Pharmaceutical, Inc.59148-0036-13Most often named Rexulti tab 0.5 mg in the filings | 67,388.89 | 85 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Rexulti
| ||||||||||||||||||||||||||||||
| Rexultibrexpiprazole1 mgtabletOtsuka America Pharmaceutical, Inc.59148-0037-13Most often named Rexulti tab 1 mg in the filings | 108,079.44 | 145 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Rexulti
| ||||||||||||||||||||||||||||||
| Rexultibrexpiprazole2 mgtabletOtsuka America Pharmaceutical, Inc.59148-0038-13Most often named Rexulti tab 2 mg in the filings | 67,342.44 | at least 79 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Rexulti
| ||||||||||||||||||||||||||||||
| Rinvoqupadacitinib45 mgtablet, extended releaseAbbVie Inc.00074-1043-28Most often named upadacitinib (Rinvoq) 45 mg Tb24 in the filings | 550,110.11 | at least 101 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Rinvoq
| ||||||||||||||||||||||||||||||
| Rinvoqupadacitinib15 mgtablet, extended releaseAbbVie Inc.00074-2306-30Most often named Rinvoq tab 15 mg ER in the filings | 3,178,924.87 | 886 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Rinvoq
| ||||||||||||||||||||||||||||||
| Rybelsusoral semaglutide7 mgtabletNovo Nordisk Pharmaceutical Industries, LP00169-4307-30Most often named Rybelsus tab 7 mg in the filings | 232,538.60 | 530 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Rybelsus
| ||||||||||||||||||||||||||||||
| Rybelsusoral semaglutide14 mgtabletNovo Nordisk Pharmaceutical Industries, LP00169-4314-30Most often named Rybelsus tab 14 mg in the filings | 272,209.88 | 594 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Rybelsus
| ||||||||||||||||||||||||||||||
| Sandostatin LAR Depotoctreotide acetatekitNovartis Pharmaceuticals Corporation00078-0825-81Most often named SandoSTATIN LAR Depot 30 mg KIT in the filings | 926,374.70 | 542 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Sandostatin LAR Depot
| ||||||||||||||||||||||||||||||
| Simlandiadalimumab-ryvkkitTeva Pharmaceuticals USA, Inc.51759-0402-02Most often named Simlandi 40 mg/0.4 mL AI 2 in the filings | 354,166.75 | 558 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Simlandi
| ||||||||||||||||||||||||||||||
| Skyrizirisankizumab-rzaa150 mg/mLinjectionAbbVie Inc.00074-1050-01Most often named Skyrizi inj 150 mg/mL in the filings | 420,432.63 | at least 35 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Skyrizi
| ||||||||||||||||||||||||||||||
| Skyrizirisankizumab-rzaakitAbbVie Inc.00074-1070-01Most often named Skyrizi 360 mg kit in the filings | 3,198,427.54 | 302 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Skyrizi
| ||||||||||||||||||||||||||||||
| Stelaraustekinumab45 mg/0.5 mLinjection, solutionJanssen Biotech, Inc.57894-0060-03Most often named Stelara PFS 45 mg/0.5 mL 1 in the filings | 507,043.78 | at least 112 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Stelara
| ||||||||||||||||||||||||||||||
| Steqeymaustekinumab-stba90 mg/mLinjection, solutionCELLTRION USA, Inc.72606-0028-01Most often named Steqeyma PFS 90 mg/mL 1 in the filings | 107,709.55 | at least 89 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Steqeyma
| ||||||||||||||||||||||||||||||
| Symtuzadarunavir, cobicistat, emtricitabine, and tenofovir alafenamide800 mg; 150 mg; 200 mg; 10 mgtablet, film coatedJanssen Products LP59676-0800-30Most often named Symtuza tab in the filings | 634,876.28 | 190 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Symtuza
| ||||||||||||||||||||||||||||||
| Tecentriqatezolizumab1,200 mg/20 mLinjection, solutionGenentech, Inc.50242-0917-01Most often named Tecentriq 1,200 mg SDV 20 mL in the filings | 5,367,652.65 | 498 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Tecentriq
| ||||||||||||||||||||||||||||||
| Toujeo Maxinsulin glargine300 units/mLinjection, solutionSanofi-Aventis U.S. LLC00024-5871-02Most often named Toujeo Max inj 300/mL in the filings | 54,072.63 | 256 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Toujeo Max
| ||||||||||||||||||||||||||||||
| Truximarituximab-abbs10 mg/mLinjection, solutionCephalon, Inc.63459-0104-50Most often named Truxima 500 mg SDV 50 mL in the filings | 399,197.62 | 175 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Truxima
| ||||||||||||||||||||||||||||||
| Ubrelvyubrogepant100 mgtabletAllergan, Inc.00023-6501-10Most often named Ubrelvy tab 100 mg in the filings | 130,405.31 | at least 231 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Ubrelvy
| ||||||||||||||||||||||||||||||
| Valtocodiazepam7.5 mg/0.1 mLsprayNeurelis, Inc72252-0515-10Most often named Valtoco 15 mg NAS SP(10x7.5 mg)5 dose in the filings | 55,324.50 | at least 59 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Valtoco
| ||||||||||||||||||||||||||||||
| Vascepaicosapent ethyl1,000 mgcapsuleAmarin Pharma Inc.52937-0001-20Most often named Vascepa cap 1 g in the filings | 38,171.82 | 82 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Vascepa
| ||||||||||||||||||||||||||||||
| Vemlidytenofovir alafenamide25 mgtabletGilead Sciences, Inc.61958-2301-01Most often named Vemlidy tab 25 mg in the filings | 221,583.32 | 215 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Vemlidy
| ||||||||||||||||||||||||||||||
| Veozahfezolinetant45 mgtablet, film coatedAstellas Pharma US, Inc.00469-2660-30Most often named Veozah tab 45 mg in the filings | 41,397.50 | 104 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Veozah
| ||||||||||||||||||||||||||||||
| Verzenioabemaciclib150 mgtabletEli Lilly and Company00002-5337-54Most often named Verzenio tab 150 mg in the filings | 2,470,265.30 | at least 202 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Verzenio
| ||||||||||||||||||||||||||||||
| Vraylarcariprazine3 mgcapsule, gelatin coatedAllergan, Inc.61874-0130-30Most often named Vraylar cap 3 mg in the filings | 206,858.87 | 246 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Vraylar
| ||||||||||||||||||||||||||||||
| Vraylarcariprazine4.5 mgcapsule, gelatin coatedAllergan, Inc.61874-0145-30Most often named Vraylar cap 4.5 mg in the filings | 91,774.86 | 110 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Vraylar
| ||||||||||||||||||||||||||||||
| Wixela Inhubfluticasone propionate and salmeterol250 mcg; 50 mcgpowderMylan Pharmaceuticals Inc.00378-9321-32Most often named Wixela Inhub aer 250/50 in the filings | 54,953.05 | 1,162 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Wixela Inhub
| ||||||||||||||||||||||||||||||
| Xgevadenosumab120 mg/1.7 mLinjectionAmgen, Inc55513-0730-01Most often named Xgeva SDV 120 mg/1.7 mL 1 in the filings | 610,997.69 | 354 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Xgeva
| ||||||||||||||||||||||||||||||
| Yervoyipilimumab5 mg/mLinjectionE.R. Squibb & Sons, L.L.C.00003-2327-11Most often named Yervoy 50 mg VL 10 mL in the filings | 3,647,330.11 | 271 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Yervoy
| ||||||||||||||||||||||||||||||
| Zepboundtirzepatide15 mg/0.5 mLinjection, solutionEli Lilly and Company00002-2457-80Most often named Zepbound inj 15/0.5 mL in the filings | 379,957.53 | 366 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Zepbound
| ||||||||||||||||||||||||||||||
| Zepboundtirzepatide12.5 mg/0.5 mLinjection, solutionEli Lilly and Company00002-2460-80Most often named Zepbound inj 12.5/0.5 in the filings | 201,584.09 | at least 205 | ||||||||||||||||||||||||||||
4 filers: the filed rows for Zepbound
| ||||||||||||||||||||||||||||||
| Abilify Maint 400 mg kit59148-0019-71The FDA directory does not list this code: the name is from the filing | 208,911.87 | 167 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Abilify Maint 400 mg kit
| ||||||||||||||||||||||||||||||
| Abilify MaintenaaripiprazolekitOtsuka America Pharmaceutical, Inc.59148-0072-80Most often named Abilify Maintena PF syr 400 mg in the filings | 102,435.19 | 72 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Abilify Maintena
| ||||||||||||||||||||||||||||||
| Abraxanepaclitaxel100 mg/20 mLinjection, powder, lyophilized, for suspensionAbraxis BioScience, LLC68817-0134-50Most often named Abraxane SDV 100 mg in the filings | 616,574.38 | 623 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Abraxane
| ||||||||||||||||||||||||||||||
| Acetaminophen10 mg/mLinjectionFresenius Kabi USA, LLC63323-0434-00Most often named Acetaminophen 10 mg/mL SOLN in the filings | 71,197.90 | 20,601 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Acetaminophen
| ||||||||||||||||||||||||||||||
| Actemratocilizumab162 mg/0.9 mLinjection, solutionGenentech, Inc.50242-0138-01Most often named Actemra inj 162/0.9 in the filings | 154,575.05 | 108 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Actemra
| ||||||||||||||||||||||||||||||
| Actemra ACTPentocilizumab162 mg/0.9 mLinjection, solutionGenentech, Inc.50242-0143-01Most often named Actemra inj ACTPen in the filings | 884,029.56 | 501 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Actemra ACTPen
| ||||||||||||||||||||||||||||||
| Aristadaaripiprazole lauroxil882 mg/3.2 mLinjection, suspension, extended releaseAlkermes, Inc.65757-0403-03Most often named Aristada inj 882 mg/3 in the filings | 278,850.28 | at least 123 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Aristada
| ||||||||||||||||||||||||||||||
| Austedodeutetrabenazine9 mgtablet, coatedTeva Neuroscience, Inc.68546-0171-60Most often named Austedo tab 9 mg in the filings | 150,539.04 | at least 23 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Austedo
| ||||||||||||||||||||||||||||||
| Austedo XRdeutetrabenazine12 mgtablet, film coated, extended releaseTeva Neuroscience, Inc.68546-0471-56Most often named Austedo XR tab 12 mg in the filings | 86,417.60 | 28 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Austedo XR
| ||||||||||||||||||||||||||||||
| Austedo XRdeutetrabenazine24 mgtablet, film coated, extended releaseTeva Neuroscience, Inc.68546-0472-56Most often named Austedo XR tab 24 mg in the filings | 118,494.37 | at least 24 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Austedo XR
| ||||||||||||||||||||||||||||||
| Benlystabelimumab200 mg/mLsolutionGlaxoSmithKline LLC49401-0088-47Most often named Benlysta 200 mg PFS 4 in the filings | 105,508.07 | at least 25 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Benlysta
| ||||||||||||||||||||||||||||||
| Breo Elliptafluticasone furoate and vilanterol trifenatate200 mcg; 25 mcgpowderGlaxoSmithKline LLC00173-0882-10Most often named Breo Ellipta inh 200-25 in the filings | 40,511.32 | 422 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Breo Ellipta
| ||||||||||||||||||||||||||||||
| Calquenceacalabrutinib100 mgtablet, film coatedAstraZeneca Pharmaceuticals LP00310-3512-60Most often named Calquence 100 mg tab 60 in the filings | 4,276,210.64 | 405 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Calquence
| ||||||||||||||||||||||||||||||
| Collagenase Santyl250 units/gointmentSmith & Nephew, Inc50484-0010-30Most often named Santyl OIN 250/GM in the filings | 150,571.24 | 86 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Collagenase Santyl
| ||||||||||||||||||||||||||||||
| Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation00078-0639-68Most often named Cosentyx pen inj 150 mg/mL in the filings | 356,780.25 | at least 453 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Cosentyx
| ||||||||||||||||||||||||||||||
| Cosentyxsecukinumab300 mg/2 mLinjectionNovartis Pharmaceuticals Corporation00078-1070-68Most often named Cosentyx Uno inj 300/2 mL in the filings | 1,085,733.60 | 478 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Cosentyx
| ||||||||||||||||||||||||||||||
| Cyramzaramucirumab10 mg/mLsolutionEli Lilly and Company00002-7669-01Most often named Cyramza 100 mg SDV 10 mL in the filings | 490,965.98 | at least 77 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Cyramza
| ||||||||||||||||||||||||||||||
| Darzalex Fasprodaratumumab and hyaluronidase-fihj (human recombinant)1,800 mg/15 mL; 30,000 units/15 mLinjectionJanssen Biotech, Inc.57894-0503-01Most often named Darzalex Faspro 1,800 mg SDV 15 mL in the filings | 15,926,306.39 | 1,673 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Darzalex Faspro
| ||||||||||||||||||||||||||||||
| Diprivanpropofol10 mg/mLinjection, emulsionFresenius Kabi USA, LLC63323-0269-29Most often named Diprivan 200 mg/20 mL EMUL in the filings | 44,494.92 | 61,452 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Diprivan
| ||||||||||||||||||||||||||||||
| Dovatodolutegravir sodium and lamivudine50 mg; 300 mgtablet, film coatedViiV Healthcare Company49702-0246-33Most often named Dovato TB 50-300 mg 30 BPK in the filings | 50,351.60 | at least 18 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Dovato
| ||||||||||||||||||||||||||||||
| Dupixentdupilumab300 mg/2 mLinjection, solutionSanofi-Aventis U.S. LLC00024-5914-01Most often named Dupixent PFS300 mg/2 mL 2 in the filings | 1,454,565.75 | 576 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Dupixent
| ||||||||||||||||||||||||||||||
| Dupixentdupilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC00024-5919-02Most often named Dupixent 200 mg/1.14 mL pen in the filings | 821,936.30 | at least 316 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Dupixent
| ||||||||||||||||||||||||||||||
| Eliquisapixaban2.5 mgtablet, film coatedE.R. Squibb & Sons, L.L.C.00003-0893-21Most often named Eliquis 2.5 mg tab 60 in the filings | 64,573.97 | 1,272 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Eliquis
| ||||||||||||||||||||||||||||||
| Emgalitygalcanezumab-gnlm120 mg/mLinjection, solutionEli Lilly and Company00002-1436-11Most often named Emgality 120 mg PFP in the filings | 52,308.36 | 82 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Emgality
| ||||||||||||||||||||||||||||||
| Erbituxcetuximab2 mg/mLsolutionImClone LLC66733-0948-23Most often named Erbitux VL 2 mg/mL 50 mL in the filings | 1,931,434.73 | 454 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Erbitux
| ||||||||||||||||||||||||||||||
| Erbituxcetuximab2 mg/mLsolutionImClone LLC66733-0958-23Most often named Erbitux VL 2 mg/mL 100 mL in the filings | 393,745.00 | 321 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Erbitux
| ||||||||||||||||||||||||||||||
| Erleadaapalutamide60 mgtablet, film coatedJanssen Products, LP59676-0600-12Most often named Erleada in the filings | 690,628.92 | 69 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Erleada
| ||||||||||||||||||||||||||||||
| Evenityromosozumab-aqqg105 mg/1.17 mLinjection, solutionAmgen, Inc55513-0998-02Most often named romosozumab-aqqg Syrg 210 mg in the filings | 1,879,412.69 | at least 889 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Evenity
| ||||||||||||||||||||||||||||||
| Fasenrabenralizumab30 mg/mLinjection, solutionAstraZeneca Pharmaceuticals LP00310-1730-30Most often named Fasenra 30 mg PFS in the filings | 600,971.52 | at least 142 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Fasenra
| ||||||||||||||||||||||||||||||
| Fluticasone Propionate HFA44 mcgaerosol, meteredPrasco Laboratories66993-0078-96Most often named Fluticas HFA aer 44 mcg in the filings | 63,230.41 | 856 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Fluticasone Propionate HFA
| ||||||||||||||||||||||||||||||
| Fluticasone Propionate HFA110 mcgaerosol, meteredPrasco Laboratories66993-0079-96Most often named Fluticas HFA aer 110 mcg in the filings | 75,552.95 | 771 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Fluticasone Propionate HFA
| ||||||||||||||||||||||||||||||
| Gammagard Liquidimmune globulin infusion (human)100 mg/mLinjection, solutionTakeda Pharmaceuticals America, Inc.00944-2700-06Most often named Gammagard liq 20 g 200 mL Nonret in the filings | 1,888,106.28 | 1,047 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Gammagard Liquid
| ||||||||||||||||||||||||||||||
| Gammagard Liquidimmune globulin infusion (human)100 mg/mLinjection, solutionTakeda Pharmaceuticals America, Inc.00944-2700-07Most often named Gammagard liquid 10% vial in the filings | 2,893,345.48 | 937 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Gammagard Liquid
| ||||||||||||||||||||||||||||||
| Gvoke HypoPen 1 mg Auto-Injectorglucagon injection, solution1 mg/0.2 mLinjection, solutionXeris Pharmaceuticals, Inc.72065-0121-12Most often named Gvoke Hypo 2 inj 1/0.2 mL in the filings | 33,844.15 | 76 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Gvoke HypoPen 1 mg Auto-Injector
| ||||||||||||||||||||||||||||||
| Hizentrahuman immunoglobulin G0.2 g/mLliquidCSL Behring AG44206-0455-25Most often named Hizentra inj 10/50 mL in the filings | 47,731.73 | 57 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Hizentra
| ||||||||||||||||||||||||||||||
| Ibrancepalbociclib75 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc00069-0284-03Most often named palbociclib (Ibrance) 75 mg Tab in the filings | 1,125,152.83 | at least 102 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Ibrance
| ||||||||||||||||||||||||||||||
| Ibrancepalbociclib100 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc00069-0486-03Most often named Ibrance 100 mg tablet in the filings | 1,589,771.15 | 165 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Ibrance
| ||||||||||||||||||||||||||||||
| Ibrancepalbociclib125 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc00069-0688-03Most often named Ibrance tab 125 mg in the filings | 1,614,983.02 | 167 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Ibrance
| ||||||||||||||||||||||||||||||
| Ilariscanakinumab150 mg/mLinjection, solutionNovartis Pharmaceuticals Corporation00078-0734-61Most often named canakinumab (Ilaris, PF,) 150 mg/mL Soln in the filings | 3,670,494.60 | 128 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Ilaris
| ||||||||||||||||||||||||||||||
| Imfinzidurvalumab120 mg/2.4 mLinjection, solutionAstraZeneca Pharmaceuticals LP00310-4500-12Most often named Imfinzi 120 mg SDV 2.4 mL in the filings | 772,223.21 | 410 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Imfinzi
| ||||||||||||||||||||||||||||||
| Imjudotremelimumab300 mg/15 mLinjection, solutionAstraZeneca Pharmaceuticals LP00310-4535-30Most often named Imjudo 300 mg SDV 15 mL in the filings | 698,634.08 | at least 14 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Imjudo
| ||||||||||||||||||||||||||||||
| Ingrezzavalbenazine40 mgcapsuleNeurocrine Biosciences, Inc.70370-2040-01Most often named Ingrezza cap 40 mg in the filings | 329,200.36 | at least 55 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Ingrezza
| ||||||||||||||||||||||||||||||
| Insulin Glargineinsulin glargine-yfgn100 IU/mLinjection, solutionBiocon Biologics Inc.83257-0015-32Most often named Glargin yfgn inj 100 units/mL in the filings | 33,795.98 | 657 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Insulin Glargine
| ||||||||||||||||||||||||||||||
| Invega Sustennapaliperidone palmitate117 mg/0.75 mLinjectionJanssen Pharmaceuticals, Inc.50458-0562-01Most often named Invega Sustenna 117 mg kit in the filings | 75,782.62 | 126 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Invega Sustenna
| ||||||||||||||||||||||||||||||
| Invega Sustennapaliperidone palmitate156 mg/mLinjectionJanssen Pharmaceuticals, Inc.50458-0563-01Most often named Invega Sustenna 156 mg kit in the filings | 288,542.30 | 331 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Invega Sustenna
| ||||||||||||||||||||||||||||||
| JevtanacabazitaxelkitSanofi-Aventis U.S. LLC00024-5824-11Most often named Jevtana 60 mg/1.5 mL SOLN in the filings | 776,189.56 | 146 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Jevtana
| ||||||||||||||||||||||||||||||
| Kadcylaado-trastuzumab emtansine20 mg/mLinjection, powder, lyophilized, for solutionGenentech, Inc.50242-0087-01Most often named Kadcyla 160 mg SOLR in the filings | 344,737.58 | 72 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Kadcyla
| ||||||||||||||||||||||||||||||
| Kisqaliribociclib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0867-42Most often named Kisqali tab 400dose in the filings | 2,599,499.38 | 330 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Kisqali
| ||||||||||||||||||||||||||||||
| Kisqaliribociclib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0874-63Most often named Kisqali tab 600dose in the filings | 2,063,842.93 | 201 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Kisqali
| ||||||||||||||||||||||||||||||
| Kyproliscarfilzomib60 mg/30 mLinjection, powder, lyophilized, for solutionOnyx Pharmaceuticals, Inc.76075-0101-01Most often named Kyprolis 60 mg SOLR in the filings | 1,996,845.83 | 690 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Kyprolis
| ||||||||||||||||||||||||||||||
| Lenvimalenvatinib4 mgcapsuleEisai Inc.62856-0708-30Most often named Lenvima 8 mg cap 60 in the filings | 405,854.21 | 40 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Lenvima
| ||||||||||||||||||||||||||||||
| Lenvimalenvatinib10 mgcapsuleEisai Inc.62856-0710-30Most often named Lenvima 10 mg cap 30 in the filings | 363,981.17 | 33 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Lenvima
| ||||||||||||||||||||||||||||||
| Lenvimalenvatinib10 mgcapsuleEisai Inc.62856-0720-30Most often named Lenvima 20 mg cap 60 in the filings | 103,541.00 | no count shown | ||||||||||||||||||||||||||||
3 filers: the filed rows for Lenvima
| ||||||||||||||||||||||||||||||
| Lupron Depotleuprolide acetatekitAbbVie Inc.00074-3346-03Most often named Lupron Depot 22.5 mg KT 3346-03 in the filings | 58,567.19 | 187 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Lupron Depot
| ||||||||||||||||||||||||||||||
| Lynparzaolaparib100 mgtablet, film coatedAstraZeneca Pharmaceuticals LP00310-0668-12Most often named olaparib (Lynparza) 100 mg Tab in the filings | 1,017,277.62 | at least 63 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Lynparza
| ||||||||||||||||||||||||||||||
| Mekinisttrametinib0.5 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-1105-15Most often named Mekinist tab 0.5 mg in the filings | 110,313.35 | at least 47 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Mekinist
| ||||||||||||||||||||||||||||||
| Mekinisttrametinib2 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-1112-15Most often named Mekinist tab 2 mg in the filings | 962,560.86 | at least 102 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Mekinist
| ||||||||||||||||||||||||||||||
| Mirenalevonorgestrel52 mgintrauterine deviceBayer HealthCare Pharmaceuticals Inc.50419-0423-01Most often named Mirena 52 mg SYS IUD in the filings | 237,904.43 | 560 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Mirena
| ||||||||||||||||||||||||||||||
| Neulastapegfilgrastim6 mg/0.6 mLinjectionAmgen, Inc55513-0190-01Most often named Neulasta 6 mg PFS 0.6 mL 340B in the filings | 653,982.07 | 1,028 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Neulasta
| ||||||||||||||||||||||||||||||
| Nplateromiplostim250 mcg/0.5 mLinjection, powder, lyophilized, for solutionAmgen, Inc55513-0221-01Most often named Nplate 250 mcg SOLR in the filings | 2,240,046.23 | 1,719 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Nplate
| ||||||||||||||||||||||||||||||
| Nplateromiplostim125 mcg/0.25 mLinjection, powder, lyophilized, for solutionAmgen, Inc55513-0223-01Most often named Nplate 125 mcg SOLR in the filings | 83,079.20 | 91 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Nplate
| ||||||||||||||||||||||||||||||
| Nubeqadarolutamide300 mgtablet, film coatedBayer HealthCare Pharmaceuticals Inc.50419-0395-01Most often named Nubeqa tab 300 mg in the filings | 3,516,603.54 | at least 420 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Nubeqa
| ||||||||||||||||||||||||||||||
| Nucalamepolizumab100 mg/mLinjection, solutionGlaxoSmithKline LLC00173-0892-42Most often named Nucala inj 100 mg/mL in the filings | 507,238.17 | at least 107 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Nucala
| ||||||||||||||||||||||||||||||
| Octagam Immune Globulin (Human)immune globulin100 mg/mLsolutionOctapharma USA Inc68982-0850-04Most often named Octagam 10% 20 g 200 mL VL in the filings | 114,372.75 | at least 75 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Octagam Immune Globulin (Human)
| ||||||||||||||||||||||||||||||
| Odefseyemtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide200 mg; 25 mg; 25 mgtabletGilead Sciences, Inc.61958-2101-01Most often named Odefsey tab in the filings | 682,450.99 | 295 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Odefsey
| ||||||||||||||||||||||||||||||
| Ofevnintedanib150 mgcapsuleBoehringer Ingelheim Pharmaceuticals, Inc.00597-0145-60Most often named Ofev 150 mg capsule in the filings | 2,022,844.86 | 301 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Ofev
| ||||||||||||||||||||||||||||||
| Onivydeirinotecan hydrochloride4.3 mg/mLinjection, powder, for solutionIpsen Biopharmaceuticals, Inc.15054-0043-01Most often named Onivyde 43 mg SDV 10 mL in the filings | 140,268.94 | at least 50 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Onivyde
| ||||||||||||||||||||||||||||||
| Opdivonivolumab10 mg/mLinjectionE.R. Squibb & Sons, L.L.C.00003-3772-11Most often named Opdivo 40 mg VL 4 mL in the filings | 1,273,761.61 | 452 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Opdivo
| ||||||||||||||||||||||||||||||
| Opzeluraruxolitinib15 mg/gcreamIncyte Corporation50881-0007-05Most often named Opzelura crm 1.5% 60 g in the filings | 39,979.48 | at least 28 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Opzelura
| ||||||||||||||||||||||||||||||
| Padcev EJFVenfortumab vedotin20 mg/2 mLinjection, powder, lyophilized, for solutionSeagen Inc.51144-0020-01Most often named Padcev 20 mg SDV in the filings | 3,353,549.61 | 983 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Padcev EJFV
| ||||||||||||||||||||||||||||||
| Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf600 mg/10 mL; 600 mg/10 mL; 20,000 units/10 mLinjection, solutionGenentech, Inc.50242-0260-01Most often named Phesgo 600 mg-600 mg SDV 10 mL in the filings | 777,313.44 | 127 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Phesgo
| ||||||||||||||||||||||||||||||
| Praluentalirocumab75 mg/mLinjection, solutionRegeneron Pharmaceuticals, Inc.61755-0020-02Most often named Praluent inj 75 mg/mL in the filings | 164,015.45 | 557 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Praluent
| ||||||||||||||||||||||||||||||
| Prezcobixdarunavir ethanolate and cobicistat800 mg; 150 mgtablet, film coatedJanssen Products, LP59676-0575-30Most often named Prezcobix tab 30 in the filings | 387,156.94 | at least 262 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Prezcobix
| ||||||||||||||||||||||||||||||
| Privigenhuman immunoglobulin G5 g/50 mLliquidCSL Behring AG44206-0436-05Most often named Privigen 5 g SDV 50 mL in the filings | 194,796.18 | 698 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Privigen
| ||||||||||||||||||||||||||||||
| Privigenhuman immunoglobulin G10 g/100 mLliquidCSL Behring AG44206-0437-10Most often named Privigen 10 g SDV 100 mL in the filings | 668,082.41 | 893 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Privigen
| ||||||||||||||||||||||||||||||
| Privigenhuman immunoglobulin G20 g/200 mLliquidCSL Behring AG44206-0438-20Most often named Privigen 20 g SDV 200 mL in the filings | 1,735,588.88 | 1,265 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Privigen
| ||||||||||||||||||||||||||||||
| Privigenhuman immunoglobulin G40 g/400 mLliquidCSL Behring AG44206-0439-40Most often named Privigen 40 g SDV 400 mL in the filings | 2,003,953.68 | 630 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Privigen
| ||||||||||||||||||||||||||||||
| Provaybluemethylene blue5 mg/mLinjectionAmerican Regent, Inc.00517-0374-05Most often named ProvayBlue 50 mg/10 mL SOLN in the filings | 41,106.69 | 426 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Provayblue
| ||||||||||||||||||||||||||||||
| Quliptaatogepant30 mgtabletAbbVie Inc.00074-7096-30Most often named Qulipta 30 mg tablets in the filings | 22,793.90 | 55 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Qulipta
| ||||||||||||||||||||||||||||||
| Qvar Redihalerbeclomethasone dipropionate HFA40 mcgaerosol, meteredTeva Respiratory, LLC59310-0302-40Most often named Qvar Redihal aer 40 mcg in the filings | 30,109.73 | at least 383 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Qvar Redihaler
| ||||||||||||||||||||||||||||||
| Qvar Redihalerbeclomethasone dipropionate HFA80 mcgaerosol, meteredTeva Respiratory, LLC59310-0304-80Most often named Qvar Rediha aer 80 mcg in the filings | 36,896.61 | 411 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Qvar Redihaler
| ||||||||||||||||||||||||||||||
| Rexultibrexpiprazole3 mgtabletOtsuka America Pharmaceutical, Inc.59148-0039-13Most often named Rexulti tab 3 mg in the filings | 53,440.33 | 74 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Rexulti
| ||||||||||||||||||||||||||||||
| Rituxanrituximab10 mg/mLinjection, solutionGenentech, Inc.50242-0053-06Most often named Rituxan 500 mg SDV 50 mL in the filings | 511,330.70 | at least 93 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Rituxan
| ||||||||||||||||||||||||||||||
| Ruxiencerituximab-pvvr100 mg/10 mLinjection, solutionPfizer Laboratories Div Pfizer Inc00069-0238-01Most often named Ruxience 100 mg SDV 10 mL in the filings | 284,229.39 | 1,098 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Ruxience
| ||||||||||||||||||||||||||||||
| Ruxiencerituximab-pvvr500 mg/50 mLinjection, solutionPfizer Laboratories Div Pfizer Inc00069-0249-01Most often named Ruxience 500 mg SDV 50 mL in the filings | 1,229,817.19 | 1,357 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Ruxience
| ||||||||||||||||||||||||||||||
| Rybelsusoral semaglutide3 mgtabletNovo Nordisk Pharmaceutical Industries, LP00169-4303-30Most often named Rybelsus tab 3 mg in the filings | 57,196.17 | 157 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Rybelsus
| ||||||||||||||||||||||||||||||
| Sandostatin LAR Depotoctreotide acetatekitNovartis Pharmaceuticals Corporation00078-0818-81Most often named SandoSTATIN LAR Depot 20 mg KIT in the filings | 209,531.61 | 177 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Sandostatin LAR Depot
| ||||||||||||||||||||||||||||||
| Sarclisaisatuximab500 mg/25 mLinjection, solution, concentrateSanofi-Aventis U.S. LLC00024-0656-01Most often named Sarclisa 500 mg SDV 25 mL in the filings | 791,160.06 | 184 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Sarclisa
| ||||||||||||||||||||||||||||||
| Skyrizirisankizumab-rzaa600 mg/10 mLinjectionAbbVie Inc.00074-5015-01Most often named Skyrizi sol 60 mg/mL in the filings | 1,342,066.28 | at least 188 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Skyrizi
| ||||||||||||||||||||||||||||||
| Spiriva Respimattiotropium bromide inhalation spray3.124 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc.00597-0100-61Most often named Spiriva RESP aer 2.5 mcg in the filings | 25,301.58 | 501 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Spiriva Respimat
| ||||||||||||||||||||||||||||||
| Steglatroertugliflozin15 mgtablet, film coatedMerck Sharp & Dohme LLC00006-5364-03Most often named Steglatro tab 15 mg in the filings | 31,901.02 | 115 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Steglatro
| ||||||||||||||||||||||||||||||
| Stiolto Respimattiotropium bromide and olodaterol3.124 mcg; 2.736 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc.00597-0155-61Most often named Stiolto aer 2.5-2.5 in the filings | 47,090.95 | 423 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Stiolto Respimat
| ||||||||||||||||||||||||||||||
| Suboxonebuprenorphine hydrochloride, naloxone hydrochloride8 mg; 2 mgfilm, solubleIndivior Inc.12496-1208-03Most often named Suboxone MIS 8-2 mg in the filings | 254,343.22 | 767 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Suboxone
| ||||||||||||||||||||||||||||||
| Taltzixekizumab80 mg/mLinjection, solutionEli Lilly and Company00002-1445-11Most often named Taltz 80 mg/mL pen (1=1) in the filings | 2,434,084.39 | at least 681 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Taltz
| ||||||||||||||||||||||||||||||
| Tepezzateprotumumab500 mginjection, powder, lyophilized, for solutionHorizon Therapeutics USA, Inc.75987-0130-15Most often named Tepezza 500 mg SDV in the filings | 1,067,751.47 | 46 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Tepezza
| ||||||||||||||||||||||||||||||
| Teriparatide250 mcg/mLinjection, solutionAlvogen, Inc.47781-0652-89Most often named Teriparatide inj 250 mcg/mL 1 in the filings | 137,935.08 | 62 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Teriparatide
| ||||||||||||||||||||||||||||||
| Tezspiretezepelumab-ekko210 mg/1.9 mLinjection, solutionAmgen Inc55513-0123-01Most often named Tezspire 210 mg PFP 1.91 mL in the filings | 540,211.99 | 190 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Tezspire
| ||||||||||||||||||||||||||||||
| Tibsovoivosidenib250 mgtablet, film coatedServier Pharmaceutical LLC72694-0617-60Most often named Tibsovo 250 mg tab 60 in the filings | 1,600,003.37 | at least 63 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Tibsovo
| ||||||||||||||||||||||||||||||
| TNKasetenecteplasekitGenentech, Inc.50242-0120-47Most often named TNKase 50 mg KIT in the filings | 234,425.95 | 253 | ||||||||||||||||||||||||||||
3 filers: the filed rows for TNKase
| ||||||||||||||||||||||||||||||
| Tremfyaguselkumab100 mg/mLinjectionJanssen Biotech, Inc.57894-0640-01Most often named Tremfya 100 mg/mL PFS in the filings | 91,795.02 | at least 20 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Tremfya
| ||||||||||||||||||||||||||||||
| Tremfyaguselkumab200 mg/2 mLinjectionJanssen Biotech, Inc.57894-0651-02Most often named Tremfya 200 mg PFP 2 mL in the filings | 244,716.56 | at least 51 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Tremfya
| ||||||||||||||||||||||||||||||
| Tresibainsulin degludec200 units/mLinjection, solutionNovo Nordisk00169-2550-13Most often named Tresiba Flex inj 200 units in the filings | 87,276.09 | 414 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Tresiba
| ||||||||||||||||||||||||||||||
| Truqapcapivasertib160 mgtablet, film coatedAstraZeneca Pharmaceuticals LP00310-9500-02Most often named capivasertib (Truqap) 160 mg Tab in the filings | 406,928.62 | at least 14 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Truqap
| ||||||||||||||||||||||||||||||
| Truqapcapivasertib200 mgtablet, film coatedAstraZeneca Pharmaceuticals LP00310-9501-01Most often named Truqap 200 mg tab 64 in the filings | 1,260,267.14 | at least 64 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Truqap
| ||||||||||||||||||||||||||||||
| Tyennetocilizumab-aazg162 mg/0.9 mLinjection, solutionFresenius Kabi USA, LLC65219-0584-01Most often named Tyenne 162 mg auto inj 0.9 mL in the filings | 151,354.13 | 201 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Tyenne
| ||||||||||||||||||||||||||||||
| Tymlosabaloparatide3.12 mg/1.56 mLinjection, solutionRadius Health, Inc.70539-0001-02Most often named Tymlos 80 mcg dose pen Injectr in the filings | 162,764.72 | 207 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Tymlos
| ||||||||||||||||||||||||||||||
| Valtocodiazepam10 mg/0.1 mLsprayNeurelis, Inc72252-0510-05Most often named Valtoco spr 10 mg in the filings | 130,353.78 | 142 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Valtoco
| ||||||||||||||||||||||||||||||
| Ventolin HFAalbuterol sulfate90 mcgaerosol, meteredGlaxoSmithKline LLC00173-0682-20Most often named Ventolin HFA aer in the filings | 17,449.07 | 1,085 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Ventolin HFA
| ||||||||||||||||||||||||||||||
| Verzenioabemaciclib50 mgtabletEli Lilly and Company00002-4483-54Most often named Verzenio 50 mg tab 14 in the filings | 1,434,509.51 | at least 107 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Verzenio
| ||||||||||||||||||||||||||||||
| Vosevisofosbuvir, velpatasvir, and voxilaprevir400 mg; 100 mg; 100 mgtablet, film coatedGilead Sciences, Inc.61958-2401-01Most often named Vosevi 400/100/100 mg tab 28 in the filings | 194,693.82 | no count shown | ||||||||||||||||||||||||||||
3 filers: the filed rows for Vosevi
| ||||||||||||||||||||||||||||||
| Wixela Inhubfluticasone propionate and salmeterol500 mcg; 50 mcgpowderMylan Pharmaceuticals Inc.00378-9322-32Most often named Wixela Inhub aer 500/50 in the filings | 37,459.09 | 419 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Wixela Inhub
| ||||||||||||||||||||||||||||||
| Xolair PFSomalizumab150 mg/mLinjection, solutionGenentech, Inc.50242-0215-55Most often named Xolair inj 150 mg/mL in the filings | 42,099.37 | 38 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Xolair PFS
| ||||||||||||||||||||||||||||||
| Xtandienzalutamide40 mgcapsuleAstellas Pharma US, Inc.00469-0125-99Most often named Enzalutamide in the filings | 344,983.58 | at least 47 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Xtandi
| ||||||||||||||||||||||||||||||
| Xtandienzalutamide40 mgtabletAstellas Pharma US, Inc.00469-0625-99Most often named Xtandi 40 mg tablet in the filings | 3,287,005.42 | at least 603 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Xtandi
| ||||||||||||||||||||||||||||||
| Yondelistrabectedin0.05 mg/mLinjection, powder, lyophilized, for solutionJanssen Products, LP59676-0610-01Most often named Yondelis 1 mg SOLR in the filings | 545,696.34 | at least 151 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Yondelis
| ||||||||||||||||||||||||||||||
| Zejulaniraparib200 mgtablet, film coatedGlaxoSmithKline LLC00173-0912-13Most often named niraparib (Zejula) 200 mg Tab in the filings | 456,662.51 | at least 32 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Zejula
| ||||||||||||||||||||||||||||||
| Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase40,000 USP units; 126,000 USP units; 168,000 USP unitscapsule, delayed releaseAimmune Therapeutics, Inc.73562-0114-01Most often named Zenpep cap 40,000 units in the filings | 54,388.20 | at least 16 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Zenpep
| ||||||||||||||||||||||||||||||
| Zepzelcalurbinectedin0.5 mg/mLinjection, powder, lyophilized, for solutionJazz Pharmaceuticals, Inc.68727-0712-01Most often named Zepzelca 4 mg SDV in the filings | 619,963.01 | 75 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Zepzelca
| ||||||||||||||||||||||||||||||
| Zoladexgoserelin3.6 mgimplantTerSera Therapeutics LLC70720-0950-36Most often named Zoladex 3.6 mg PFS DS in the filings | 631,309.43 | 656 | ||||||||||||||||||||||||||||
3 filers: the filed rows for Zoladex
| ||||||||||||||||||||||||||||||
| Abilify Asimtufiiaripiprazole720 mg/2.4 mLinjection, suspension, extended releaseOtsuka America Pharmaceutical, Inc59148-0102-80Most often named Abilify Asmtfl PFS720 mg2.4 mL 1 in the filings | 23,531.93 | no count shown | ||||||||||||||||||||||||||||
2 filers: the filed rows for Abilify Asimtufii
| ||||||||||||||||||||||||||||||
| Abilify Asimtufiiaripiprazole960 mg/3.2 mLinjection, suspension, extended releaseOtsuka America Pharmaceutical, Inc59148-0114-80Most often named Abilify ASIM inj 960 mg in the filings | 100,150.76 | 23 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Abilify Asimtufii
| ||||||||||||||||||||||||||||||
| Abilify MaintenaaripiprazolekitOtsuka America Pharmaceutical, Inc.59148-0045-80Most often named Abilify Maintena 300 mg syringe in the filings | 42,941.99 | 37 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Abilify Maintena
| ||||||||||||||||||||||||||||||
| Abilify MaintenaaripiprazolekitOtsuka America Pharmaceutical, Inc.59148-0232-12Most often named Abilify Maintena 300 mg kit in the filings | 118,673.22 | 90 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Abilify Maintena
| ||||||||||||||||||||||||||||||
| Actemratocilizumab80 mg/4 mLinjection, solution, concentrateGenentech, Inc.50242-0135-01Most often named Actemra 80 mg SDV 4 mL in the filings | 212,184.10 | 559 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Actemra
| ||||||||||||||||||||||||||||||
| Actemratocilizumab200 mg/10 mLinjection, solution, concentrateGenentech, Inc.50242-0136-01Most often named Actemra 200 mg SDV 10 mL in the filings | 313,717.62 | 279 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Actemra
| ||||||||||||||||||||||||||||||
| Adcetrisbrentuximab vedotin50 mg/10.5 mLinjection, powder, lyophilized, for solutionSeagen Inc.51144-0050-01Most often named Adcetris 50 mg SDV in the filings | 779,461.28 | 179 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Adcetris
| ||||||||||||||||||||||||||||||
| Admeloginsulin lispro100 units/mLinjection, solutionSanofi-Aventis U.S. LLC00024-5925-05Most often named Admelog SoloStar 100 units/mL SOPN in the filings | 21,773.85 | at least 140 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Admelog
| ||||||||||||||||||||||||||||||
| Admeloginsulin lispro100 units/mLinjection, solutionSanofi-Aventis U.S. LLC00024-5926-05Most often named Admelog 100 units/mL SOLN in the filings | 16,321.73 | 7,321 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Admelog
| ||||||||||||||||||||||||||||||
| Aimovigerenumab-aooe140 mg/mLinjection, solutionAmgen, Inc55513-0843-01Most often named Aimovig inj 140 mg/mL in the filings | 20,297.56 | 155 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Aimovig
| ||||||||||||||||||||||||||||||
| Alecensaalectinib hydrochloride150 mgcapsuleGenentech, Inc.50242-0130-01Most often named Alecensa 150 mg cap 240 in the filings | 1,378,626.64 | 128 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Alecensa
| ||||||||||||||||||||||||||||||
| Alogliptin25 mgtablet, film coatedPadagis Israel Pharmaceuticals Ltd45802-0150-65Most often named Alogliptin tab 25 mg in the filings | 20,978.74 | 234 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Alogliptin
| ||||||||||||||||||||||||||||||
| Anoro Elliptaumeclidinium bromide and vilanterol trifenatate62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC00173-0869-10Most often named Anoro Ellipt aer 62.5-25 in the filings | 27,049.13 | 471 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Anoro Ellipta
| ||||||||||||||||||||||||||||||
| Aranespdarbepoetin alfa200 mcg/0.4 mLinjection, solutionAmgen, Inc55513-0028-01Most often named Aranesp 200 mcg PFS 0.4 mL in the filings | 215,734.40 | 459 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Aranesp
| ||||||||||||||||||||||||||||||
| Aranespdarbepoetin alfa500 mcg/mLinjection, solutionAmgen, Inc55513-0032-01Most often named Aranesp 500 mcg PFS 1 mL in the filings | 122,376.19 | 103 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Aranesp
| ||||||||||||||||||||||||||||||
| Aranespdarbepoetin alfa300 mcg/0.6 mLinjection, solutionAmgen, Inc55513-0111-01Most often named Aranesp 300 mcg PFS 0.6 mL in the filings | 126,977.34 | 207 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Aranesp
| ||||||||||||||||||||||||||||||
| Aristadaaripiprazole lauroxil441 mg/1.6 mLinjection, suspension, extended releaseAlkermes, Inc.65757-0401-03Most often named Aristada 441 mg SYG 1.6 mL in the filings | 65,732.01 | 54 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Aristada
| ||||||||||||||||||||||||||||||
| Aristadaaripiprazole lauroxil1,064 mg/3.9 mLinjection, suspension, extended releaseAlkermes, Inc.65757-0404-03Most often named Aristada 1,064 mg SYG 3.9 mL in the filings | 54,013.78 | at least 17 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Aristada
| ||||||||||||||||||||||||||||||
| Arnuity Elliptafluticasone furoate100 mcgpowderGlaxoSmithKline LLC00173-0874-10Most often named Arnuity ELPT inh 100 mcg in the filings | 15,486.05 | 313 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Arnuity Ellipta
| ||||||||||||||||||||||||||||||
| Austedodeutetrabenazine6 mgtablet, coatedTeva Neuroscience, Inc.68546-0170-60Most often named Austedo tab 6 mg in the filings | 45,233.12 | at least 33 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Austedo
| ||||||||||||||||||||||||||||||
| Austedodeutetrabenazine12 mgtablet, coatedTeva Neuroscience, Inc.68546-0172-60Most often named Austedo tab 12 mg in the filings | 296,422.93 | 56 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Austedo
| ||||||||||||||||||||||||||||||
| Auvelitydextromethorphan hydrobromide, bupropion hydrochloride45 mg; 105 mgtablet, multilayer, extended releaseAxsome Therapeutics, Inc.81968-0045-60Named Auvelity tab 45-105 mg in the filings | 21,079.06 | 33 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Auvelity
| ||||||||||||||||||||||||||||||
| Avsolainfliximab-axxq100 mg/10 mLinjection, powder, lyophilized, for solutionAmgen, Inc55513-0670-01Most often named Avsola 100 mg SDV in the filings | 408,031.33 | 701 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Avsola
| ||||||||||||||||||||||||||||||
| Bavencioavelumab20 mg/mLinjection, solution, concentrateEMD Serono, Inc.44087-3535-01Most often named Bavencio 200 mg VL 10 mL in the filings | 238,396.74 | 41 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Bavencio
| ||||||||||||||||||||||||||||||
| Belbucabuprenorphine hydrochloride900 mcgfilm, solubleBioDelivery Sciences International Inc59385-0027-60Most often named Belbuca buccal film in the filings | 25,709.20 | 82 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Belbuca
| ||||||||||||||||||||||||||||||
| Belrapzobendamustine hydrochloride100 mg/4 mLinjectionEagle Pharmaceuticals, Inc42367-0521-25Most often named Belrapzo inj 100 mg/4 mL in the filings | 72,827.18 | 77 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Belrapzo
| ||||||||||||||||||||||||||||||
| Bendekabendamustine hydrochloride25 mg/mLinjection, solutionTeva Pharmaceuticals USA, Inc.63459-0348-04Most often named Bendeka MDV 100 mg 4 mL in the filings | 72,647.62 | 83 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Bendeka
| ||||||||||||||||||||||||||||||
| Benlystabelimumab200 mg/mLsolutionGlaxoSmithKline LLC49401-0088-35Most often named Benlysta 200 mg inj 4 in the filings | 1,207,259.69 | 338 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Benlysta
| ||||||||||||||||||||||||||||||
| Benlystabelimumab120 mg/1.5 mLinjection, powder, lyophilized, for solutionGlaxoSmithKline LLC49401-0101-01Most often named Benlysta 120 mg SDV in the filings | 338,808.61 | 228 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Benlysta
| ||||||||||||||||||||||||||||||
| Benlystabelimumab400 mg/5 mLinjection, powder, lyophilized, for solutionGlaxoSmithKline LLC49401-0102-01Most often named Benlysta 400 mg SDV in the filings | 456,690.40 | at least 116 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Benlysta
| ||||||||||||||||||||||||||||||
| BESREMiropeginterferon alfa-2b500 mcg/mLinjectionPharmaEssentia USA73536-0500-01Most often named BESREMi 500 mcg PFS 1 mL in the filings | 207,300.99 | 47 | ||||||||||||||||||||||||||||
2 filers: the filed rows for BESREMi
| ||||||||||||||||||||||||||||||
| Bimzelxbimekizumab320 mg/2 mLinjection, solutionUCB, Inc.50474-0782-84Most often named Bimzelx inj 320 mg/2 in the filings | 689,381.95 | at least 64 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Bimzelx
| ||||||||||||||||||||||||||||||
| Bosulifbosutinib100 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc00069-0135-01Most often named Bosulif 100 mg tablet in the filings | 122,035.56 | 33 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Bosulif
| ||||||||||||||||||||||||||||||
| Bosulifbosutinib500 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc00069-0136-01Most often named Bosulif 500 mg tab 30 in the filings | 64,238.94 | at least 12 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Bosulif
| ||||||||||||||||||||||||||||||
| Braftoviencorafenib75 mgcapsuleArray BioPharma Inc.70255-0025-01Most often named MPB Braftovi 75 mg cap 90x2 in the filings | 187,547.16 | 25 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Braftovi
| ||||||||||||||||||||||||||||||
| Braftoviencorafenib75 mgcapsuleArray BioPharma Inc.70255-0025-03Most often named MPB Braftovi 75 mg cap 60x2 in the filings | 321,802.45 | 51 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Braftovi
| ||||||||||||||||||||||||||||||
| Brilintaticagrelor90 mgtabletAstraZeneca Pharmaceuticals LP00186-0777-60Most often named Brilinta 90 mg tab 60 in the filings | 64,387.47 | 265 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Brilinta
| ||||||||||||||||||||||||||||||
| Brixadibuprenorphine96 mg/0.27 mLinjectionBraeburn Inc.58284-0296-01Most often named Brixadi 96 mg ER PFS kit 0.27 mL in the filings | 81,430.83 | at least 61 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Brixadi
| ||||||||||||||||||||||||||||||
| Brukinsazanubrutinib80 mgcapsuleBeOne Medicines USA, Inc.72579-0011-02Most often named Brukinsa 80 mg cap 120 in the filings | 4,383,574.99 | 463 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Brukinsa
| ||||||||||||||||||||||||||||||
| Brukinsazanubrutinib160 mgtablet, film coatedBeOne Medicines USA, Inc.72579-0122-01Most often named Brukinsa 160 mg tab 60 in the filings | 1,026,867.66 | 99 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Brukinsa
| ||||||||||||||||||||||||||||||
| Buprenorphine20 mcg/hourpatchRhodes Pharmaceuticals LLC42858-0839-40Named Buprenorphine 20 mcg-hr pat 4 in the filings | 17,386.17 | 232 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Buprenorphine
| ||||||||||||||||||||||||||||||
| Cabometyxcabozantinib20 mgtabletExelixis, Inc.42388-0024-46Most often named Cabometyx 20 mg tab 30 in the filings | 801,365.96 | at least 71 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Cabometyx
| ||||||||||||||||||||||||||||||
| Cabometyxcabozantinib40 mgtabletExelixis, Inc.42388-0025-46Most often named Cabometyx 40 mg tab 30 in the filings | 1,426,079.91 | at least 153 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Cabometyx
| ||||||||||||||||||||||||||||||
| Caplytalumateperone10.5 mgcapsuleIntra-Cellular Therapies, Inc72060-0110-40Most often named Caplyta cap 10.5 mg in the filings | 15,944.65 | 16 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Caplyta
| ||||||||||||||||||||||||||||||
| Cathflo Activasealteplase2.2 mg/2 mLinjection, powder, lyophilized, for solutionGenentech, Inc.50242-0041-64Most often named Activase Cathflo 2 mg SDV in the filings | 55,180.32 | 922 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Cathflo Activase
| ||||||||||||||||||||||||||||||
| Cefazolin330 mg/mLinjection, powder, for solutionHikma Pharmaceuticals USA Inc.00143-9924-90Most often named Cefazolin 1 g VL 25 in the filings | 23,701.85 | 17,251 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Cefazolin
| ||||||||||||||||||||||||||||||
| Cetirizine Hydrochloride1 mg/mLsolutionPAI Holdings, LLC dba PAI Pharma00121-0874-16Most often named Cetirizine sol 1 mg/mL in the filings | 16,081.58 | 1,070 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Cetirizine Hydrochloride
| ||||||||||||||||||||||||||||||
| Cimziacertolizumab pegol200 mg/mLinjection, solutionUCB, Inc.50474-0710-79Most often named Cimzia 2x200 mg/mL PFS kit in the filings | 50,591.38 | 363 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Cimzia
| ||||||||||||||||||||||||||||||
| Cinvantiaprepitant130 mg/18 mLinjection, emulsionHeron Therapeutics, Inc.47426-0201-01Most often named Cinvanti inj SDV 130 mg/18 mL 1 in the filings | 84,984.07 | 614 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Cinvanti
| ||||||||||||||||||||||||||||||
| Collagenase Santyl250 units/gointmentSmith & Nephew, Inc50484-0010-90Most often named Santyl 250 units/g ointment 90 g in the filings | 49,737.08 | no count shown | ||||||||||||||||||||||||||||
2 filers: the filed rows for Collagenase Santyl
| ||||||||||||||||||||||||||||||
| Compleraemtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate200 mg; 25 mg; 300 mgtablet, film coatedGilead Sciences, Inc.61958-1101-01Most often named Complera tab in the filings | 42,920.19 | at least 25 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Complera
| ||||||||||||||||||||||||||||||
| Copaxoneglatiramer acetate40 mg/mLinjection, solutionTeva Neuroscience, Inc.68546-0325-12Most often named Copaxone inj 40 mg/mL in the filings | 16,201.88 | at least 8 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Copaxone
| ||||||||||||||||||||||||||||||
| Cresembaisavuconazonium sulfate100 mgcapsuleAstellas Pharma US, Inc.00469-0520-02Most often named Cresemba 186 mg cap 14 in the filings | 99,614.83 | 42 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Cresemba
| ||||||||||||||||||||||||||||||
| Cyclophosphamide1 g/50 mLinjection, powder, for solutionBaxter Healthcare Company10019-0956-01Most often named Cyclophosphamide 1 g SDV in the filings | 87,361.03 | 1,072 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Cyclophosphamide
| ||||||||||||||||||||||||||||||
| Cyramzaramucirumab10 mg/mLsolutionEli Lilly and Company00002-7678-01Most often named Cyramza 500 mg/50 mL SOLN in the filings | 97,359.58 | at least 11 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Cyramza
| ||||||||||||||||||||||||||||||
| Darzalex IVdaratumumab100 mg/5 mLinjection, solution, concentrateJanssen Biotech, Inc.57894-0505-20Most often named MPB Darzalex 400 mg/20 mL SDV in the filings | 138,548.20 | 32 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Darzalex IV
| ||||||||||||||||||||||||||||||
| Dasatinib100 mgtablet, film coatedApotex Corp.60505-3631-03Most often named Dasatinib 100 mg tab 30 in the filings | 77,333.54 | 65 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Dasatinib
| ||||||||||||||||||||||||||||||
| Delstrigodoravirine, lamivudine, and tenofovir disoproxil fumarate100 mg; 300 mg; 300 mgtablet, film coatedMerck Sharp & Dohme LLC00006-5007-01Most often named Delstrigo tab in the filings | 47,439.05 | 24 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Delstrigo
| ||||||||||||||||||||||||||||||
| Diazepam5 mg/mLinjection, solutionHospira, Inc.00409-1273-32Most often named diazePAM 5 mg/mL SOLN in the filings | 34,432.22 | 4,737 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Diazepam
| ||||||||||||||||||||||||||||||
| Dificidfidaxomicin200 mgtablet, film coatedMerck Sharp & Dohme LLC52015-0080-01Most often named Dificid 200 mg TABS in the filings | 34,646.25 | 58 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Dificid
| ||||||||||||||||||||||||||||||
| Dopteletavatrombopag maleate20 mgtablet, film coatedAkaRx, Inc.71369-0020-15Most often named Doptelet 20 mg tab 15 in the filings | 178,834.48 | 48 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Doptelet
| ||||||||||||||||||||||||||||||
| Doxorubicin Hydrochloride2 mg/mLinjectable, liposomalZydus Pharmaceuticals USA Inc.70710-1530-01Most often named Doxorubicin HCl Liposome 20 mg SDV 10 mL in the filings | 14,045.88 | 46 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Doxorubicin Hydrochloride
| ||||||||||||||||||||||||||||||
| Dupixentdupilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC00024-5918-01Most often named Dupixent 200 mg PFS 2x1.14 mL in the filings | 577,310.38 | 213 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Dupixent
| ||||||||||||||||||||||||||||||
| Elaheremirvetuximab soravtansine5 mg/mLinjection, solutionImmunoGen, Inc.72903-0853-01Most often named Elahere 100 mg SDV 20 mL in the filings | 2,444,685.35 | 219 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Elahere
| ||||||||||||||||||||||||||||||
| ElitekrasburicasekitSanofi-Aventis U.S. LLC00024-5150-10Most often named Elitek 1.5 mg SOLR in the filings | 16,535.85 | at least 6 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Elitek
| ||||||||||||||||||||||||||||||
| Emerphedephedrine sulfate5 mg/mLinjectionNexus Pharamaceuticals Inc.14789-0250-10Named Emerphed 5 mg/mL SOLN in the filings | 10,704.79 | 1,741 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Emerphed
| ||||||||||||||||||||||||||||||
| Emplicitielotuzumab300 mginjection, powder, lyophilized, for solutionE.R. Squibb & Sons, L.L.C.00003-2291-11Most often named Empliciti 300 mg SDV LYO in the filings | 380,860.85 | 88 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Empliciti
| ||||||||||||||||||||||||||||||
| Enbreletanercept50 mg/mLsolutionImmunex Corporation58406-0044-04Most often named Enbrel Mini 50 mg/mL CRT 4 in the filings | 44,852.84 | 471 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Enbrel
| ||||||||||||||||||||||||||||||
| Entyviovedolizumab300 mg/5 mLinjection, powder, lyophilized, for solutionTakeda Pharmaceuticals America, Inc.64764-0300-20Most often named Entyvio 300 mg SDV in the filings | 5,973,889.63 | 1,108 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Entyvio
| ||||||||||||||||||||||||||||||
| Entyvio Penvedolizumab108 mg/0.68 mLinjection, solutionTakeda Pharmaceuticals America, Inc.64764-0108-21Most often named Entyvio 108 mg PFP 0.68 mL in the filings | 423,037.92 | 113 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Entyvio Pen
| ||||||||||||||||||||||||||||||
| Envarsus XRtacrolimus4 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc68992-3040-03Most often named Envarsus XR tab 4 mg in the filings | 27,252.69 | 35 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Envarsus XR
| ||||||||||||||||||||||||||||||
| Epinephrine0.3 mg/0.3 mLinjectionTeva Pharmaceuticals USA, Inc.00093-5986-27Most often named Epinephrine inj 0.3 mg in the filings | 31,846.44 | 258 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Epinephrine
| ||||||||||||||||||||||||||||||
| Epinephrine0.3 mg/0.3 mLinjectionAmneal Pharmaceuticals of New York LLC00115-1694-49Most often named Epinephrine inj 0.3 mg in the filings | 58,288.91 | 632 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Epinephrine
| ||||||||||||||||||||||||||||||
| Epinephrine0.1 mg/mLinjectionInternational Medication Systems, Limited76329-3318-01Most often named EPINEPHrine 1 mg/10 mL SOSY in the filings | 13,297.81 | 1,019 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Epinephrine
| ||||||||||||||||||||||||||||||
| Erleadaapalutamide240 mgtablet, film coatedJanssen Products, LP59676-0604-30Most often named Erleada in the filings | 109,796.68 | at least 11 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Erleada
| ||||||||||||||||||||||||||||||
| Ferahemeferumoxytol510 mg/17 mLinjectionAMAG Pharmaceuticals, Inc59338-0775-01Most often named Feraheme vial 510 mg 17 mL 1 in the filings | 97,007.21 | 203 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Feraheme
| ||||||||||||||||||||||||||||||
| Fluticasone Furoate and Vilanterol100 mcg; 25 mcgpowderPrasco Laboratories66993-0135-97Most often named Flutic/Vilan inh 100-25 in the filings | 15,646.71 | 105 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Fluticasone Furoate and Vilanterol
| ||||||||||||||||||||||||||||||
| Fluticasone Furoate and Vilanterol200 mcg; 25 mcgpowderPrasco Laboratories66993-0136-97Most often named Flutic/Vilan inh 200-25 in the filings | 14,198.41 | 87 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Fluticasone Furoate and Vilanterol
| ||||||||||||||||||||||||||||||
| Fluticasone Propionate HFA220 mcgaerosol, meteredPrasco Laboratories66993-0080-96Most often named Fluticas HFA aer 220 mcg in the filings | 26,726.12 | 165 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Fluticasone Propionate HFA
| ||||||||||||||||||||||||||||||
| Gammagard Liquidimmune globulin infusion (human)100 mg/mLinjection, solutionTakeda Pharmaceuticals America, Inc.00944-2700-05Most often named Gammagard 10% 10 g VL 100 mL DS in the filings | 148,092.45 | 214 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Gammagard Liquid
| ||||||||||||||||||||||||||||||
| Gamunex-Cimmune globulin (human)10 g/100 mLinjectionGrifols USA, LLC13533-0800-20Most often named Gamunex-C 5 g VL 50 mL in the filings | 121,163.63 | 311 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Gamunex-C
| ||||||||||||||||||||||||||||||
| Gamunex-Cimmune globulin (human)10 g/100 mLinjectionGrifols USA, LLC13533-0800-40Most often named MPB Gamunex-C 40 g/400 mL in the filings | 233,153.58 | 86 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Gamunex-C
| ||||||||||||||||||||||||||||||
| Gilenyafingolimod hcl0.5 mgcapsuleNovartis Pharmaceuticals Corporation00078-0607-15Most often named Gilenya cap 0.5 mg in the filings | 29,701.88 | no count shown | ||||||||||||||||||||||||||||
2 filers: the filed rows for Gilenya
| ||||||||||||||||||||||||||||||
| Glatiramer Acetateglatiramer40 mg/mLinjection, solutionMylan Pharmaceuticals Inc.00378-6961-12Most often named glatiramer 40 mg/mL Syrg in the filings | 20,792.63 | 27 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Glatiramer Acetate
| ||||||||||||||||||||||||||||||
| Gonal-f RFF Redi-jectfollitropin900 IU/1.5 mLinjection, solutionEMD Serono, Inc.44087-1117-01Most often named Gonal-F Redi-ject 900 IU PFP in the filings | 31,826.17 | 63 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Gonal-f RFF Redi-ject
| ||||||||||||||||||||||||||||||
| Hadlimaadalimumab-bwwd40 mg/0.4 mLsolutionOrganon LLC78206-0186-01Most often named Hadlima inj 40/0.4 mL in the filings | 40,013.59 | 61 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Hadlima
| ||||||||||||||||||||||||||||||
| Halaveneribulin mesylate0.5 mg/mLinjectionEisai Inc.62856-0389-01Most often named Halaven 1 mg SDV 2 mL in the filings | 192,315.35 | 192 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Halaven
| ||||||||||||||||||||||||||||||
| Harvoniledipasvir and sofosbuvir90 mg; 400 mgtablet, film coatedGilead Sciences, Inc61958-1801-01Named Harvoni 90 mg/400 mg tab 28 in the filings | 13,024.00 | no count shown | ||||||||||||||||||||||||||||
2 filers: the filed rows for Harvoni
| ||||||||||||||||||||||||||||||
| Herceptintrastuzumab150 mg/7.4 mLinjection, powder, lyophilized, for solutionGenentech, Inc.50242-0132-01Most often named Herceptin 150 mg SDV in the filings | 170,643.24 | 56 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Herceptin
| ||||||||||||||||||||||||||||||
| Herceptin Hylectatrastuzumab and hyaluronidase-oysk600 mg/5 mL; 10,000 units/5 mLinjection, solutionGenentech, Inc.50242-0077-01Most often named Herceptin Hylecta 600 mg SDV in the filings | 153,215.26 | at least 119 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Herceptin Hylecta
| ||||||||||||||||||||||||||||||
| HumiraadalimumabkitAbbVie Inc.00074-0243-02Most often named Humira inj 40/0.4 mL in the filings | 235,878.67 | 124 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Humira
| ||||||||||||||||||||||||||||||
| HyperRABrabies immune globulin (human)300 IU/mLinjection, solutionGrifols USA, LLC13533-0318-01Most often named HyperRAB 300 IU VL 1 mL in the filings | 287,676.74 | 156 | ||||||||||||||||||||||||||||
2 filers: the filed rows for HyperRAB
| ||||||||||||||||||||||||||||||
| Ibrancepalbociclib100 mgcapsulePfizer Laboratories Div Pfizer Inc00069-0188-21Most often named Ibrance 100 mg cap 21 in the filings | 146,540.88 | at least 13 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Ibrance
| ||||||||||||||||||||||||||||||
| Idhifaenasidenib mesylate100 mgtablet, film coatedCelgene Corporation59572-0710-30Most often named Idhifa 100 mg tab 30 in the filings | 370,060.35 | at least 15 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Idhifa
| ||||||||||||||||||||||||||||||
| Imbruvicaibrutinib140 mgcapsulePharmacyclics LLC57962-0140-09Most often named Imbruvica 140 mg cap 90 in the filings | 452,693.62 | 50 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Imbruvica
| ||||||||||||||||||||||||||||||
| Imbruvicaibrutinib420 mgtablet, film coatedPharmacyclics LLC57962-0420-28Most often named Imbruvica 420 mg tab 28 in the filings | 1,595,362.36 | 164 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Imbruvica
| ||||||||||||||||||||||||||||||
| INFeDiron dextran50 mg/mLinjectionAllergan, Inc.00023-6082-10Most often named INFeD 100 mg SDV 10x2 mL in the filings | 823,943.23 | 2,713 | ||||||||||||||||||||||||||||
2 filers: the filed rows for INFeD
| ||||||||||||||||||||||||||||||
| Inflectrainfliximab-dyyb100 mg/10 mLinjection, powder, lyophilized, for solutionPfizer Laboratories Div Pfizer Inc00069-0809-01Most often named Inflectra 100 mg VL in the filings | 3,351,110.71 | 4,819 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Inflectra
| ||||||||||||||||||||||||||||||
| Injectaferferric carboxymaltose injection50 mg/mLinjection, solutionAmerican Regent, Inc.00517-0650-01Most often named Injectafer 750 mg/15 mL SOLN in the filings | 480,674.06 | 816 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Injectafer
| ||||||||||||||||||||||||||||||
| Inlytaaxitinib5 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc00069-0151-11Most often named Inlyta tab 5 mg in the filings | 204,787.45 | 27 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Inlyta
| ||||||||||||||||||||||||||||||
| Inqovicedazuridine and decitabine100 mg; 35 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd.64842-0727-09Most often named Inqovi 35 mg/100 mg tab 5 in the filings | 248,985.22 | 37 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Inqovi
| ||||||||||||||||||||||||||||||
| Invega Trinzapaliperidone palmitate410 mg/1.32 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc50458-0607-01Most often named Invega Trinza 410 mg SYG 1.32 mL in the filings | 92,148.07 | at least 34 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Invega Trinza
| ||||||||||||||||||||||||||||||
| Invega Trinzapaliperidone palmitate819 mg/2.63 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc50458-0609-01Most often named Invega Trinza 819 mg SYG 2.63 mL in the filings | 1,381,984.94 | 268 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Invega Trinza
| ||||||||||||||||||||||||||||||
| Jakafiruxolitinib5 mgtabletIncyte Corporation50881-0005-60Most often named Jakafi 5 mg tab 60 in the filings | 280,631.71 | at least 41 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Jakafi
| ||||||||||||||||||||||||||||||
| Jakafiruxolitinib10 mgtabletIncyte Corporation50881-0010-60Most often named Jakafi 10 mg tab 60 in the filings | 325,004.43 | 65 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Jakafi
| ||||||||||||||||||||||||||||||
| Jakafiruxolitinib15 mgtabletIncyte Corporation50881-0015-60Most often named Jakafi 15 mg tab 60 in the filings | 209,393.39 | 35 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Jakafi
| ||||||||||||||||||||||||||||||
| Jakafiruxolitinib20 mgtabletIncyte Corporation50881-0020-60Most often named Jakafi 20 mg tab 60 in the filings | 185,941.58 | 32 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Jakafi
| ||||||||||||||||||||||||||||||
| Jakafiruxolitinib25 mgtabletIncyte Corporation50881-0025-60Most often named Jakafi 25 mg tab 60 in the filings | 87,519.56 | at least 9 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Jakafi
| ||||||||||||||||||||||||||||||
| Januviasitagliptin100 mgtablet, film coatedMerck Sharp & Dohme LLC00006-0277-31Named Januvia 100 mg Tablets in the filings | 20,545.52 | 243 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Januvia
| ||||||||||||||||||||||||||||||
| Jaypircapirtobrutinib100 mgtablet, coatedEli Lilly and Company00002-7026-60Most often named Jaypirca 100 mg tab 60 in the filings | 552,593.88 | 44 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Jaypirca
| ||||||||||||||||||||||||||||||
| Jemperlidostarlimab50 mg/mLinjectionGlaxoSmithKline LLC00173-0898-03Most often named Jemperli 500 mg SDV 10 mL in the filings | 3,975,229.73 | 303 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Jemperli
| ||||||||||||||||||||||||||||||
| Kanjintitrastuzumab-anns150 mg/7.15 mLinjection, powder, lyophilized, for solutionAmgen, Inc55513-0141-01Named Kanjinti 150 mg SOLR in the filings | 300,318.91 | 1,362 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Kanjinti
| ||||||||||||||||||||||||||||||
| Kcentraprothrombin, coagulation factor VII human, coagulation factor IX human, coagulation factor X human, protein C, protein S human, and waterkitCSL Behring GmbH63833-0386-02Most often named Kcentra 511 IU SDV in the filings | 271,386.33 | 298 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Kcentra
| ||||||||||||||||||||||||||||||
| Kerendiafinerenone10 mgtablet, film coatedBayer HealthCare Pharmaceuticals Inc.50419-0540-01Most often named Kerendia tab 10 mg in the filings | 21,811.03 | 50 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Kerendia
| ||||||||||||||||||||||||||||||
| Kesimptaofatumumab20 mg/0.4 mLinjection, solutionNovartis Pharmaceuticals Corporation00078-1007-68Most often named Kesimpta 20 mg PFP 0.4 mL in the filings | 2,317,419.03 | 341 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Kesimpta
| ||||||||||||||||||||||||||||||
| Kevzarasarilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC00024-5910-01Most often named Kevzara 200 mg PFS 2x1.14 mL in the filings | 54,407.68 | at least 17 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Kevzara
| ||||||||||||||||||||||||||||||
| Kevzarasarilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC00024-5922-01Most often named Kevzara 200 mg PFP 2x1.14 mL in the filings | 898,081.38 | 417 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Kevzara
| ||||||||||||||||||||||||||||||
| Krazatiadagrasib200 mgtablet, coatedMirati Therapeutics, Inc80739-0812-18Most often named Krazati 200 mg tab 180 in the filings | 744,576.01 | at least 63 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Krazati
| ||||||||||||||||||||||||||||||
| Kyleenalevonorgestrel19.5 mgintrauterine deviceBayer HealthCare Pharmaceuticals Inc.50419-0424-01Most often named Kyleena 19.5 mg IUD in the filings | 36,212.04 | 57 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Kyleena
| ||||||||||||||||||||||||||||||
| Kyproliscarfilzomib30 mg/15 mLinjection, powder, lyophilized, for solutionOnyx Pharmaceuticals, Inc.76075-0102-01Most often named Kyprolis 30 mg SOLR in the filings | 48,888.23 | 53 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Kyprolis
| ||||||||||||||||||||||||||||||
| Kyproliscarfilzomib10 mg/5 mLinjection, powder, lyophilized, for solutionOnyx Pharmaceuticals, Inc.76075-0103-01Most often named Kyprolis 10 mg SOLR in the filings | 25,418.74 | 73 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Kyprolis
| ||||||||||||||||||||||||||||||
| Lazcluzelazertinib80 mgtablet, film coatedJanssen Biotech, Inc.57894-0080-60Most often named Lazcluze 80 mg tab 60 in the filings | 137,124.69 | at least 8 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Lazcluze
| ||||||||||||||||||||||||||||||
| Lazcluzelazertinib240 mgtablet, film coatedJanssen Biotech, Inc.57894-0240-30Most often named Lazcluze 240 mg tab 30 in the filings | 305,616.81 | at least 17 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Lazcluze
| ||||||||||||||||||||||||||||||
| Lenvimalenvatinib4 mgcapsuleEisai Inc.62856-0704-30Most often named Lenvima 4 mg cap 30 in the filings | 167,031.93 | at least 12 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Lenvima
| ||||||||||||||||||||||||||||||
| LenvimalenvatinibkitEisai Inc.62856-0714-30Most often named Lenvima 14 mg cap 60 in the filings | 619,447.37 | 60 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Lenvima
| ||||||||||||||||||||||||||||||
| LenvimalenvatinibkitEisai Inc.62856-0718-30Most often named Lenvima 18 mg cap 90 in the filings | 131,438.59 | 11 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Lenvima
| ||||||||||||||||||||||||||||||
| Leqvioinclisiran284 mg/1.5 mLinjection, solutionNovartis Pharmaceuticals Corporation00078-1000-60Most often named Leqvio 284 mg PFS 1.5 mL in the filings | 101,312.98 | 35 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Leqvio
| ||||||||||||||||||||||||||||||
| Leukinesargramostim250 mcg/mLinjection, powder, lyophilized, for solutionPartner Therapeutics, Inc.71837-5843-05Most often named Leukine 250 mcg SDV 5 in the filings | 55,722.29 | 48 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Leukine
| ||||||||||||||||||||||||||||||
| Libtayocemiplimab-rwlc50 mg/mLinjectionRegeneron Pharmaceuticals, Inc.61755-0008-01Most often named Libtayo 350 mg SDV 7 mL in the filings | 919,789.29 | 96 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Libtayo
| ||||||||||||||||||||||||||||||
| Lilettalevonorgestrel52 mgintrauterine deviceAllergan, Inc.00023-5858-01Most often named Liletta (52 mg) 20.1 mcg/DAY IUD in the filings | 41,067.59 | 446 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Liletta
| ||||||||||||||||||||||||||||||
| Liraglutide6 mg/mLinjectionTeva Pharmaceuticals USA, Inc.00480-3667-22Most often named Liraglutide inj 18 mg/3 mL in the filings | 11,492.67 | 43 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Liraglutide
| ||||||||||||||||||||||||||||||
| Litfuloritlecitinib50 mgcapsulePfizer Laboratories Div Pfizer Inc00069-0334-28Most often named Litfulo 50 mg cap 28 in the filings | 96,745.89 | 39 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Litfulo
| ||||||||||||||||||||||||||||||
| Lokelmasodium zirconium cyclosilicate10 g/10 gpowder, for suspensionAstraZeneca Pharmaceuticals LP00310-1110-30Most often named Lokelma 10 g PKT 30 in the filings | 23,989.05 | 537 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Lokelma
| ||||||||||||||||||||||||||||||
| Lonsurftrifluridine and tipiracil20 mg; 8.19 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd.64842-1020-03Most often named Lonsurf in the filings | 243,881.95 | at least 19 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Lonsurf
| ||||||||||||||||||||||||||||||
| Medroxyprogesterone Acetate150 mg/mLinjection, suspensionPrasco Laboratories66993-0370-25Most often named Depo Provera 150 mg in the filings | 176,817.89 | 1,647 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Medroxyprogesterone Acetate
| ||||||||||||||||||||||||||||||
| Mektovibinimetinib15 mgtablet, film coatedArray BioPharma Inc.70255-0010-02Most often named Mektovi 15 mg tab 180 in the filings | 162,476.09 | 14 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Mektovi
| ||||||||||||||||||||||||||||||
| Monjuvitafasitamab-cxix200 mg/5 mLinjection, powder, lyophilized, for solutionIncyte Corporation50881-0013-03Most often named Monjuvi 200 mg SDV in the filings | 561,498.15 | 170 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Monjuvi
| ||||||||||||||||||||||||||||||
| Motegrityprucalopride2 mgtablet, film coatedTakeda Pharmaceuticals America, Inc.54092-0547-01Most often named Motegrity 2 mg tab 30 in the filings | 19,060.46 | 43 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Motegrity
| ||||||||||||||||||||||||||||||
| Novologinsulin aspart100 IU/mLinjection, solutionNovo Nordisk00169-7501-11Most often named NovoLOG 100 units/mL SOLN in the filings | 22,629.08 | 211 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Novolog
| ||||||||||||||||||||||||||||||
| Nplateromiplostim500 mcg/mLinjection, powder, lyophilized, for solutionAmgen, Inc55513-0222-01Most often named Nplate 500 mcg SOLR in the filings | 178,734.35 | 178 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Nplate
| ||||||||||||||||||||||||||||||
| Ofevnintedanib100 mgcapsuleBoehringer Ingelheim Pharmaceuticals, Inc.00597-0143-60Most often named Ofev 100 mg capsule in the filings | 685,406.25 | 79 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Ofev
| ||||||||||||||||||||||||||||||
| Ojjaaramomelotinib200 mgtabletGlaxoSmithKline LLC81864-0101-30Most often named Ojjaara 200 mg tab 30 in the filings | 313,756.63 | at least 12 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Ojjaara
| ||||||||||||||||||||||||||||||
| Olumiantbaricitinib2 mgtablet, film coatedEli Lilly and Company00002-4182-30Most often named Olumiant tab 2 mg 30 in the filings | 256,442.28 | 88 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Olumiant
| ||||||||||||||||||||||||||||||
| Omvohmirikizumab-mrkz20 mg/mLinjection, solutionEli Lilly and Company00002-7575-01Most often named Omvoh 300 mg SDV 15 mL in the filings | 112,227.52 | no count shown | ||||||||||||||||||||||||||||
2 filers: the filed rows for Omvoh
| ||||||||||||||||||||||||||||||
| Opdivonivolumab10 mg/mLinjectionE.R. Squibb & Sons, L.L.C.00003-3774-12Most often named Opdivo 100 mg/10 mL SOLN in the filings | 90,778.73 | at least 40 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Opdivo
| ||||||||||||||||||||||||||||||
| Opdualagnivolumab and relatlimab-rmbw12 mg/mL; 4 mg/mLinjectionE.R. Squibb & Sons, L.L.C.00003-7125-11Most often named Opdualag 240-80 mg/20 mL SOLN in the filings | 3,245,106.48 | 118 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Opdualag
| ||||||||||||||||||||||||||||||
| Orenciaabatacept250 mg/15 mLinjection, powder, lyophilized, for solutionE.R. Squibb & Sons, L.L.C.00003-2187-13Most often named Orencia 250 mg VL in the filings | 1,426,464.92 | 853 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Orencia
| ||||||||||||||||||||||||||||||
| Orenciaabatacept125 mg/mLinjection, solutionE.R. Squibb & Sons, L.L.C.00003-2188-11Most often named Orencia 125 mg/mL PFS 4x1 mL in the filings | 25,860.15 | at least 71 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Orencia
| ||||||||||||||||||||||||||||||
| Orenciaabatacept125 mg/mLinjection, solutionE.R. Squibb & Sons, L.L.C.00003-2188-51Most often named Orencia Clickject 125 mg/mL in the filings | 147,117.97 | 454 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Orencia
| ||||||||||||||||||||||||||||||
| Orgovyxrelugolix120 mgtablet, film coatedSumitomo Pharma America, Inc.72974-0120-01Most often named Orgovyx 120 mg tab 30 in the filings | 1,090,843.32 | 560 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Orgovyx
| ||||||||||||||||||||||||||||||
| Paclitaxel Protein Bound Particles Albumin Boundpaclitaxel100 mg/20 mLinjection, powder, lyophilized, for suspensionAmerican Regent, Inc.00517-4300-01Most often named Paclitaxel Protein-Bound 100 mg SDV in the filings | 887,288.52 | 873 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Paclitaxel Protein Bound Particles Albumin Bound
| ||||||||||||||||||||||||||||||
| Padcev EJFVenfortumab vedotin30 mg/3 mLinjection, powder, lyophilized, for solutionSeagen Inc.51144-0030-01Most often named Padcev 30 mg SDV in the filings | 67,275.54 | at least 11 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Padcev EJFV
| ||||||||||||||||||||||||||||||
| Pemgardapemivibart125 mg/mLinjectionInvivyd, Inc81960-0031-03Most often named MPB Pemgarda 500 mg/4 mL 9 DS in the filings | 105,650.00 | at least 13 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Pemgarda
| ||||||||||||||||||||||||||||||
| Plaquenilhydroxychloroquine sulfate200 mgtabletAdvanz Pharma (US) Corp.59212-0562-10Most often named Plaquenil tab 200 mg in the filings | 17,425.58 | at least 17 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Plaquenil
| ||||||||||||||||||||||||||||||
| Polivypolatuzumab vedotin30 mg/1.88 mLinjection, powder, lyophilized, for solutionGenentech, Inc.50242-0103-01Most often named Polivy 30 mg SDV in the filings | 1,129,175.64 | 231 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Polivy
| ||||||||||||||||||||||||||||||
| Pomalystpomalidomide2 mgcapsuleCelgene Corporation59572-0502-21Most often named Pomalyst 2 mg capsule in the filings | 204,458.58 | at least 10 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Pomalyst
| ||||||||||||||||||||||||||||||
| Pomalystpomalidomide3 mgcapsuleCelgene Corporation59572-0503-21Most often named Pomalyst 3 mg capsule in the filings | 284,319.12 | 27 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Pomalyst
| ||||||||||||||||||||||||||||||
| Praluentalirocumab150 mg/mLinjection, solutionRegeneron Pharmaceuticals, Inc.61755-0021-02Most often named Praluent 150 mg/mL PFP 2 in the filings | 20,120.36 | 80 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Praluent
| ||||||||||||||||||||||||||||||
| Prevymisletermovir480 mgtablet, film coatedMerck Sharp & Dohme LLC00006-3076-02Most often named Prevymis tab 480 mg in the filings | 31,464.13 | no count shown | ||||||||||||||||||||||||||||
2 filers: the filed rows for Prevymis
| ||||||||||||||||||||||||||||||
| Promactaeltrombopag olamine50 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0686-15Most often named Promacta 50 mg tab 30 in the filings | 125,742.88 | 41 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Promacta
| ||||||||||||||||||||||||||||||
| Promactaeltrombopag olamine75 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0687-15Most often named Promacta 75 mg tab 30 in the filings | 113,108.52 | at least 30 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Promacta
| ||||||||||||||||||||||||||||||
| RabAvertrabies vaccinekitBavarian Nordic A/S50632-0010-01Most often named RabAvert SUSR in the filings | 50,914.77 | 163 | ||||||||||||||||||||||||||||
2 filers: the filed rows for RabAvert
| ||||||||||||||||||||||||||||||
| Radicava ORSedaravonekitShionogi Inc.70510-2322-01Most often named Radicava ORS sus 105/5 mL in the filings | 135,318.24 | at least 12 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Radicava ORS
| ||||||||||||||||||||||||||||||
| Remicadeinfliximab100 mg/10 mLinjection, powder, lyophilized, for solutionJanssen Biotech, Inc.57894-0030-01Most often named Remicade 100 mg SDV in the filings | 310,222.48 | 348 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Remicade
| ||||||||||||||||||||||||||||||
| Renflexisinfliximab100 mginjection, powder, lyophilized, for solutionOrganon LLC78206-0162-01Most often named Renflexis 100 mg SDV in the filings | 23,684.99 | 22 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Renflexis
| ||||||||||||||||||||||||||||||
| Repathaevolocumab140 mg/mLinjection, solutionAmgen USA Inc.72511-0393-02Most often named Repatha LF inj 140 mg 1 mL 2 in the filings | 437,779.22 | 1,622 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Repatha
| ||||||||||||||||||||||||||||||
| Repathaevolocumab140 mg/mLinjection, solutionAmgen USA Inc.72511-0760-02Most often named Repatha 140 mg/mL auto inj 2PK in the filings | 634,735.21 | 1,118 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Repatha
| ||||||||||||||||||||||||||||||
| Retacritepoetin alfa-epbx10,000 IU/mLinjection, solutionPfizer Laboratories Div Pfizer Inc00069-1308-10Most often named Retacrit 10,000 units/mL SOLN in the filings | 12,494.27 | 325 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Retacrit
| ||||||||||||||||||||||||||||||
| Revlimidlenalidomide5 mgcapsuleCelgene Corporation59572-0405-28Most often named Revlimid 5 mg capsule in the filings | 56,809.42 | 20 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Revlimid
| ||||||||||||||||||||||||||||||
| Revlimidlenalidomide10 mgcapsuleCelgene Corporation59572-0410-28Most often named Revlimid 10 mg capsule in the filings | 93,056.34 | 38 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Revlimid
| ||||||||||||||||||||||||||||||
| Risperdal ConstarisperidonekitJanssen Pharmaceuticals, Inc.50458-0306-11Most often named RisperDAL Consta 25 mg SRER 1x1 EA in the filings | 16,493.28 | 51 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Risperdal Consta
| ||||||||||||||||||||||||||||||
| Risperdal ConstarisperidonekitJanssen Pharmaceuticals, Inc.50458-0308-11Most often named Risperdal Con 50 mg ER SYG 2 mL kit in the filings | 17,913.68 | 41 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Risperdal Consta
| ||||||||||||||||||||||||||||||
| RisperidonekitTeva Pharmaceuticals, Inc.00480-1453-08Most often named Risperidone 50 mg ER inj sus kit in the filings | 113,184.89 | 149 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Risperidone
| ||||||||||||||||||||||||||||||
| Rubracarucaparib300 mgtablet, film coatedpharmaand GmbH82154-0785-01Most often named Rubraca 300 mg tab 60 in the filings | 63,437.70 | no count shown | ||||||||||||||||||||||||||||
2 filers: the filed rows for Rubraca
| ||||||||||||||||||||||||||||||
| Rybrevantamivantamab-vmjw350 mginjectionJanssen Biotech, Inc.57894-0501-01Most often named Rybrevant 350 mg SDV 7 mL in the filings | 1,983,996.69 | 176 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Rybrevant
| ||||||||||||||||||||||||||||||
| Saphneloanifrolumab-fnia300 mg/2 mLinjection, solutionAstraZeneca Pharmaceuticals LP00310-3040-00Most often named Saphnelo 300 mg SDV 2 mL in the filings | 568,037.07 | 132 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Saphnelo
| ||||||||||||||||||||||||||||||
| Sarclisaisatuximab100 mg/5 mLinjection, solution, concentrateSanofi-Aventis U.S. LLC00024-0654-01Most often named Sarclisa 100 mg SDV 5 mL in the filings | 226,187.83 | 278 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Sarclisa
| ||||||||||||||||||||||||||||||
| Saxendaliraglutide6 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP00169-2800-15Most often named Saxenda inj 18 mg/3 mL in the filings | 18,287.03 | 36 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Saxenda
| ||||||||||||||||||||||||||||||
| Scemblixasciminib40 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-1098-20Most often named Scemblix 40 mg tab 60 in the filings | 846,120.70 | 64 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Scemblix
| ||||||||||||||||||||||||||||||
| Shingrixzoster vaccine recombinant, adjuvantedkitGlaxoSmithKline Biologicals SA58160-0823-11Most often named Shingrix 50 mcg/0.5 mL SUSR in the filings | 97,936.60 | 173 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Shingrix
| ||||||||||||||||||||||||||||||
| Simponigolimumab100 mg/mLinjection, solutionJanssen Biotech, Inc.57894-0071-02Most often named Simponi inj 100 mg/mL in the filings | 71,092.44 | 45 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Simponi
| ||||||||||||||||||||||||||||||
| Simponi Ariagolimumab50 mg/4 mLsolutionJanssen Biotech, Inc.57894-0350-01Most often named Simponi Aria 50 mg SDV 4 mL in the filings | 231,349.60 | 190 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Simponi Aria
| ||||||||||||||||||||||||||||||
| Skyrizirisankizumab-rzaakitAbbVie Inc.00074-1065-01Most often named Skyrizi 180 mg kit in the filings | 278,205.70 | 19 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Skyrizi
| ||||||||||||||||||||||||||||||
| SlynddrospirenonekitExeltis USA, Inc.00642-7470-01Most often named Slynd tab 4 mg in the filings | 15,957.68 | 82 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Slynd
| ||||||||||||||||||||||||||||||
| Soliriseculizumab300 mg/30 mLinjection, solution, concentrateAlexion Pharmaceuticals Inc.25682-0001-01Most often named MPB Soliris 10 mg/mL30 mL SDV DS in the filings | 1,252,996.26 | 69 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Soliris
| ||||||||||||||||||||||||||||||
| Somatuline Depotlanreotide acetate120 mg/0.5 mLinjectionIpsen Biopharmaceuticals, Inc.15054-1120-04Most often named Somatuline Depot 120 mg PFS 0.5 mL in the filings | 791,967.52 | 191 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Somatuline Depot
| ||||||||||||||||||||||||||||||
| Sotyktudeucravacitinib6 mgtablet, film coatedE.R. Squibb & Sons, L.L.C.00003-0895-11Most often named Sotyktu 6 mg tab 30 in the filings | 49,329.59 | at least 22 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Sotyktu
| ||||||||||||||||||||||||||||||
| Spiriva Respimattiotropium bromide inhalation spray1.562 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc.00597-0160-61Most often named Spiriva RESP aer 1.25 mcg in the filings | 22,044.49 | 333 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Spiriva Respimat
| ||||||||||||||||||||||||||||||
| Steglatroertugliflozin5 mgtablet, film coatedMerck Sharp & Dohme LLC00006-5363-03Most often named Steglatro tab 5 mg in the filings | 12,974.53 | 42 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Steglatro
| ||||||||||||||||||||||||||||||
| Stelaraustekinumab130 mg/26 mLsolutionJanssen Biotech, Inc.57894-0054-27Most often named Stelara IV 130 mg SDV 26 mL in the filings | 36,268.84 | at least 7 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Stelara
| ||||||||||||||||||||||||||||||
| Stivargaregorafenib40 mgtablet, film coatedBayer HealthCare Pharmaceuticals Inc.50419-0171-06Most often named Stivarga 40 mg tab 4x21 in the filings | 97,686.92 | 16 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Stivarga
| ||||||||||||||||||||||||||||||
| Sublocadebuprenorphine300 mgsolutionIndivior Inc.12496-0300-01Most often named Sublocade 300 mg SDV 1.5 mL in the filings | 496,553.66 | 324 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Sublocade
| ||||||||||||||||||||||||||||||
| Symbicortbudesonide and formoterol fumarate dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP00186-0370-20Most often named Symbicort 160-4.5 mcg inhaler in the filings | 20,432.40 | 299 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Symbicort
| ||||||||||||||||||||||||||||||
| Symbicortbudesonide and formoterol fumarate dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP00186-0370-28Most often named Symbicort 160-4.5 mcg/ACT AERO in the filings | 25,858.76 | 963 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Symbicort
| ||||||||||||||||||||||||||||||
| Tabrectacapmatinib150 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0709-56Most often named capmatinib 150 mg Tab in the filings | 150,775.53 | 13 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tabrecta
| ||||||||||||||||||||||||||||||
| Tabrectacapmatinib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0716-56Most often named capmatinib 200 mg Tab in the filings | 463,218.74 | 29 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tabrecta
| ||||||||||||||||||||||||||||||
| Tafinlardabrafenib75 mgcapsuleNovartis Pharmaceuticals Corporation00078-0681-66Most often named Tafinlar 75 mg cap 120 in the filings | 975,575.81 | 110 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tafinlar
| ||||||||||||||||||||||||||||||
| Tagrissoosimertinib40 mgtablet, film coatedAstraZeneca Pharmaceuticals LP00310-1349-30Most often named Tagrisso 40 mg tab 30 in the filings | 870,177.68 | 63 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tagrisso
| ||||||||||||||||||||||||||||||
| Tagrissoosimertinib80 mgtablet, film coatedAstraZeneca Pharmaceuticals LP00310-1350-30Most often named Tagrisso 80 mg tab 30 in the filings | 6,399,925.00 | 500 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tagrisso
| ||||||||||||||||||||||||||||||
| Taltzixekizumab80 mg/mLinjection, solutionEli Lilly and Company00002-7724-11Most often named Taltz 80 mg/mL inj PFS 1 mL in the filings | 62,868.86 | at least 12 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Taltz
| ||||||||||||||||||||||||||||||
| Talveytalquetamab-tgvs40 mg/mLinjectionJanssen Biotech, Inc.57894-0470-01Most often named Talvey 40 mg SDV 1 mL in the filings | 1,230,495.26 | 124 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Talvey
| ||||||||||||||||||||||||||||||
| Tasignanilotinib150 mgcapsuleNovartis Pharmaceuticals Corporation00078-0592-87Most often named nilotinib HCl 150 mg cap in the filings | 341,490.81 | 85 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tasigna
| ||||||||||||||||||||||||||||||
| Tavalissefostamatinib100 mgtabletRigel Pharmaceuticals, Inc.71332-0001-01Most often named Tavalisse 100 mg tab 60 in the filings | 332,079.58 | 44 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tavalisse
| ||||||||||||||||||||||||||||||
| Tecentriqatezolizumab840 mg/14 mLinjection, solutionGenentech, Inc.50242-0918-01Most often named Tecentriq 840 mg/14 mL SOLN in the filings | 94,711.99 | at least 8 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tecentriq
| ||||||||||||||||||||||||||||||
| Tezspiretezepelumab-ekko210 mg/1.9 mLinjection, solutionAmgen Inc55513-0112-01Most often named Tezspire 210 mg PFS 1.91 mL in the filings | 338,662.37 | 116 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tezspire
| ||||||||||||||||||||||||||||||
| Tiotropium Bromide18 mcgcapsuleLupin Pharmaceuticals, Inc.68180-0964-12Most often named Tiotrop Brom cap 18 mcg in the filings | 44,641.18 | 220 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tiotropium Bromide
| ||||||||||||||||||||||||||||||
| TNKasetenecteplasekitGenentech, Inc.50242-0176-01Most often named TNKase 50 mg KIT in the filings | 167,567.22 | 96 | ||||||||||||||||||||||||||||
2 filers: the filed rows for TNKase
| ||||||||||||||||||||||||||||||
| Tremfyaguselkumab200 mg/20 mLinjectionJanssen Biotech, Inc.57894-0650-02Most often named Tremfya 200 mg SDV 20 mL in the filings | 465,193.38 | 35 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tremfya
| ||||||||||||||||||||||||||||||
| Tremfyaguselkumab200 mg/2 mLinjectionJanssen Biotech, Inc.57894-0651-04Most often named Tremfya pen 200 mg/2 mL 2 in the filings | 52,331.09 | at least 6 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tremfya
| ||||||||||||||||||||||||||||||
| Trintellixvortioxetine20 mgtablet, film coatedTakeda Pharmaceuticals America, Inc.64764-0750-30Most often named Trintellix tab 20 mg in the filings | 16,568.87 | 233 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Trintellix
| ||||||||||||||||||||||||||||||
| Triumeqabacavir sulfate, dolutegravir sodium, lamivudine600 mg; 50 mg; 300 mgtablet, film coatedViiV Healthcare Company49702-0231-13Most often named Triumeq tab 30 in the filings | 619,181.47 | 300 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Triumeq
| ||||||||||||||||||||||||||||||
| Trodelvysacituzumab govitecan180 mgpowder, for solutionGilead Sciences, Inc.55135-0132-01Most often named Trodelvy 180 mg SDV in the filings | 1,146,852.63 | 345 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Trodelvy
| ||||||||||||||||||||||||||||||
| Truximarituximab-abbs10 mg/mLinjection, solutionCephalon, Inc.63459-0103-10Most often named Truxima 100 mg SDV 10 mL in the filings | 18,422.49 | 56 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Truxima
| ||||||||||||||||||||||||||||||
| Tukysatucatinib150 mgtabletSeagen Inc.51144-0002-60Most often named Tukysa 150 mg tab 60 in the filings | 876,035.03 | 56 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tukysa
| ||||||||||||||||||||||||||||||
| Tyennetocilizumab-aazg162 mg/0.9 mLinjection, solutionFresenius Kabi USA, LLC65219-0586-04Most often named Tyenne 162 mg PFS 0.9 mL in the filings | 46,113.06 | 55 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tyenne
| ||||||||||||||||||||||||||||||
| Tyennetocilizumab-aazg162 mg/0.9 mLinjection, solutionFresenius Kabi USA, LLC65219-0596-01Most often named Tyenne 162 mg auto inj 0.9 mL in the filings | 18,262.06 | 40 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tyenne
| ||||||||||||||||||||||||||||||
| Tysabrinatalizumab300 mg/15 mLinjectionBiogen Inc.64406-0008-01Most often named Tysabri inj 300/15 mL in the filings | 82,395.53 | 67 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Tysabri
| ||||||||||||||||||||||||||||||
| Ubrelvyubrogepant50 mgtabletAllergan, Inc.00023-6498-10Most often named Ubrelvy tab 50 mg in the filings | 24,217.73 | 57 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Ubrelvy
| ||||||||||||||||||||||||||||||
| Ultomirisravulizumab300 mg/3 mLsolution, concentrateAlexion Pharmaceuticals Inc.25682-0025-01Most often named Ultomiris 300 mg/3 mL VL DS in the filings | 2,568,670.04 | 42 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Ultomiris
| ||||||||||||||||||||||||||||||
| Uzedyrisperidone125 mg/0.35 mLinjection, suspension, extended releaseTeva Pharmaceuticals USA, Inc.51759-0630-10Most often named Uzedy 125 mg ER PFS 0.35 mL in the filings | 26,970.64 | 21 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Uzedy
| ||||||||||||||||||||||||||||||
| Vectibixpanitumumab100 mg/5 mLsolutionAmgen, Inc55513-0954-01Most often named Vectibix 100 mg SDV 5 mL in the filings | 542,407.27 | 192 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Vectibix
| ||||||||||||||||||||||||||||||
| Vekluryremdesivir100 mginjection, powder, lyophilized, for solutionGilead Sciences, Inc.61958-2901-02Most often named Veklury 100 mg SOLR in the filings | 31,986.49 | at least 18 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Veklury
| ||||||||||||||||||||||||||||||
| Venclextavenetoclax100 mgtablet, film coatedAbbVie Inc.00074-0576-22Most often named Venclexta 100 mg tab 120 in the filings | 3,080,635.21 | 504 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Venclexta
| ||||||||||||||||||||||||||||||
| Venoferiron sucrose20 mg/mLinjection, solutionAmerican Regent, Inc.00517-2310-05Named Venofer 20 mg/mL SOLN in the filings | 152,920.22 | 802 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Venofer
| ||||||||||||||||||||||||||||||
| Venoferiron sucrose20 mg/mLinjection, solutionAmerican Regent, Inc.00517-2340-10Most often named Venofer 20 mg/mL SOLN in the filings | 135,021.43 | 1,907 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Venofer
| ||||||||||||||||||||||||||||||
| Verzenioabemaciclib100 mgtabletEli Lilly and Company00002-4815-54Most often named Verzenio 100 mg tab 14 in the filings | 2,203,185.40 | 175 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Verzenio
| ||||||||||||||||||||||||||||||
| Vonjopacritinib100 mgcapsuleSobi, Inc.72482-0100-12Most often named Vonjo 100 mg cap 120 in the filings | 153,564.64 | at least 9 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Vonjo
| ||||||||||||||||||||||||||||||
| Vraylarcariprazine6 mgcapsule, gelatin coatedAllergan, Inc.61874-0160-30Most often named Vraylar cap 6 mg in the filings | 105,537.88 | 127 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Vraylar
| ||||||||||||||||||||||||||||||
| Vumeritydiroximel fumarate231 mgcapsuleBiogen Inc.64406-0020-03Most often named Vumerity 231 mg cap in the filings | 129,353.15 | 36 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Vumerity
| ||||||||||||||||||||||||||||||
| Vyeptieptinezumab-jjmr100 mg/mLinjectionLundbeck Pharmaceuticals LLC67386-0130-51Most often named Vyepti 100 mg/mL SDV in the filings | 69,832.35 | 23 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Vyepti
| ||||||||||||||||||||||||||||||
| Vyndamaxtafamidis61 mgcapsule, liquid filledPfizer Laboratories Div Pfizer Inc00069-8730-30Most often named tafamidis 61 mg cap in the filings | 11,794,481.11 | 663 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Vyndamax
| ||||||||||||||||||||||||||||||
| Wixela Inhubfluticasone propionate and salmeterol100 mcg; 50 mcgpowderMylan Pharmaceuticals Inc.00378-9320-32Most often named Wixela Inhub aer 100/50 in the filings | 17,196.59 | 474 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Wixela Inhub
| ||||||||||||||||||||||||||||||
| Xcopricenobamate100 mgtablet, film coatedSK Life Science, Inc.71699-0100-30Most often named Xcopri tab 100 mg in the filings | 38,135.62 | 47 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Xcopri
| ||||||||||||||||||||||||||||||
| Xcopricenobamate150 mgtablet, film coatedSK Life Science, Inc.71699-0150-30Most often named Xcopri 150 mg in the filings | 28,559.79 | 33 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Xcopri
| ||||||||||||||||||||||||||||||
| Xcopricenobamate200 mgtablet, film coatedSK Life Science, Inc.71699-0200-30Most often named Xcopri tab 200 mg in the filings | 18,157.83 | at least 15 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Xcopri
| ||||||||||||||||||||||||||||||
| Xolairomalizumab150 mg/1.2 mLinjection, solutionGenentech, Inc.50242-0040-62Most often named Xolair 150 mg Psvfree Lypoh SDV in the filings | 258,951.30 | 200 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Xolair
| ||||||||||||||||||||||||||||||
| Xolairomalizumab300 mg/2 mLinjection, solutionGenentech, Inc.50242-0227-01Most often named Xolair inj 300/2 mL in the filings | 180,775.46 | 60 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Xolair
| ||||||||||||||||||||||||||||||
| Xolair PFSomalizumab75 mg/0.5 mLinjection, solutionGenentech, Inc.50242-0214-03Most often named Xolair inj 75/0.5 in the filings | 22,931.46 | 44 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Xolair PFS
| ||||||||||||||||||||||||||||||
| Xolair PFSomalizumab75 mg/0.5 mLinjection, solutionGenentech, Inc.50242-0214-55Most often named Xolair 75 mg auto inj 0.5 mL in the filings | 10,987.62 | 19 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Xolair PFS
| ||||||||||||||||||||||||||||||
| Xolair PFSomalizumab150 mg/mLinjection, solutionGenentech, Inc.50242-0215-01The FDA directory lists this product, not this packageMost often named Xolair inj 150 mg/mL in the filings | 259,734.30 | 176 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Xolair PFS
| ||||||||||||||||||||||||||||||
| Xolair PFSomalizumab150 mg/mLinjection, solutionGenentech, Inc.50242-0215-03Most often named Xolair inj 150 mg/mL in the filings | 349,308.56 | 195 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Xolair PFS
| ||||||||||||||||||||||||||||||
| Xyostedtestosterone enanthate75 mg/0.5 mLinjectionAntares Pharma, Inc.54436-0275-04Most often named Xyosted inj 75/0.5 mL in the filings | 19,823.37 | 67 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Xyosted
| ||||||||||||||||||||||||||||||
| Yeztugolenacapavir sodiumkitGilead Sciences, Inc.61958-3402-01Most often named Yeztugo 463.5 mg SDV 2x1.5 mL in the filings | 129,899.52 | at least 11 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Yeztugo
| ||||||||||||||||||||||||||||||
| Zarxiofilgrastim-sndz480 mcg/0.8 mLinjection, solutionSandoz Inc.61314-0326-10Most often named Zarxio in the filings | 56,419.84 | at least 202 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Zarxio
| ||||||||||||||||||||||||||||||
| Zejulaniraparib100 mgtablet, film coatedGlaxoSmithKline LLC00173-0909-13Most often named Zejula 100 mg tab 30 in the filings | 320,616.21 | at least 21 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Zejula
| ||||||||||||||||||||||||||||||
| Zejulaniraparib300 mgtablet, film coatedGlaxoSmithKline LLC00173-0915-13Most often named Zejula 300 mg tab 30 in the filings | 87,826.61 | at least 6 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Zejula
| ||||||||||||||||||||||||||||||
| Zoladexgoserelin10.8 mgimplantTerSera Therapeutics LLC70720-0951-30Most often named Zoladex 10.8 mg PFS DS in the filings | 273,101.31 | 135 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Zoladex
| ||||||||||||||||||||||||||||||
| Zubsolvbuprenorphine hydrochloride and naloxone hydrochloride8.6 mg; 2.1 mgtablet, orally disintegratingOrexo US, Inc.54123-0986-30Most often named Zubsolv SUB 8.6-2.1 in the filings | 40,605.63 | 68 | ||||||||||||||||||||||||||||
2 filers: the filed rows for Zubsolv
| ||||||||||||||||||||||||||||||
| Abilify Maint 300 mg kit59148-0018-71The FDA directory does not list this code: the name is from the filingFiled by Rhode Island Hospital, line 535 | 37,777.47 (Rhode Island Hospital, Schedule G, line 535, page 25 of the filing PDF) | 40 | ||||||||||||||||||||||||||||
| Abirateroneabiraterone acetate250 mgtabletNovadoz Pharmaceuticals LLC72205-0030-92Named Abiraterone Acetate 250 mg tab 120 by Rhode Island Hospital, line 874 | 7,614.19 (Rhode Island Hospital, Schedule G, line 874, page 34 of the filing PDF) | 124 | ||||||||||||||||||||||||||||
| Abiraterone Acetate250 mgtabletApotex Corp.60505-4327-01Named Abiraterone Acetate 250 mg tab 120 by Rhode Island Hospital, line 947 | 5,512.03 (Rhode Island Hospital, Schedule G, line 947, page 36 of the filing PDF) | 39 | ||||||||||||||||||||||||||||
| Abiraterone Acetate250 mgtabletGlenmark Pharmaceuticals Inc., USA68462-0135-08Named Abiraterone Acet 250 mg tab 120 by Rhode Island Hospital, line 826 | 9,031.32 (Rhode Island Hospital, Schedule G, line 826, page 33 of the filing PDF) | 162 | ||||||||||||||||||||||||||||
| Abiraterone Acetate250 mgtabletFlorida Pharmaceutical Products, LLC.71921-0178-20Named Abiraterone Acetate 250 mg tab 120 by Rhode Island Hospital, line 648 | 20,305.62 (Rhode Island Hospital, Schedule G, line 648, page 28 of the filing PDF) | 465 | ||||||||||||||||||||||||||||
| Acarbose25 mgtabletHikma Pharmaceuticals USA Inc.00054-0140-25Named acarbose (Precose) 25 mg tablet by Women & Infants Hospital of RI, line 228 | 10,416.25 (Women & Infants Hospital of RI, Schedule G, line 228, page 16 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Accu-Chek Guide test STRP65702071110, 65702071210Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 26 | 17,185.84 (Blackstone Valley Community Health Care, Schedule G, line 26, page 8 of the filing PDF) | 389 | ||||||||||||||||||||||||||||
| Acetaminophen10 mg/mLinjection, solutionHikma Pharmaceuticals USA Inc.24201-0100-24Named Acetaminophen 10 mg/mL SOLN by Kent County Memorial Hospital, line 330 | 8,507.32 (Kent County Memorial Hospital, Schedule G, line 330, page 19 of the filing PDF) | 2,544 | ||||||||||||||||||||||||||||
| Acetylcysteine6 g/30 mLinjection, solutionEugia US LLC55150-0259-30Named Acetylcysteine 200 mg/mL SOLN by Kent County Memorial Hospital, line 387 | 5,020.50 (Kent County Memorial Hospital, Schedule G, line 387, page 20 of the filing PDF) | 117 | ||||||||||||||||||||||||||||
| Actemratocilizumab400 mg/20 mLinjection, solution, concentrateGenentech, Inc.50242-0137-01Named Actemra 400 mg SDV 20 mL by Rhode Island Hospital, line 155 | 506,448.75 (Rhode Island Hospital, Schedule G, line 155, page 15 of the filing PDF) | 276 | ||||||||||||||||||||||||||||
| ActivasealteplasekitGenentech, Inc.50242-0044-13Named Activase 50 mg VL by Rhode Island Hospital, line 741 | 13,202.58 (Rhode Island Hospital, Schedule G, line 741, page 30 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| ActivasealteplasekitGenentech, Inc.50242-0085-27Named Activase 100 mg VL by Rhode Island Hospital, line 801 | 10,367.83 (Rhode Island Hospital, Schedule G, line 801, page 32 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Adakveocrizanlizumab10 mg/mLinjectionNovartis Pharmaceuticals Corporation00078-0883-61Named Adakveo 100 mg SDV 10 mL by Rhode Island Hospital, line 325 | 135,267.34 (Rhode Island Hospital, Schedule G, line 325, page 20 of the filing PDF) | 36 | ||||||||||||||||||||||||||||
| Adalimumabadalimumab-adaz80 mg/0.8 mLinjection, solutionSandoz Inc61314-0325-20Named Adalimumab-adaz 80 mg PFP 2x0.8 mL by Rhode Island Hospital, line 670 | 17,521.33 (Rhode Island Hospital, Schedule G, line 670, page 29 of the filing PDF) | 16 | ||||||||||||||||||||||||||||
| Adalimumabadalimumab-adaz40 mg/0.4 mLinjection, solutionSandoz Inc61314-0327-64Named Adalimumab-adaz 40 mg PFS 2x0.4 mL by Rhode Island Hospital, line 549 | 35,134.29 (Rhode Island Hospital, Schedule G, line 549, page 25 of the filing PDF) | 56 | ||||||||||||||||||||||||||||
| Adalimumab-aacfadalimumabkitFresenius Kabi USA, LLC65219-0612-99Named Adalimumab-aacf 40 mg-0.8 mL PFP kit 2 by Rhode Island Hospital, line 778 | 11,194.32 (Rhode Island Hospital, Schedule G, line 778, page 31 of the filing PDF) | 17 | ||||||||||||||||||||||||||||
| Adalimumab-adbmkitBoehringer Ingelheim Pharmaceuticals, Inc.00597-0545-22Named Adalimumab-adbm 40 mg-0.8 mL PFP kit 2 by Rhode Island Hospital, line 834 | 8,790.70 (Rhode Island Hospital, Schedule G, line 834, page 33 of the filing PDF) | 17 | ||||||||||||||||||||||||||||
| Adalimumab-adbmkitBoehringer Ingelheim Pharmaceuticals, Inc.00597-0575-50Named Adalimumab-adbm 40 mg-0.4 mL PFP kit 2 by Rhode Island Hospital, line 660 | 18,841.69 (Rhode Island Hospital, Schedule G, line 660, page 28 of the filing PDF) | 43 | ||||||||||||||||||||||||||||
| Adbrytralokinumab-ldrm150 mg/mLinjection, solutionLEO Pharma Inc.50222-0346-04Named Adbry 150 mg PFS 4x1 mL by Rhode Island Hospital, line 503 | 43,334.37 (Rhode Island Hospital, Schedule G, line 503, page 24 of the filing PDF) | 20 | ||||||||||||||||||||||||||||
| Adrenalin (epinephrine in sodium chloride)epinephrine in sodium chloride16 mcg/mLinjectionPar Health USA, LLC42023-0315-10Named Adrenalin 4 mg bag 10x250 mL by Rhode Island Hospital, line 963 | 5,183.47 (Rhode Island Hospital, Schedule G, line 963, page 36 of the filing PDF) | 163 | ||||||||||||||||||||||||||||
| Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc.00944-3045-10Named Advate Baxject III 5 mL 1,801-2,400 IU by Rhode Island Hospital, line 238 | 235,923.31 (Rhode Island Hospital, Schedule G, line 238, page 17 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc.00944-3046-10Named Advate Baxject III 5 mL 2,401- 3,600 IU by Rhode Island Hospital, line 177 | 387,578.40 (Rhode Island Hospital, Schedule G, line 177, page 16 of the filing PDF) | 31 | ||||||||||||||||||||||||||||
| Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc.00944-3047-10Named Advate Baxject III 5 mL 3,601- 4,800 IU by Rhode Island Hospital, line 463 | 54,129.48 (Rhode Island Hospital, Schedule G, line 463, page 23 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc.00944-3051-02Named Advate Baxject III 2 mL 200-400 IU by Rhode Island Hospital, line 938 | 5,683.99 (Rhode Island Hospital, Schedule G, line 938, page 36 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc.00944-3053-02Named Advate Baxject III 2 mL 801-1,200 IU by Rhode Island Hospital, line 616 | 23,122.55 (Rhode Island Hospital, Schedule G, line 616, page 27 of the filing PDF) | 15 | ||||||||||||||||||||||||||||
| Advateantihemophilic factor (recombinant)kitTakeda Pharmaceuticals America, Inc.00944-3054-02Named Advate Baxject III 2 mL 1,201- 1,800 IU by Rhode Island Hospital, line 478 | 48,751.36 (Rhode Island Hospital, Schedule G, line 478, page 24 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Adzynmaapadamtase alfakitTakeda Pharmaceuticals America, Inc.64764-0140-05Named Adzynma 0500 units 1 EA by Rhode Island Hospital, line 441 | 62,647.80 (Rhode Island Hospital, Schedule G, line 441, page 23 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Adzynmaapadamtase alfakitTakeda Pharmaceuticals America, Inc.64764-0145-05Named Adzynma 1,664 units 1 EA by Rhode Island Hospital, line 375 | 92,684.80 (Rhode Island Hospital, Schedule G, line 375, page 21 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Afinitoreverolimus5 mgtabletNovartis Pharmaceuticals Corporation00078-0566-51Named Afinitor 5 mg tab 4x7 by Rhode Island Hospital, line 332 | 131,368.50 (Rhode Island Hospital, Schedule G, line 332, page 20 of the filing PDF) | 25 | ||||||||||||||||||||||||||||
| Afinitoreverolimus10 mgtabletNovartis Pharmaceuticals Corporation00078-0567-51Named Afinitor 10 mg tab 28 by Rhode Island Hospital, line 577 | 28,089.44 (Rhode Island Hospital, Schedule G, line 577, page 26 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Afinitor Disperzeverolimus2 mgtablet, for suspensionNovartis Pharmaceuticals Corporation00078-0626-51Named Afinitor Disperz 2 mg tab 28 (4x7) by Rhode Island Hospital, line 610 | 24,099.34 (Rhode Island Hospital, Schedule G, line 610, page 27 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Afinitor Disperzeverolimus3 mgtablet, for suspensionNovartis Pharmaceuticals Corporation00078-0627-51Named Afinitor Disperz 3 mg tab 28 (4x7) by Rhode Island Hospital, line 920 | 6,106.58 (Rhode Island Hospital, Schedule G, line 920, page 35 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Afrin Originaloxymetazoline hydrochloride0.05 g/100 mLsprayBayer HealthCare LLC.11523-1167-05Named Afrin Original spray 30 mL by Rhode Island Hospital, line 868 | 7,787.68 (Rhode Island Hospital, Schedule G, line 868, page 34 of the filing PDF) | 1,029 | ||||||||||||||||||||||||||||
| Afstyla Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinantkitCSL Behring Lengnau AG69911-0478-02Named Afstyla 3,347 IU SDV by Rhode Island Hospital, line 423 | 72,161.32 (Rhode Island Hospital, Schedule G, line 423, page 22 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Afstyla Antihemophilic Factor (Recombinant), Single Chainantihemophilic factor, human recombinantkitCSL Behring Lengnau AG69911-0481-02Named Afstyla 2,768 IU SDV by Rhode Island Hospital, line 369 | 95,911.20 (Rhode Island Hospital, Schedule G, line 369, page 21 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Ajovyfremanezumab-vfrm225 mg/1.5 mLinjectionTeva Pharmaceuticals USA, Inc.51759-0204-10Named Ajovy 225 mg/1.5 mL PF syr 1.5 mL by The Providence Community Health Centers, Inc, line 155 | 6,430.35 (The Providence Community Health Centers, Inc, Schedule G, line 155, page 13 of the filing PDF) | 32 | ||||||||||||||||||||||||||||
| Akovazephedrine sulfate5 mg/mLinjectionExela Pharma Sciences, LLC51754-4250-03Named Akovaz 25 mg PFS 10x5 mL by Rhode Island Hospital, line 459 | 56,136.65 (Rhode Island Hospital, Schedule G, line 459, page 23 of the filing PDF) | 5,515 | ||||||||||||||||||||||||||||
| Akynzeonetupitant and palonosetron300 mg; 0.5 mgcapsuleHelsinn Therapeutics (U.S.), Inc.69639-0101-01Named netupitant-palonosetron (Akynzeo, netupitant,) 300-0.5 mg cap by Women & Infants Hospital of RI, line 239 | 9,161.12 (Women & Infants Hospital of RI, Schedule G, line 239, page 16 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Albukedalbumin (human)2.5 g/50 mLsolutionKedrion Biopharma, Inc.76125-0790-25Named Albuked 5% VL 250 mL by Rhode Island Hospital, line 797 | 10,635.35 (Rhode Island Hospital, Schedule G, line 797, page 32 of the filing PDF) | 154 | ||||||||||||||||||||||||||||
| AlbuRxalbumin (human)12.5 g/50 mLsolutionCSL Behring AG44206-0251-05Named AlbuRx 25% VL 50 mL by Rhode Island Hospital, line 734 | 13,557.62 (Rhode Island Hospital, Schedule G, line 734, page 30 of the filing PDF) | 207 | ||||||||||||||||||||||||||||
| AlbuRxalbumin (human)12.5 g/50 mLsolutionCSL Behring AG44206-0251-10Named AlbuRx 25% SOLN by Kent County Memorial Hospital, line 323 | 9,345.45 (Kent County Memorial Hospital, Schedule G, line 323, page 18 of the filing PDF) | 157 | ||||||||||||||||||||||||||||
| Alburxalbumin (human)12.5 g/250 mLsolutionCSL Behring AG44206-0310-25Named AlbuRx 5% VL 250 mL by Rhode Island Hospital, line 522 | 39,594.67 (Rhode Island Hospital, Schedule G, line 522, page 25 of the filing PDF) | 226 | ||||||||||||||||||||||||||||
| Albuterol Sulfate108 mcgaerosol, meteredSandoz Inc00781-7296-85Named Albuterol Sulf HFA 90 mcg inh aer 6.7 g by Rhode Island Hospital, line 836 | 8,752.21 (Rhode Island Hospital, Schedule G, line 836, page 33 of the filing PDF) | 1,041 | ||||||||||||||||||||||||||||
| Albuterol Sulfate90 mcginhalantAmerican Health Packaging60687-0662-91Named Albuterol Sulf 90 mcg inh aer 6.7 g by Rhode Island Hospital, line 818 | 9,572.41 (Rhode Island Hospital, Schedule G, line 818, page 33 of the filing PDF) | 2,176 | ||||||||||||||||||||||||||||
| Albuterol Sulfate90 mcginhalantCipla USA Inc.69097-0142-60Named Albuterol aer HFA by Thundermist Health Center, line 119 | 17,284.36 (Thundermist Health Center, Schedule G, line 119, page 10 of the filing PDF) | 3,784 | ||||||||||||||||||||||||||||
| Albuterol Sulfate HFA90 mcgaerosol, meteredTeva Pharmaceuticals USA, Inc.00093-3174-31Named Albuterol aer HFA by Thundermist Health Center, line 128 | 15,771.88 (Thundermist Health Center, Schedule G, line 128, page 10 of the filing PDF) | 2,085 | ||||||||||||||||||||||||||||
| Albuterol Sulfate HFA 108 AERS66993001968, 68180096301Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 31 | 12,008.38 (Blackstone Valley Community Health Care, Schedule G, line 31, page 8 of the filing PDF) | 357 | ||||||||||||||||||||||||||||
| Alphanateantihemophilic factor/von willebrand factor complex (human)kitGrifols USA, LLC68516-4618-02Named Alphanate AHF 1,070 IU RCOF 1,120 IU VL by Rhode Island Hospital, line 613 | 23,593.50 (Rhode Island Hospital, Schedule G, line 613, page 27 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Alphanateantihemophilic factor/von willebrand factor complex (human)kitGrifols USA, LLC68516-4620-02Named Alphanate AHF 2,110 IU RCOF 2,360 IU VL by Rhode Island Hospital, line 499 | 44,106.39 (Rhode Island Hospital, Schedule G, line 499, page 24 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Altuviiioantihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtlkitBioverativ Therapeutics Inc.71104-0979-01Named Altuviiio 500 IU LFP VL by Rhode Island Hospital, line 515 | 41,197.08 (Rhode Island Hospital, Schedule G, line 515, page 25 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Altuviiioantihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtlkitBioverativ Therapeutics Inc.71104-0982-01Named Altuviiio 2,000 IU LFP VL by Rhode Island Hospital, line 300 | 152,739.96 (Rhode Island Hospital, Schedule G, line 300, page 19 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Altuviiioantihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtlkitBioverativ Therapeutics Inc.71104-0984-01Named Altuviiio 4,000 IU LFP VL by Rhode Island Hospital, line 141 | 567,323.70 (Rhode Island Hospital, Schedule G, line 141, page 15 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Alunbrigbrigatinib180 mgtablet, film coatedTakeda Pharmaceuticals America, Inc.63020-0180-30Named MPB Alunbrig 180 mg tab 30CT by Kent County Memorial Hospital, line 126 | 73,273.87 (Kent County Memorial Hospital, Schedule G, line 126, page 13 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Alyftrekvanzacaftor, tezacaftor, and deutivacaftor10 mg; 50 mg; 125 mgtablet, film coatedVertex Pharmaceuticals Incorporated51167-0121-01Named Alyftrek 10/50/125 tab 56 by Rhode Island Hospital, line 235 | 238,523.91 (Rhode Island Hospital, Schedule G, line 235, page 17 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Ambrisentan10 mgtablet, film coatedMylan Pharmaceuticals Inc.00378-4271-93Named Ambrisentan 10 mg tab 30 by Rhode Island Hospital, line 869 | 7,778.26 (Rhode Island Hospital, Schedule G, line 869, page 34 of the filing PDF) | 47 | ||||||||||||||||||||||||||||
| Ambrisentan5 mgtablet, film coatedActavis Pharma, Inc.00591-2405-30Named Ambrisentan 5 mg tab 30 by Rhode Island Hospital, line 772 | 11,475.45 (Rhode Island Hospital, Schedule G, line 772, page 31 of the filing PDF) | 17 | ||||||||||||||||||||||||||||
| Ambrisentan10 mgtablet, film coatedActavis Pharma, Inc.00591-2406-30Named Ambrisentan 10 mg tab 30 by Rhode Island Hospital, line 667 | 17,748.65 (Rhode Island Hospital, Schedule G, line 667, page 29 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Aminocaproic Acid0.25 g/mLsolutionCamber Pharmaceuticals, Inc.31722-0035-23Named Aminocaproic Acid 0.25 g-mL sol 236.5 mL by Rhode Island Hospital, line 921 | 6,099.21 (Rhode Island Hospital, Schedule G, line 921, page 35 of the filing PDF) | 34 | ||||||||||||||||||||||||||||
| Ampicillin and Sulbactamampicillin sodium and sulbactam sodium2 g; 1 ginjection, powder, for solutionMeitheal Pharmaceuticals Inc.71288-0032-21Named Ampicillin-Sulbactam 3 g SDV 10 by Rhode Island Hospital, line 790 | 10,714.45 (Rhode Island Hospital, Schedule G, line 790, page 32 of the filing PDF) | 3,327 | ||||||||||||||||||||||||||||
| Amvuttravutrisiran25 mg/0.5 mLinjectionAlnylam Pharmaceuticals, Inc.71336-1003-01Named Amvuttra 25 mg/0.5 mL PFS by Rhode Island Hospital, line 10 | 4,112,254.59 (Rhode Island Hospital, Schedule G, line 10, page 11 of the filing PDF) | 31 | ||||||||||||||||||||||||||||
| Anecreamlidocaine 4%4 g/100 gcreamFocus Health Group24357-0701-07Named Anecream 4% TEGA patch kit 5x5 g by Rhode Island Hospital, line 816 | 9,718.13 (Rhode Island Hospital, Schedule G, line 816, page 32 of the filing PDF) | 2,165 | ||||||||||||||||||||||||||||
| Aprepitant80 mgcapsuleGlenmark Pharmaceuticals Inc., USA68462-0584-76Named Aprepitant 80 mg cap 6 by Rhode Island Hospital, line 775 | 11,308.10 (Rhode Island Hospital, Schedule G, line 775, page 31 of the filing PDF) | 237 | ||||||||||||||||||||||||||||
| Aranespdarbepoetin alfa40 mcg/0.4 mLinjection, solutionAmgen, Inc55513-0021-04Named Aranesp 40 mcg SYG 4x0.4 mL by Rhode Island Hospital, line 320 | 140,786.67 (Rhode Island Hospital, Schedule G, line 320, page 19 of the filing PDF) | 1,176 | ||||||||||||||||||||||||||||
| Aranespdarbepoetin alfa60 mcg/0.3 mLinjection, solutionAmgen, Inc55513-0023-04Named Aranesp 60 mcg PFS 4x0.3 mL by Rhode Island Hospital, line 391 | 85,009.18 (Rhode Island Hospital, Schedule G, line 391, page 21 of the filing PDF) | 668 | ||||||||||||||||||||||||||||
| Aranespdarbepoetin alfa100 mcg/0.5 mLinjection, solutionAmgen, Inc55513-0025-04Named Aranesp 100 mcg PFS 4x0.5 mL by Rhode Island Hospital, line 321 | 140,518.83 (Rhode Island Hospital, Schedule G, line 321, page 19 of the filing PDF) | 536 | ||||||||||||||||||||||||||||
| Aranespdarbepoetin alfa25 mcg/0.42 mLinjection, solutionAmgen, Inc55513-0057-04Named Aranesp 25 mcg PFS 4x0.42 mL by Rhode Island Hospital, line 474 | 49,285.56 (Rhode Island Hospital, Schedule G, line 474, page 23 of the filing PDF) | 724 | ||||||||||||||||||||||||||||
| Aranespdarbepoetin alfa10 mcg/0.4 mLinjection, solutionAmgen, Inc55513-0098-04Named Aranesp 10 mcg PFS 4x0.4 mL by Rhode Island Hospital, line 683 | 16,455.99 (Rhode Island Hospital, Schedule G, line 683, page 29 of the filing PDF) | 1,106 | ||||||||||||||||||||||||||||
| Aripiprazole15 mgtabletTorrent Pharmaceuticals Limited13668-0219-30Named aripiprazole (Abilify) 15 mg tablet by Women & Infants Hospital of RI, line 250 | 7,064.24 (Women & Infants Hospital of RI, Schedule G, line 250, page 17 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Aristadaaripiprazole lauroxil662 mg/2.4 mLinjection, suspension, extended releaseAlkermes, Inc.65757-0402-03Named Aristada 662 mg SYG 2.4 mL by Rhode Island Hospital, line 715 | 14,589.99 (Rhode Island Hospital, Schedule G, line 715, page 30 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Arnuity Elliptafluticasone furoate200 mcgpowderGlaxoSmithKline LLC00173-0876-10Named Arnuity ELPT inh 200 mcg by Thundermist Health Center, line 139 | 14,399.94 (Thundermist Health Center, Schedule G, line 139, page 10 of the filing PDF) | 196 | ||||||||||||||||||||||||||||
| Arnuity Ellipta T AEPB173087410Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 44 | 7,181.55 (Blackstone Valley Community Health Care, Schedule G, line 44, page 8 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Asparlascalaspargase pegol750 units/mLinjection, solutionServier Pharmaceuticals LLC72694-0515-01Named Asparlas inj 3750/5 mL by Rhode Island Hospital, line 22 | 2,995,940.39 (Rhode Island Hospital, Schedule G, line 22, page 12 of the filing PDF) | 107 | ||||||||||||||||||||||||||||
| Ativanlorazepam2 mg/mLinjectionHikma Pharmaceuticals USA Inc.00641-6001-25Named Ativan 2 mg/mL SOLN by Women & Infants Hospital of RI, line 205 | 15,227.04 (Women & Infants Hospital of RI, Schedule G, line 205, page 15 of the filing PDF) | 137 | ||||||||||||||||||||||||||||
| Atorvastatin Calcium tabs60505258008, 60505258009Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 36 | 10,856.33 (Blackstone Valley Community Health Care, Schedule G, line 36, page 8 of the filing PDF) | 777 | ||||||||||||||||||||||||||||
| Atropine Sulfate0.4 mg/mLinjection, solutionAmerican Regent, Inc.00517-1004-25Named Atropine Sulf 0.4 mg SDV 25x1 mL by Rhode Island Hospital, line 952 | 5,445.19 (Rhode Island Hospital, Schedule G, line 952, page 36 of the filing PDF) | 1,079 | ||||||||||||||||||||||||||||
| Attrubyacoramidis hydrochloride356 mgtablet, film coatedBridgeBio Pharma, Inc.82228-0712-28Named Attruby 356 mg tab 112 (4x28) BP by Rhode Island Hospital, line 36 | 2,345,998.47 (Rhode Island Hospital, Schedule G, line 36, page 12 of the filing PDF) | 131 | ||||||||||||||||||||||||||||
| Austedo XRdeutetrabenazine30 mgtablet, film coated, extended releaseTeva Neuroscience, Inc.68546-0473-56Named Austedo XR 30 mg tablet by Kent County Memorial Hospital, line 301 | 12,353.86 (Kent County Memorial Hospital, Schedule G, line 301, page 18 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Auvi-Qepinephrine0.1 mg/0.1 mLinjection, solutionkaleo, Inc60842-0021-02Named Auvi-Q 0.1 mg auto inj 2x0.1 mL by Rhode Island Hospital, line 776 | 11,215.39 (Rhode Island Hospital, Schedule G, line 776, page 31 of the filing PDF) | 19 | ||||||||||||||||||||||||||||
| Auvi-Qepinephrine0.15 mg/0.15 mLinjection, solutionkaleo, Inc60842-0022-02Named Auvi-Q 0.15 mg auto inj 2x0.15 mL by Rhode Island Hospital, line 851 | 8,227.41 (Rhode Island Hospital, Schedule G, line 851, page 33 of the filing PDF) | 15 | ||||||||||||||||||||||||||||
| Auvi-Qepinephrine0.3 mg/0.3 mLinjection, solutionkaleo, Inc60842-0023-02Named Auvi-Q 0.3 mg auto inj 2x0.3 mL by Rhode Island Hospital, line 934 | 5,791.89 (Rhode Island Hospital, Schedule G, line 934, page 36 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Avastinbevacizumab100 mg/4 mLinjection, solutionGenentech, Inc.50242-0060-01Named Avastin 100 mg SDV 4 mL by Rhode Island Hospital, line 889 | 7,262.34 (Rhode Island Hospital, Schedule G, line 889, page 34 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Avastinbevacizumab400 mg/16 mLinjection, solutionGenentech, Inc.50242-0061-01Named Avastin 400 mg SDV 16 mL by Rhode Island Hospital, line 437 | 64,614.75 (Rhode Island Hospital, Schedule G, line 437, page 22 of the filing PDF) | 23 | ||||||||||||||||||||||||||||
| Azacitidine100 mginjection, powder, lyophilized, for solutionMeitheal Pharmaceuticals Inc.71288-0115-30Named Azacitidine 100 mg SDV by Rhode Island Hospital, line 508 | 42,238.57 (Rhode Island Hospital, Schedule G, line 508, page 24 of the filing PDF) | 1,032 | ||||||||||||||||||||||||||||
| Azathioprine75 mgtabletOceanside Pharmaceuticals68682-0231-01Named Azathioprine 75 mg tab 100 by Rhode Island Hospital, line 891 | 7,208.92 (Rhode Island Hospital, Schedule G, line 891, page 34 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| Baclofen10 mg/5 mLsolutionTrupharma, LLC52817-0620-08Named Baclofen 10 mg-5 mL oral sol 237 mL by Rhode Island Hospital, line 584 | 27,442.33 (Rhode Island Hospital, Schedule G, line 584, page 26 of the filing PDF) | 39 | ||||||||||||||||||||||||||||
| Balversaerdafitinib3 mgtablet, film coatedJanssen Products LP59676-0030-56Named Balversa 3 mg tab 56 by Rhode Island Hospital, line 588 | 27,061.68 (Rhode Island Hospital, Schedule G, line 588, page 26 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Balversaerdafitinib4 mgtablet, film coatedJanssen Products LP59676-0040-56Named Balversa 4 mg tab 56 by Rhode Island Hospital, line 664 | 18,043.95 (Rhode Island Hospital, Schedule G, line 664, page 28 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Baqsimiglucagon3 mgpowderAmphastar Pharmaceuticals, Inc.00548-8351-01Named Baqsimi 3 mg pwd by Rhode Island Hospital, line 864 | 7,870.71 (Rhode Island Hospital, Schedule G, line 864, page 34 of the filing PDF) | 22 | ||||||||||||||||||||||||||||
| Baqsimiglucagon3 mgpowderAmphastar Pharmaceuticals, Inc.00548-8352-02Named Baqsimi 3 mg pwd 2 by Rhode Island Hospital, line 390 | 85,196.97 (Rhode Island Hospital, Schedule G, line 390, page 21 of the filing PDF) | 239 | ||||||||||||||||||||||||||||
| Belbucabuprenorphine hydrochloride600 mcgfilm, solubleBioDelivery Sciences International Inc59385-0025-60Named Belbuca 600 mcg FLM 60 by Rhode Island Hospital, line 808 | 10,115.15 (Rhode Island Hospital, Schedule G, line 808, page 32 of the filing PDF) | 41 | ||||||||||||||||||||||||||||
| Belbucabuprenorphine hydrochloride750 mcgfilm, solubleBioDelivery Sciences International Inc59385-0026-60Named Belbuca MIS 750 mcg by Thundermist Health Center, line 221 | 5,342.58 (Thundermist Health Center, Schedule G, line 221, page 12 of the filing PDF) | 17 | ||||||||||||||||||||||||||||
| Bendamustine Hydrochloride25 mg/mLinjection, solutionApotex Corp60505-6228-00Named Bendamustine HCl 100 mg/4 mL SOLN by Landmark Medical center, line 47 | 13,259.75 (Landmark Medical center, Schedule G, line 47, page 12 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| BeneFIXcoagulation factor ix (recombinant)kitWyeth BioPharma Division of Wyeth Pharmaceuticals LLC58394-0635-03Named BeneFIX-RT PDS 1,080 IU VL by Rhode Island Hospital, line 739 | 13,268.58 (Rhode Island Hospital, Schedule G, line 739, page 30 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| BeneFIXcoagulation factor ix (recombinant)kitWyeth BioPharma Division of Wyeth Pharmaceuticals LLC58394-0636-03Named BeneFIX-RT PDS 2,080 IU VL by Rhode Island Hospital, line 706 | 15,015.51 (Rhode Island Hospital, Schedule G, line 706, page 30 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| BeneFIXcoagulation factor ix (recombinant)kitWyeth BioPharma Division of Wyeth Pharmaceuticals LLC58394-0637-03Named BeneFIX-RT PDS 3,100 IU VL by Rhode Island Hospital, line 396 | 82,864.74 (Rhode Island Hospital, Schedule G, line 396, page 21 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Besponsainotuzumab ozogamicin0.25 mg/mLinjection, powder, lyophilized, for solutionWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.00008-0100-01Named Besponsa 0.9 mg SDV by Rhode Island Hospital, line 147 | 544,435.78 (Rhode Island Hospital, Schedule G, line 147, page 15 of the filing PDF) | 19 | ||||||||||||||||||||||||||||
| Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate30 mg; 120 mg; 15 mgtabletGilead Sciences, Inc.61958-2505-01Named Biktarvy 30-120-15 mg tablet by Kent County Memorial Hospital, line 294 | 13,203.41 (Kent County Memorial Hospital, Schedule G, line 294, page 18 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Bimzelxbimekizumab160 mg/mLinjection, solutionUCB, Inc.50474-0781-84Named Bimzelx 160 mg inj 1 mL by Rhode Island Hospital, line 493 | 45,495.42 (Rhode Island Hospital, Schedule G, line 493, page 24 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Bimzelxbimekizumab160 mg/mLinjection, solutionUCB, Inc.50474-0781-85Named Bimzelx 160 mg inj 2x1 mL by Rhode Island Hospital, line 151 | 514,892.89 (Rhode Island Hospital, Schedule G, line 151, page 15 of the filing PDF) | 68 | ||||||||||||||||||||||||||||
| Bimzelxbimekizumab320 mg/2 mLinjection, solutionUCB, Inc.50474-0783-78Named Bimzelx 320 mg/2 mL PFS kit by Kent County Memorial Hospital, line 378 | 5,327.36 (Kent County Memorial Hospital, Schedule G, line 378, page 20 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Bizengrizenocutuzumab20 mg/mLinjectionPartner Therapeutics, Inc.71837-1000-02Named Bizengri 375 mg SDV 2x18.75 mL DS by Rhode Island Hospital, line 236 | 237,428.75 (Rhode Island Hospital, Schedule G, line 236, page 17 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| BlincytoblinatumomabkitAmgen, Inc55513-0160-01Named Blincyto 35 mcg kit by Rhode Island Hospital, line 28 | 2,674,633.89 (Rhode Island Hospital, Schedule G, line 28, page 12 of the filing PDF) | 476 | ||||||||||||||||||||||||||||
| Breo Ellipta AEPB173088210Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 51 | 5,455.98 (Blackstone Valley Community Health Care, Schedule G, line 51, page 8 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Breynabudesonide and formoterol fumarate80 mcg; 4.5 mcgaerosol, meteredMylan Pharmaceuticals Inc.00378-7502-32Named Breyna 80/4.5 mcg oral inh (120 inh) by The Providence Community Health Centers, Inc, line 164 | 5,802.39 (The Providence Community Health Centers, Inc, Schedule G, line 164, page 13 of the filing PDF) | 46 | ||||||||||||||||||||||||||||
| Breynabudesonide and formoterol fumarate160 mcg; 4.5 mcgaerosol, meteredMylan Pharmaceuticals Inc.00378-7503-32Named Breyna 160/4.5 mcg oral inh(120 inh) by Thundermist Health Center, line 229 | 5,053.50 (Thundermist Health Center, Schedule G, line 229, page 12 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Briumviublituximab150 mg/6 mLinjection, solution, concentrateTG Therapeutics, Inc.73150-0150-06Named ublituximab (Briumvi) 450 mg in sodium chloride 0.9% 250 mL IVPB by Women & Infants Hospital of RI, line 135 | 52,364.20 (Women & Infants Hospital of RI, Schedule G, line 135, page 14 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Brixadibuprenorphine128 mg/0.36 mLinjectionBraeburn Inc.58284-0228-01Named Brixadi 128 mg ER PFS kit 0.36 mL by Rhode Island Hospital, line 262 | 204,277.67 (Rhode Island Hospital, Schedule G, line 262, page 18 of the filing PDF) | 177 | ||||||||||||||||||||||||||||
| Brixadibuprenorphine64 mg/0.18 mLinjectionBraeburn Inc.58284-0264-01Named Brixadi 64 mg ER PFS kit 0.18 mL by Rhode Island Hospital, line 570 | 30,682.75 (Rhode Island Hospital, Schedule G, line 570, page 26 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Budesonide9 mgtablet, extended releaseOceanside Pharmaceuticals68682-0309-30Named budesonide (Uceris) 9 mg TaDE by Women & Infants Hospital of RI, line 89 | 94,045.07 (Women & Infants Hospital of RI, Schedule G, line 89, page 12 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Buprenorphine10 mcg/hourpatchRhodes Pharmaceuticals LLC42858-0493-40Named Buprenorphine 10 mcg-hr pat 4 by Rhode Island Hospital, line 717 | 14,402.05 (Rhode Island Hospital, Schedule G, line 717, page 30 of the filing PDF) | 568 | ||||||||||||||||||||||||||||
| Buprenorphine5 mcg/hourpatchRhodes Pharmaceuticals LLC42858-0750-40Named Buprenorphine 5 mcg-hr pat 4 by Rhode Island Hospital, line 937 | 5,735.38 (Rhode Island Hospital, Schedule G, line 937, page 36 of the filing PDF) | 466 | ||||||||||||||||||||||||||||
| Buprenorphine and Naloxone8 mg; 2 mgtabletHikma Pharmaceuticals USA Inc.00054-0189-13Named Bupren/Nalox SUB 8-2 mg by Thundermist Health Center, line 117 | 18,152.68 (Thundermist Health Center, Schedule G, line 117, page 10 of the filing PDF) | 732 | ||||||||||||||||||||||||||||
| Buprenorphine and Naloxone8 mg; 2 mgfilmMylan Pharmaceuticals Inc.00378-8767-93Named Buprenorphine-Naloxone 8-2 mg FLM 30 by Rhode Island Hospital, line 736 | 13,509.38 (Rhode Island Hospital, Schedule G, line 736, page 30 of the filing PDF) | 277 | ||||||||||||||||||||||||||||
| Buprenorphine and Naloxone8 mg; 2 mgfilmIngenus Pharmaceuticals, LLC50742-0364-30Named Bupren/Nalox MIS 8-2 mg by Thundermist Health Center, line 29 | 101,992.92 (Thundermist Health Center, Schedule G, line 29, page 8 of the filing PDF) | 2,716 | ||||||||||||||||||||||||||||
| Buprenorphine and Naloxone8 mg; 2 mgtabletSun Pharmaceutical Industries, Inc.62756-0970-83Named Bupren/Nalox SUB 8-2 mg by Thundermist Health Center, line 197 | 6,304.33 (Thundermist Health Center, Schedule G, line 197, page 11 of the filing PDF) | 394 | ||||||||||||||||||||||||||||
| Buprenorphine and Naloxone Sublingual Film4 mg; 1 mgfilmAlvogen Inc.47781-0356-03Named Bupren/Nalox MIS 4-1 mg by Thundermist Health Center, line 210 | 5,596.15 (Thundermist Health Center, Schedule G, line 210, page 11 of the filing PDF) | 113 | ||||||||||||||||||||||||||||
| Buprenorphine and Naloxone Sublingual Film8 mg; 2 mgfilmAlvogen Inc.47781-0357-03Named Bupren/Nalox MIS 8-2 mg by Thundermist Health Center, line 69 | 41,770.71 (Thundermist Health Center, Schedule G, line 69, page 9 of the filing PDF) | 1,230 | ||||||||||||||||||||||||||||
| Buprenorphine HCl-Naloxon 12-3 film378876893Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 40 | 8,878.37 (Blackstone Valley Community Health Care, Schedule G, line 40, page 8 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Cabenuvacabotegravir and rilpivirinekitViiV Healthcare Company49702-0253-15Named Cabenuva 400-600 mg sus kit by The Miriam Hospital Ryan White Care Program, line 23 | 245,780.78 (The Miriam Hospital Ryan White Care Program, Schedule G, line 23, page 12 of the filing PDF) | 65 | ||||||||||||||||||||||||||||
| CablivicaplacizumabkitGenzyme Corporation58468-0225-01Named Cablivi 11 mg LYP pwd SDV kit by Rhode Island Hospital, line 271 | 188,395.50 (Rhode Island Hospital, Schedule G, line 271, page 18 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Calcium Gluconate in Sodium Chloridecalcium gluconate20 mg/mLinjection, solutionWG Critical Care, LLC44567-0621-24Named Calcium Glucon-NaCl 2,000 mg bag 24x100 mL by Rhode Island Hospital, line 842 | 8,493.20 (Rhode Island Hospital, Schedule G, line 842, page 33 of the filing PDF) | 463 | ||||||||||||||||||||||||||||
| Capecitabine500 mgtabletDr. Reddy's Laboratories Limited55111-0497-04Named Capecitabine 500 mg tab 120 by Rhode Island Hospital, line 914 | 6,336.18 (Rhode Island Hospital, Schedule G, line 914, page 35 of the filing PDF) | 293 | ||||||||||||||||||||||||||||
| Caplytalumateperone21 mgcapsuleIntra-Cellular Therapies, Inc72060-0121-40Named Caplyta cap 21 mg by Thundermist Health Center, line 82 | 32,362.13 (Thundermist Health Center, Schedule G, line 82, page 9 of the filing PDF) | 31 | ||||||||||||||||||||||||||||
| Carboplatin600 mg/60 mLinjection, solutionEugia US LLC55150-0386-01Named CARBOplatin 600 mg/60 mL SOLN by Women & Infants Hospital of RI, line 232 | 9,888.06 (Women & Infants Hospital of RI, Schedule G, line 232, page 16 of the filing PDF) | 142 | ||||||||||||||||||||||||||||
| Carboplatin10 mg/mLinjection, solutionHospira, Inc.61703-0339-50Named Carboplatin 450 mg MDV 45 mL by Rhode Island Hospital, line 551 | 34,907.85 (Rhode Island Hospital, Schedule G, line 551, page 25 of the filing PDF) | 1,571 | ||||||||||||||||||||||||||||
| Cardene IVnicardipine hydrochloride0.2 mg/mLinjection, solutionBaxter Healthcare Corporation43066-0016-10Named Cardene IV 40 mg bag 10x200 mL by Rhode Island Hospital, line 804 | 10,251.09 (Rhode Island Hospital, Schedule G, line 804, page 32 of the filing PDF) | 559 | ||||||||||||||||||||||||||||
| CaystonaztreonamkitGilead Sciences, Inc.61958-0901-01Named Cayston 75 mg 28day kit GIL by Rhode Island Hospital, line 417 | 74,248.76 (Rhode Island Hospital, Schedule G, line 417, page 22 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| Cefazolin2 ginjection, powder, for solutionHikma Pharmaceuticals USA Inc.00143-9139-25Named ceFAZolin Sodium 2 g SOLR by Women & Infants Hospital of RI, line 255 | 6,710.77 (Women & Infants Hospital of RI, Schedule G, line 255, page 17 of the filing PDF) | 2,651 | ||||||||||||||||||||||||||||
| Cefazolin Sodium2 g/50 mLsolutionB. Braun Medical Inc.00264-3105-11Named Cefazolin-Dext 2 g/50 mL DUP bag 24x50 mL by Rhode Island Hospital, line 625 | 22,159.93 (Rhode Island Hospital, Schedule G, line 625, page 27 of the filing PDF) | 2,614 | ||||||||||||||||||||||||||||
| Cefepime1 g/50 mLinjection, solutionBaxter Healthcare Corporation00338-1301-48Named Cefepime-Dext 2 g IVPB 12x100 mL DS by Rhode Island Hospital, line 829 | 8,935.65 (Rhode Island Hospital, Schedule G, line 829, page 33 of the filing PDF) | 689 | ||||||||||||||||||||||||||||
| Ceftriaxoneceftriaxone sodium1 g/50 mLinjection, solutionBaxter Healthcare Company00338-5002-41Named Ceftriaxone-Dext 1 g bag 24x50 mL DS by Rhode Island Hospital, line 635 | 21,480.32 (Rhode Island Hospital, Schedule G, line 635, page 28 of the filing PDF) | 2,403 | ||||||||||||||||||||||||||||
| Ceftriaxoneceftriaxone sodium2 g/50 mLinjection, solutionBaxter Healthcare Company00338-5003-41Named Ceftriaxone-Dext 2 g bag 24x50 mL DS by Rhode Island Hospital, line 647 | 20,324.97 (Rhode Island Hospital, Schedule G, line 647, page 28 of the filing PDF) | 933 | ||||||||||||||||||||||||||||
| Celestone Soluspanbetamethasone acetate and betamethasone sodium phosphate3 mg/mL; 3 mg/mLinjection, suspensionOrganon LLC78206-0118-01Named betamethasone acet,sod phos (Celestone) injection 12 mg by Women & Infants Hospital of RI, line 206 | 15,174.72 (Women & Infants Hospital of RI, Schedule G, line 206, page 15 of the filing PDF) | 418 | ||||||||||||||||||||||||||||
| Cephalexin125 mg/5 mLfor suspensionLupin Pharmaceuticals, Inc.68180-0440-01Named cephalexin (Kefelx) 125 mg/5 mL suspension by Women & Infants Hospital of RI, line 236 | 9,475.89 (Women & Infants Hospital of RI, Schedule G, line 236, page 16 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Cerezymeimiglucerase40 units/mLinjection, powder, lyophilized, for solutionGenzyme Corporation58468-4663-01Named Cerezyme inj 400 units by Rhode Island Hospital, line 75 | 1,073,665.99 (Rhode Island Hospital, Schedule G, line 75, page 13 of the filing PDF) | 777 | ||||||||||||||||||||||||||||
| Cibinqoabrocitinib100 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc00069-0335-30Named Cibinqo 100 mg tab 30 by Rhode Island Hospital, line 879 | 7,549.10 (Rhode Island Hospital, Schedule G, line 879, page 34 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Cibinqoabrocitinib200 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc00069-0435-30Named Cibinqo 200 mg tab 30 by Rhode Island Hospital, line 605 | 25,076.18 (Rhode Island Hospital, Schedule G, line 605, page 27 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Cimziacertolizumab pegolkitUCB, Inc.50474-0700-62Named Cimzia 2x200 mg/mL SDV kit by Rhode Island Hospital, line 261 | 206,739.49 (Rhode Island Hospital, Schedule G, line 261, page 18 of the filing PDF) | 117 | ||||||||||||||||||||||||||||
| Cimziacertolizumab pegol200 mg/mLinjection, solutionUCB, Inc.50474-0710-81Named Cimzia Start 2x200 mg/mL kit 3 by Rhode Island Hospital, line 897 | 6,907.28 (Rhode Island Hospital, Schedule G, line 897, page 35 of the filing PDF) | 15 | ||||||||||||||||||||||||||||
| Cinqairreslizumab10 mg/mLinjection, solution, concentrateTeva Respiratory, LLC59310-0610-31Named reslizumab (Cinqair) 410 mg in sodium chloride 0.9% 50 mL IVPB by Women & Infants Hospital of RI, line 148 | 43,655.71 (Women & Infants Hospital of RI, Schedule G, line 148, page 14 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Ciprofloxacin and dexamethasone3 mg/mL; 1 mg/mLsuspension/ dropsArmas Pharmaceuticals Inc.72485-0625-13Named Ciprofloxacin-Dexame 0.3-0.1% sus 7.5 mL by Rhode Island Hospital, line 932 | 5,795.90 (Rhode Island Hospital, Schedule G, line 932, page 36 of the filing PDF) | 373 | ||||||||||||||||||||||||||||
| Cobenfyxanomeline and trospium chloride100 mg; 20 mgcapsule, coated pelletsE.R. Squibb & Sons, L.L.C.00003-1100-60Named Cobenfy 100-20 mg cap 60 by Rhode Island Hospital, line 965 | 5,147.55 (Rhode Island Hospital, Schedule G, line 965, page 36 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Columviglofitamab2.5 mg/2.5 mLsolution, concentrateGenentech, Inc.50242-0125-01Named Columvi 2.5 mg SDV 2.5 mL by Rhode Island Hospital, line 810 | 10,090.12 (Rhode Island Hospital, Schedule G, line 810, page 32 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Columviglofitamab10 mg/10 mLconcentrateGenentech, Inc.50242-0127-01Named Columvi 10 mg SDV 10 mL by Rhode Island Hospital, line 65 | 1,239,274.72 (Rhode Island Hospital, Schedule G, line 65, page 13 of the filing PDF) | 55 | ||||||||||||||||||||||||||||
| Contrave Extended-Releasenaltrexone hydrochloride and bupropion hydrochloride8 mg; 90 mgtablet, extended releaseNalpropion Pharmaceuticals LLC51267-0890-99Named Contrave tab 8-90 mg by Thundermist Health Center, line 180 | 7,854.35 (Thundermist Health Center, Schedule G, line 180, page 11 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation00078-0639-97Named Cosentyx syringe 150 mg/mL by Rhode Island Hospital, line 696 | 15,560.25 (Rhode Island Hospital, Schedule G, line 696, page 29 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation00078-0639-98Named Cosentyx PFS 150 mg/mL 2 by Rhode Island Hospital, line 675 | 16,973.62 (Rhode Island Hospital, Schedule G, line 675, page 29 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Cosentyxsecukinumab25 mg/mLinjection, solution, concentrateNovartis Pharmaceuticals Corporation00078-1168-61Named Cosentyx 125 mg SDV 5 mL by Rhode Island Hospital, line 226 | 255,343.94 (Rhode Island Hospital, Schedule G, line 226, page 17 of the filing PDF) | 69 | ||||||||||||||||||||||||||||
| Creonpancrelipase60,000 USP units; 12,000 USP units; 38,000 USP unitscapsule, delayed release pelletsAbbVie Inc.00032-0047-70Named Creon 12,000 DR cap 100 by Rhode Island Hospital, line 615 | 23,185.33 (Rhode Island Hospital, Schedule G, line 615, page 27 of the filing PDF) | 173 | ||||||||||||||||||||||||||||
| Creonpancrelipase24,000 USP units; 76,000 USP units; 120,000 USP unitscapsule, delayed release pelletsAbbVie Inc.00032-2636-01Named Creon 24,000 DR cap 100 by Rhode Island Hospital, line 821 | 9,444.37 (Rhode Island Hospital, Schedule G, line 821, page 33 of the filing PDF) | 342 | ||||||||||||||||||||||||||||
| Crinoneprogesterone90 mg/1.125 ggelAllergan, Inc.00023-6151-08Named Crinone GL 8% 15x1.125 g PFA VAG by Women & Infants Hospital of RI, line 272 | 13,072.44 (Women & Infants Hospital of RI, Schedule G, line 272, page 17 of the filing PDF) | 48 | ||||||||||||||||||||||||||||
| Crysvitaburosumab20 mg/mLinjectionKyowa Kirin, Inc.42747-0203-01Named Crysvita inj 20 mg/mL by Rhode Island Hospital, line 206 | 313,127.65 (Rhode Island Hospital, Schedule G, line 206, page 16 of the filing PDF) | 32 | ||||||||||||||||||||||||||||
| Crysvitaburosumab30 mg/mLinjectionKyowa Kirin, Inc.42747-0304-01Named Crysvita inj 30 mg/mL by Rhode Island Hospital, line 110 | 719,549.66 (Rhode Island Hospital, Schedule G, line 110, page 14 of the filing PDF) | 44 | ||||||||||||||||||||||||||||
| Cyclophosphamide500 mg/25 mLinjection, powder, for solutionBaxter Healthcare Company10019-0955-01Named cycloPHOSphamide 500 mg PWDI by Women & Infants Hospital of RI, line 244 | 8,843.05 (Women & Infants Hospital of RI, Schedule G, line 244, page 16 of the filing PDF) | 224 | ||||||||||||||||||||||||||||
| Cyltezoadalimumab-adbmkitBoehringer Ingelheim Pharmaceuticals, Inc.00597-0375-97Named Cyltezo 40 mg-0.8 mL PFP kit 2 by Rhode Island Hospital, line 838 | 8,646.14 (Rhode Island Hospital, Schedule G, line 838, page 33 of the filing PDF) | 16 | ||||||||||||||||||||||||||||
| Cyltezoadalimumab-adbmkitBoehringer Ingelheim Pharmaceuticals, Inc.00597-0495-50Named Cyltezo 40 mg-0.4 mL PFP kit 2 by Rhode Island Hospital, line 612 | 23,910.39 (Rhode Island Hospital, Schedule G, line 612, page 27 of the filing PDF) | 44 | ||||||||||||||||||||||||||||
| Dactinomycin0.5 mg/mLinjection, powder, lyophilized, for solutionEugia US LLC55150-0431-01Named Dactinomycin 500 mcg SDV by Rhode Island Hospital, line 631 | 21,851.30 (Rhode Island Hospital, Schedule G, line 631, page 28 of the filing PDF) | 20 | ||||||||||||||||||||||||||||
| Dalvancedalbavancin500 mg/25 mLinjection, powder, for solutionAllergan, Inc.57970-0100-01Named Dalvance 500 mg VL by Rhode Island Hospital, line 699 | 15,499.60 (Rhode Island Hospital, Schedule G, line 699, page 29 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Dapagliflozin Propanediol tabs66993045630, 66993045730Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 13 | 36,497.74 (Blackstone Valley Community Health Care, Schedule G, line 13, page 8 of the filing PDF) | 206 | ||||||||||||||||||||||||||||
| daratumumab-hyaluronidase 1,800 mg-30,000 units INJ 15 mL7894050301Not grouped: the code is not filed as one 11-digit codeFiled by Kent County Memorial Hospital, line 3 | 1,240,777.54 (Kent County Memorial Hospital, Schedule G, line 3, page 10 of the filing PDF) | 206 | ||||||||||||||||||||||||||||
| Darzalex IVdaratumumab100 mg/5 mLinjection, solution, concentrateJanssen Biotech, Inc.57894-0505-05Named MPB Darzalex 100 mg/5 mL SDV by Kent County Memorial Hospital, line 361 | 6,127.96 (Kent County Memorial Hospital, Schedule G, line 361, page 19 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Dasatinib80 mgtablet, film coatedApotex Corp.60505-3816-03Named Dasatinib 80 mg tab 30 by Rhode Island Hospital, line 528 | 39,012.70 (Rhode Island Hospital, Schedule G, line 528, page 25 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| Dasatinib140 mgtablet, film coatedApotex Corp.60505-3817-03Named Dasatinib 140 mg tab 30 by Rhode Island Hospital, line 622 | 22,336.01 (Rhode Island Hospital, Schedule G, line 622, page 27 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Datrowaydatopotamab deruxtecan100 mg/5 mLinjection, powder, lyophilized, for solutionDaiichi Sankyo Inc.65597-0801-01Named Datroway 100 mg SDV by Rhode Island Hospital, line 352 | 112,006.20 (Rhode Island Hospital, Schedule G, line 352, page 20 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Decitabine50 mg/20 mLinjection, powder, lyophilized, for solutionMeitheal Pharmaceuticals Inc.71288-0119-20Named Decitabine 50 mg SDV by Rhode Island Hospital, line 930 | 5,868.43 (Rhode Island Hospital, Schedule G, line 930, page 35 of the filing PDF) | 401 | ||||||||||||||||||||||||||||
| Deferiprone1,000 mgtablet, coatedHikma Pharmaceuticals USA Inc.00054-0711-19Named Deferiprone 1,000 mg tab 50 by Rhode Island Hospital, line 539 | 37,527.20 (Rhode Island Hospital, Schedule G, line 539, page 25 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Deferiprone500 mgtabletSun Pharmaceutical Industries, Inc.51672-4196-01Named Deferiprone TB 500Mgtaro100@=@ by Kent County Memorial Hospital, line 232 | 25,114.83 (Kent County Memorial Hospital, Schedule G, line 232, page 16 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Dehydrated Alcoholalcohol1 mL/mLinjection, solutionBPI Labs, LLC54288-0105-15Named Ablysinol SOLN by Landmark Medical center, line 48 | 11,989.99 (Landmark Medical center, Schedule G, line 48, page 12 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Depo-Medrolmethylprednisolone acetate40 mg/mLinjection, suspensionPharmacia & Upjohn Company LLC00009-3073-03Named Depo Medrol 40 mg SDV 25x1 mL by Rhode Island Hospital, line 704 | 15,111.19 (Rhode Island Hospital, Schedule G, line 704, page 30 of the filing PDF) | 2,788 | ||||||||||||||||||||||||||||
| Descovyemtricitabine and tenofovir alafenamide200 mg; 25 mgtabletGilead Sciences, Inc.61958-2002-02Named Descovy 200 mg-25 mg tab 30 UD by The Miriam Hospital Immunology Center, line 8 | 8,762.95 (The Miriam Hospital Immunology Center, Schedule G, line 8, page 10 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Desmopressin Acetate4 mcg/mLinjection, solutionAvenacy, LLC83634-0451-10Named Desmopressin Acetate 40 mcg MDV 10 mL by Rhode Island Hospital, line 671 | 17,516.72 (Rhode Island Hospital, Schedule G, line 671, page 29 of the filing PDF) | 154 | ||||||||||||||||||||||||||||
| Dexamethasone4 mgtabletAmerican Health Packaging60687-0718-01Named Dexamethasone 4 mg tab 100 (10x10) by Rhode Island Hospital, line 888 | 7,284.17 (Rhode Island Hospital, Schedule G, line 888, page 34 of the filing PDF) | 5,127 | ||||||||||||||||||||||||||||
| Dexamethasone6 mgtabletAmerican Health Packaging60687-0729-01Named Dexamethasone 6 mg tab 100(10x10) by Rhode Island Hospital, line 800 | 10,458.15 (Rhode Island Hospital, Schedule G, line 800, page 32 of the filing PDF) | 4,232 | ||||||||||||||||||||||||||||
| Dexamethasone Sodium Phosphate4 mg/mLinjection, solutionMylan Institutional LLC67457-0423-12Named Dexamethasone 4 mg SDV 25x1 mL by Rhode Island Hospital, line 662 | 18,494.21 (Rhode Island Hospital, Schedule G, line 662, page 28 of the filing PDF) | 19,543 | ||||||||||||||||||||||||||||
| Dexcom G7 Sensor MISC8627007701Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 42 | 8,755.41 (Blackstone Valley Community Health Care, Schedule G, line 42, page 8 of the filing PDF) | 72 | ||||||||||||||||||||||||||||
| DexrazoxanekitEugia US LLC55150-0434-01Named Dexrazoxane-Sod Lac 250 mg SDV kit by Rhode Island Hospital, line 713 | 14,640.52 (Rhode Island Hospital, Schedule G, line 713, page 30 of the filing PDF) | 128 | ||||||||||||||||||||||||||||
| Diazepam10 mg/2 mLgelOceanside Pharmaceuticals68682-0652-20Named Diazepam rectal gel 10 mg kit 2 by Rhode Island Hospital, line 856 | 8,077.70 (Rhode Island Hospital, Schedule G, line 856, page 34 of the filing PDF) | 58 | ||||||||||||||||||||||||||||
| DigiFabovine digoxin immune fab40 mginjection, powder, lyophilized, for solutionBTG International Inc.50633-0120-11Named DigiFab 40 mg VL 1 by Rhode Island Hospital, line 618 | 22,930.15 (Rhode Island Hospital, Schedule G, line 618, page 27 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Diprivanpropofol10 mg/mLinjection, emulsionFresenius Kabi USA, LLC63323-0269-65Named Diprivan 1,000 mg EML VL 10x100 mL by Rhode Island Hospital, line 819 | 9,533.81 (Rhode Island Hospital, Schedule G, line 819, page 33 of the filing PDF) | 2,177 | ||||||||||||||||||||||||||||
| Docetaxel20 mg/mLinjection, solutionHospira, Inc.00409-0366-01Named DOCEtaxeL (Taxotere) 130 mg in sodium chloride 0.9% 250 mL IVPB by Women & Infants Hospital of RI, line 161 | 36,653.92 (Women & Infants Hospital of RI, Schedule G, line 161, page 14 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Docetaxel20 mg/mLinjection, solutionHospira, Inc.00409-0367-01Named Docetaxel 80 mg MDV 4 mL by Rhode Island Hospital, line 657 | 19,267.40 (Rhode Island Hospital, Schedule G, line 657, page 28 of the filing PDF) | 634 | ||||||||||||||||||||||||||||
| Docetaxeldocetaxel anhydrous20 mg/mLinjection, solutionSagent Pharmaceuticals25021-0245-04Named DOCEtaxeL (Taxotere) 104 mg in sodium chloride 0.9% 250 mL IVPB by Women & Infants Hospital of RI, line 268 | 5,270.58 (Women & Infants Hospital of RI, Schedule G, line 268, page 17 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Dopteletavatrombopag maleate20 mgtablet, film coatedAkaRx, Inc.71369-0020-10Named Doptelet 20 mg tab 10 by Rhode Island Hospital, line 278 | 182,442.57 (Rhode Island Hospital, Schedule G, line 278, page 18 of the filing PDF) | 38 | ||||||||||||||||||||||||||||
| Dopteletavatrombopag maleate20 mgtablet, film coatedAkaRx, Inc.71369-0020-30Named Doptelet 20 mg tab 30 by Rhode Island Hospital, line 99 | 771,861.13 (Rhode Island Hospital, Schedule G, line 99, page 14 of the filing PDF) | 71 | ||||||||||||||||||||||||||||
| Doxildoxorubicin hydrochloride2 mg/mLinjection, suspension, liposomalBaxter Healthcare Company00338-0063-01Named Doxil 20 mg SDV 10 mL by Rhode Island Hospital, line 789 | 10,800.32 (Rhode Island Hospital, Schedule G, line 789, page 32 of the filing PDF) | 43 | ||||||||||||||||||||||||||||
| Doxildoxorubicin hydrochloride2 mg/mLinjection, suspension, liposomalBaxter Healthcare Corporation00338-9667-01Named Doxil 20 mg SDV 10 mL by Rhode Island Hospital, line 786 | 10,987.32 (Rhode Island Hospital, Schedule G, line 786, page 32 of the filing PDF) | 44 | ||||||||||||||||||||||||||||
| Doxorubicin Hydrochloride2 mg/mLinjectable, liposomalZydus Pharmaceuticals USA Inc.70710-1531-01Named DOXOrubicin HCl Liposomal 2 mg/mL SUSP by Women & Infants Hospital of RI, line 231 | 10,027.47 (Women & Infants Hospital of RI, Schedule G, line 231, page 16 of the filing PDF) | 94 | ||||||||||||||||||||||||||||
| Doxycycline Hyclate 100 mg SOLR16714-0644-10The FDA directory does not list this code: the name is from the filingFiled by Women & Infants Hospital of RI, line 258 | 6,527.82 (Women & Infants Hospital of RI, Schedule G, line 258, page 17 of the filing PDF) | 374 | ||||||||||||||||||||||||||||
| Durolane 60 mg/3 mL PRSY89130-2020-01The FDA directory does not list this code: the name is from the filingFiled by Kent County Memorial Hospital, line 167 | 48,005.86 (Kent County Memorial Hospital, Schedule G, line 167, page 14 of the filing PDF) | 41 | ||||||||||||||||||||||||||||
| durvalumab (Imfinzi) 860 mg in sodium chloride 0.9% 250 mL IVPB0310450012Not grouped: the code is not filed as one 11-digit codeFiled by Kent County Memorial Hospital, line 210 | 30,287.32 (Kent County Memorial Hospital, Schedule G, line 210, page 16 of the filing PDF) | 20 | ||||||||||||||||||||||||||||
| Dysportbotulinum toxin type A500 unitsinjection, powder, lyophilized, for solutionIpsen Biopharmaceuticals, Inc.15054-0500-01Named Dysport 500 units SDV by Rhode Island Hospital, line 336 | 126,105.00 (Rhode Island Hospital, Schedule G, line 336, page 20 of the filing PDF) | 116 | ||||||||||||||||||||||||||||
| Dysportbotulinum toxin type A300 unitsinjection, powder, lyophilized, for solutionIpsen Biopharmaceuticals, Inc.15054-0530-06Named Dysport 300 units VL by Rhode Island Hospital, line 858 | 8,066.50 (Rhode Island Hospital, Schedule G, line 858, page 34 of the filing PDF) | 29 | ||||||||||||||||||||||||||||
| Ebglysslebrikizumab-lbkz250 mg/2 mLinjection, solutionEli Lilly and Company00002-7772-11Named Ebglyss 250 mg PFP 2 mL by Rhode Island Hospital, line 558 | 33,410.00 (Rhode Island Hospital, Schedule G, line 558, page 26 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Edurantrilpivirine hydrochloride25 mgtablet, film coatedJanssen Products, LP59676-0278-01Named Edurant 25 mg tab 30 by The Miriam Hospital Ryan White Care Program, line 26 | 22,241.16 (The Miriam Hospital Ryan White Care Program, Schedule G, line 26, page 12 of the filing PDF) | 41 | ||||||||||||||||||||||||||||
| Eligardleuprolide acetate22.5 mg/0.375 mLinjection, suspension, extended releaseTOLMAR Inc.62935-0227-10Named Eligard PSS 22.5 mg 3 month Rplcment kit by Rhode Island Hospital, line 170 | 426,311.86 (Rhode Island Hospital, Schedule G, line 170, page 15 of the filing PDF) | 1,279 | ||||||||||||||||||||||||||||
| Eligardleuprolide acetate45 mg/0.375 mLinjection, suspension, extended releaseTOLMAR Inc.62935-0461-50Named Eligard PSS 45 mg 6 month sus kit DS by Rhode Island Hospital, line 542 | 36,690.23 (Rhode Island Hospital, Schedule G, line 542, page 25 of the filing PDF) | 50 | ||||||||||||||||||||||||||||
| Eliquis tabs3089321, 3089421Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 7 | 97,349.06 (Blackstone Valley Community Health Care, Schedule G, line 7, page 8 of the filing PDF) | 127 | ||||||||||||||||||||||||||||
| Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc.71104-0802-01Named Eloctate kit 499 IU VL by Rhode Island Hospital, line 557 | 33,682.50 (Rhode Island Hospital, Schedule G, line 557, page 26 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc.71104-0803-01Named Eloctate kit 744 IU VL by Rhode Island Hospital, line 364 | 102,528.09 (Rhode Island Hospital, Schedule G, line 364, page 21 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc.71104-0805-01Named Eloctate kit 1,679 IU VL by Rhode Island Hospital, line 239 | 232,822.38 (Rhode Island Hospital, Schedule G, line 239, page 17 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc.71104-0806-01Named Eloctate kit 2,000 IU VL by Rhode Island Hospital, line 307 | 150,655.00 (Rhode Island Hospital, Schedule G, line 307, page 19 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc.71104-0807-01Named Eloctate kit 3,200 IU VL by Rhode Island Hospital, line 555 | 34,304.00 (Rhode Island Hospital, Schedule G, line 555, page 26 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Eloctateantihemophilic factor (recombinant), fc fusion proteinkitBioverativ Therapeutics Inc.71104-0808-01Named Eloctate kit 4,000 IU VL by Rhode Island Hospital, line 118 | 676,912.09 (Rhode Island Hospital, Schedule G, line 118, page 14 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Eltrombopageltrombopag olamine25 mgpowder, for suspensionCamber Pharmaceuticals, Inc.31722-0301-32Named Eltrombopag 25 mg oral sus 30 PKT kit by Rhode Island Hospital, line 752 | 12,627.27 (Rhode Island Hospital, Schedule G, line 752, page 31 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Eltrombopag12.5 mgtablet, film coatedCamber Pharmaceuticals, Inc.31722-0841-30Named Eltrombopag 12.5 mg tab 30 by Rhode Island Hospital, line 663 | 18,255.31 (Rhode Island Hospital, Schedule G, line 663, page 28 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Eltrombopag25 mgtablet, film coatedCamber Pharmaceuticals, Inc.31722-0842-30Named Eltrombopag 25 mg tab 30 by Rhode Island Hospital, line 484 | 46,591.03 (Rhode Island Hospital, Schedule G, line 484, page 24 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Eltrombopag50 mgtablet, film coatedCamber Pharmaceuticals, Inc.31722-0843-30Named Eltrombopag 50 mg tab 30 by Rhode Island Hospital, line 833 | 8,813.18 (Rhode Island Hospital, Schedule G, line 833, page 33 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Eltrombopag75 mgtablet, film coatedCamber Pharmaceuticals, Inc.31722-0844-30Named Eltrombopag 75 mg tab 30 by Rhode Island Hospital, line 492 | 45,516.90 (Rhode Island Hospital, Schedule G, line 492, page 24 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Emgalitygalcanezumab-gnlm120 mg/mLinjection, solutionEli Lilly and Company00002-2377-11Named Emgality inj PFS 120 mg 1 by Kent County Memorial Hospital, line 290 | 13,758.92 (Kent County Memorial Hospital, Schedule G, line 290, page 18 of the filing PDF) | 28 | ||||||||||||||||||||||||||||
| Emplicitielotuzumab400 mginjection, powder, lyophilized, for solutionE.R. Squibb & Sons, L.L.C.00003-4522-11Named elotuzumab (Empliciti) 2,400 mg in sodium chloride 0.9% 500 mL IVPB by Women & Infants Hospital of RI, line 64 | 145,351.17 (Women & Infants Hospital of RI, Schedule G, line 64, page 12 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Emrelistelisotuzumab vedotin20 mg/mLinjection, powder, lyophilized, for solutionAbbVie Inc.00074-1044-01Named telisotuzumab vedotin-tllv (Emrelis) 120 mg in sodium chloride 0.9% 50 mL IVPB by Women & Infants Hospital of RI, line 130 | 49,698.90 (Women & Infants Hospital of RI, Schedule G, line 130, page 13 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Emrelistelisotuzumab vedotin100 mg/mLinjection, powder, lyophilized, for solutionAbbVie Inc.00074-1055-01Named telisotuzumab vedotin tllv 100 mg PWDI by Women & Infants Hospital of RI, line 62 | 146,837.44 (Women & Infants Hospital of RI, Schedule G, line 62, page 12 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Emverm CHW 100 mg64896-0669-30The FDA directory does not list this code: the name is from the filingFiled by Thundermist Health Center, line 157 | 11,199.60 (Thundermist Health Center, Schedule G, line 157, page 10 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Enbreletanercept50 mg/mLsolutionImmunex Corporation58406-0021-04Named Enbrel 50 mg/mL inj (4 Syringes) by The Providence Community Health Centers, Inc, line 136 | 8,058.12 (The Providence Community Health Centers, Inc, Schedule G, line 136, page 13 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Enjaymosutimlimab-jome50 mg/mLinjection, solution, concentrateRecordati Rare Diseases, Inc.55292-0820-01Named MPB Enjaymo 1,100 mg/22 mL SDV by Kent County Memorial Hospital, line 170 | 45,205.20 (Kent County Memorial Hospital, Schedule G, line 170, page 14 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Entresto tab00078-0777-20, 00078-0777-67Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 52 | 5,424.49 (Blackstone Valley Community Health Care, Schedule G, line 52, page 8 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Envarsus XRtacrolimus1 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc68992-3010-01Named Envarsus XR 1 mg tab 100 by Rhode Island Hospital, line 518 | 40,799.03 (Rhode Island Hospital, Schedule G, line 518, page 25 of the filing PDF) | 149 | ||||||||||||||||||||||||||||
| Envarsus XRtacrolimus1 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc68992-3010-03Named Envarsus XR 1 mg tab 30 by Rhode Island Hospital, line 730 | 13,736.29 (Rhode Island Hospital, Schedule G, line 730, page 30 of the filing PDF) | 635 | ||||||||||||||||||||||||||||
| Envarsus XRtacrolimus4 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc68992-3040-01Named Envarsus 4 mg tab 100 by Rhode Island Hospital, line 435 | 66,056.53 (Rhode Island Hospital, Schedule G, line 435, page 22 of the filing PDF) | 434 | ||||||||||||||||||||||||||||
| Envarsus XRtacrolimus0.75 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc68992-3075-01Named Envarsus 0.75 mg tab 100 by Rhode Island Hospital, line 759 | 12,210.95 (Rhode Island Hospital, Schedule G, line 759, page 31 of the filing PDF) | 290 | ||||||||||||||||||||||||||||
| Envarsus XRtacrolimus0.75 mgtablet, extended releaseVeloxis Pharmaceuticals, Inc68992-3075-03Named Envarsus XR 0.75 mg tab 30 by Rhode Island Hospital, line 849 | 8,263.70 (Rhode Island Hospital, Schedule G, line 849, page 33 of the filing PDF) | 67 | ||||||||||||||||||||||||||||
| Eohiliabudesonide2 mg/10 mLsuspensionTakeda Pharmaceuticals America, Inc.64764-0105-60Named Eohilia 2 mg sus PKT 60x10 mL by Rhode Island Hospital, line 855 | 8,091.51 (Rhode Island Hospital, Schedule G, line 855, page 33 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Epidiolexcannabidiol100 mg/mLsolutionJazz Pharmaceuticals, Inc.70127-0100-10Named Epidiolex 100 mg/mL sol kit 100 mL by Rhode Island Hospital, line 102 | 762,519.41 (Rhode Island Hospital, Schedule G, line 102, page 14 of the filing PDF) | 432 | ||||||||||||||||||||||||||||
| Epidiolexcannabidiol100 mg/mLsolutionJazz Pharmaceuticals, Inc.70127-0100-60Named Epidiolex 100 mg/mL sol kit 60 mL by Rhode Island Hospital, line 215 | 287,073.29 (Rhode Island Hospital, Schedule G, line 215, page 17 of the filing PDF) | 136 | ||||||||||||||||||||||||||||
| Epinephrine0.15 mg/0.3 mLinjectionTeva Pharmaceuticals USA, Inc.00093-5985-27Named Epinephrine inj 0.15 mg by Thundermist Health Center, line 170 | 9,148.82 (Thundermist Health Center, Schedule G, line 170, page 11 of the filing PDF) | 41 | ||||||||||||||||||||||||||||
| Epinephrine0.3 mg/0.3 mLinjectionViatris Specialty LLC49502-0102-02Named Epinephrine 0.3 mg inj PFS 2 by Rhode Island Hospital, line 872 | 7,636.04 (Rhode Island Hospital, Schedule G, line 872, page 34 of the filing PDF) | 268 | ||||||||||||||||||||||||||||
| Epkinlyepcoritamab-bysp4 mg/0.8 mLinjection, solutionGenmab US, Inc.82705-0002-01Named Epkinly 4 mg SDV 0.8 mL by Rhode Island Hospital, line 923 | 6,027.42 (Rhode Island Hospital, Schedule G, line 923, page 35 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Epkinlyepcoritamab-bysp48 mg/0.8 mLinjection, solutionGenmab US, Inc.82705-0010-01Named Epkinly 48 mg SDV 0.8 mL by Rhode Island Hospital, line 157 | 493,545.78 (Rhode Island Hospital, Schedule G, line 157, page 15 of the filing PDF) | 36 | ||||||||||||||||||||||||||||
| Eprontiatopiramate25 mg/mLsolutionAzurity Pharmaceuticals, Inc.52652-9001-01Named Eprontia 25 mg oral sol 473 mL by Rhode Island Hospital, line 843 | 8,481.97 (Rhode Island Hospital, Schedule G, line 843, page 33 of the filing PDF) | 37 | ||||||||||||||||||||||||||||
| Eribulin Mesylate0.5 mg/mLinjectionApotex Corp.60505-6289-00Named Eribulin Mesylate 1 mg SDV 2 mL by Rhode Island Hospital, line 714 | 14,617.08 (Rhode Island Hospital, Schedule G, line 714, page 30 of the filing PDF) | 16 | ||||||||||||||||||||||||||||
| Erivedgevismodegib150 mgcapsuleGenentech, Inc.50242-0140-01Named Erivedge 150 mg cap 28 by Rhode Island Hospital, line 401 | 80,088.20 (Rhode Island Hospital, Schedule G, line 401, page 22 of the filing PDF) | 17 | ||||||||||||||||||||||||||||
| Esbrietpirfenidone801 mgtablet, coatedGenentech, Inc.50242-0123-01Named MPB Esbriet 801 mg tab 90 by Kent County Memorial Hospital, line 142 | 62,538.08 (Kent County Memorial Hospital, Schedule G, line 142, page 14 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Esbriet 267 mg cap 27050242-0121-01The FDA directory does not list this code: the name is from the filingFiled by Rhode Island Hospital, line 859 | 7,934.36 (Rhode Island Hospital, Schedule G, line 859, page 34 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Esperoctantihemophilic factor (recombinant), glycopegylated-exeikitNovo Nordisk00169-8100-01Named Esperoct 1,082 IU VL by Rhode Island Hospital, line 792 | 10,674.66 (Rhode Island Hospital, Schedule G, line 792, page 32 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Esperoctantihemophilic factor (recombinant), glycopegylated-exeikitNovo Nordisk00169-8200-01Named Esperoct 2,235 IU VL by Rhode Island Hospital, line 901 | 6,749.70 (Rhode Island Hospital, Schedule G, line 901, page 35 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Estradiol Valerate20 mg/mLinjectionHikma Pharmaceuticals USA Inc.00143-9290-01Named Estrad Val inj 20 mg/mL by Thundermist Health Center, line 219 | 5,384.34 (Thundermist Health Center, Schedule G, line 219, page 12 of the filing PDF) | 88 | ||||||||||||||||||||||||||||
| Estradiol Valerate40 mg/mLinjectionHikma Pharmaceuticals USA Inc.00143-9291-01Named Estrad Val inj 40 mg/mL by Thundermist Health Center, line 220 | 5,368.75 (Thundermist Health Center, Schedule G, line 220, page 12 of the filing PDF) | 57 | ||||||||||||||||||||||||||||
| Estradiol valerate10 mg/mLinjectionXiromed, LLC70700-0273-22Named Estrad Val inj 10 mg/mL by Thundermist Health Center, line 171 | 8,840.57 (Thundermist Health Center, Schedule G, line 171, page 11 of the filing PDF) | 91 | ||||||||||||||||||||||||||||
| Estradiol valerate20 mg/mLinjectionXiromed, LLC70700-0274-22Named Estrad Val inj 20 mg/mL by Thundermist Health Center, line 135 | 15,209.62 (Thundermist Health Center, Schedule G, line 135, page 10 of the filing PDF) | 213 | ||||||||||||||||||||||||||||
| Estradiol valerate40 mg/mLinjectionXiromed, LLC70700-0275-22Named Estrad Val inj 40 mg/mL by Thundermist Health Center, line 212 | 5,562.88 (Thundermist Health Center, Schedule G, line 212, page 11 of the filing PDF) | 47 | ||||||||||||||||||||||||||||
| Etoposide50 mgcapsuleMylan Pharmaceuticals Inc.00378-3266-94Named Etoposide 50 mg cap 20 BP by Rhode Island Hospital, line 793 | 10,662.06 (Rhode Island Hospital, Schedule G, line 793, page 32 of the filing PDF) | 15 | ||||||||||||||||||||||||||||
| Etoposide20 mg/mLinjectionAccord Healthcare Inc.16729-0114-11Named Etoposide 1 g MDV 50 mL by Rhode Island Hospital, line 835 | 8,780.72 (Rhode Island Hospital, Schedule G, line 835, page 33 of the filing PDF) | 842 | ||||||||||||||||||||||||||||
| Everolimus5 mgtabletHikma Pharmaceuticals USA Inc.00054-0481-13Named Everolimus 5 mg tab 30 by Rhode Island Hospital, line 769 | 11,599.25 (Rhode Island Hospital, Schedule G, line 769, page 31 of the filing PDF) | 24 | ||||||||||||||||||||||||||||
| Everolimus10 mgtabletHikma Pharmaceuticals USA Inc.00054-0482-13Named Everolimus 10 mg tab 30 by Rhode Island Hospital, line 959 | 5,289.34 (Rhode Island Hospital, Schedule G, line 959, page 36 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Everolimus5 mgtabletBiocon Pharma Inc.70377-0011-23Named everolimus, antineoplastic, 5 mg Tab by Women & Infants Hospital of RI, line 224 | 11,170.62 (Women & Infants Hospital of RI, Schedule G, line 224, page 16 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Exparelbupivacaine13.3 mg/mLinjection, suspension, liposomalPacira Pharmaceuticals, Inc.65250-0133-04Named Exparel 1.3% SUSP by Women & Infants Hospital of RI, line 67 | 133,592.70 (Women & Infants Hospital of RI, Schedule G, line 67, page 12 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Exparelbupivacaine13.3 mg/mLinjection, suspension, liposomalPacira Pharmaceuticals, Inc.65250-0133-09Named Exparel 1.3% SUSP by Kent County Memorial Hospital, line 250 | 21,434.43 (Kent County Memorial Hospital, Schedule G, line 250, page 17 of the filing PDF) | 156 | ||||||||||||||||||||||||||||
| Exparelbupivacaine13.3 mg/mLinjection, suspension, liposomalPacira Pharmaceuticals, Inc.65250-0266-09Named Exparel 1.3% SUSP by Kent County Memorial Hospital, line 309 | 10,998.39 (Kent County Memorial Hospital, Schedule G, line 309, page 18 of the filing PDF) | 48 | ||||||||||||||||||||||||||||
| Eyleaaflibercept40 mg/mLinjection, solutionRegeneron Pharmaceuticals, Inc.61755-0005-02Named Eylea 2 mg VL kit PAP by Rhode Island Hospital, line 651 | 19,561.16 (Rhode Island Hospital, Schedule G, line 651, page 28 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Fabrazymeagalsidase beta5 mg/mLinjection, powder, lyophilized, for solutionGenzyme Corporation58468-0040-01Named Fabrazyme vial 35 mg D/S by Rhode Island Hospital, line 59 | 1,363,847.54 (Rhode Island Hospital, Schedule G, line 59, page 13 of the filing PDF) | 182 | ||||||||||||||||||||||||||||
| Fabrazymeagalsidase beta5 mg/mLinjection, powder, lyophilized, for solutionGenzyme Corporation58468-0041-01Named Fabrazyme vial 5 mg D/S by Rhode Island Hospital, line 232 | 240,447.90 (Rhode Island Hospital, Schedule G, line 232, page 17 of the filing PDF) | 262 | ||||||||||||||||||||||||||||
| Farxiga tabs310621030, 310621090, 310620530, 310620590Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 5 | 173,518.31 (Blackstone Valley Community Health Care, Schedule G, line 5, page 8 of the filing PDF) | 206 | ||||||||||||||||||||||||||||
| Fensolvileuprolide acetate45 mg/0.375 mLinjection, suspension, extended releaseTOLMAR Inc.62935-0163-60Named Fensolvi 45 mg SYG kit DS by Rhode Island Hospital, line 543 | 36,573.67 (Rhode Island Hospital, Schedule G, line 543, page 25 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Fentanyl100 mcg/hourpatchMylan Pharmaceuticals Inc.00378-9124-98Named fentaNYL (Duragesic) 100 mcg/hr by Women & Infants Hospital of RI, line 263 | 5,887.96 (Women & Infants Hospital of RI, Schedule G, line 263, page 17 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Fentanyl Citrate50 mcg/mLinjection, solutionHospira, Inc.00409-9094-22Named Fentanyl Cit PF 100 mcg SDV 25x2 mL by Rhode Island Hospital, line 788 | 10,880.24 (Rhode Island Hospital, Schedule G, line 788, page 32 of the filing PDF) | 27,726 | ||||||||||||||||||||||||||||
| FirmagondegarelixkitFerring Pharmaceuticals Inc.55566-8303-01Named Firmagon 80 mg kit by Rhode Island Hospital, line 342 | 120,102.73 (Rhode Island Hospital, Schedule G, line 342, page 20 of the filing PDF) | 415 | ||||||||||||||||||||||||||||
| FirmagondegarelixkitFerring Pharmaceuticals Inc.55566-8403-01Named Firmagon 240 mg kit by Rhode Island Hospital, line 400 | 80,102.17 (Rhode Island Hospital, Schedule G, line 400, page 22 of the filing PDF) | 99 | ||||||||||||||||||||||||||||
| Fluorouracil50 mg/mLinjection, solutionFresenius Kabi USA, LLC63323-0117-51Named Fluorouracil 2.5 g PBP VL 50 mL by Rhode Island Hospital, line 498 | 44,545.93 (Rhode Island Hospital, Schedule G, line 498, page 24 of the filing PDF) | 2,865 | ||||||||||||||||||||||||||||
| Fluticasone Propionate50 mcgspray, meteredHikma Pharmaceuticals USA Inc.00054-3270-99Named Fluticasone spr 50 mcg by Thundermist Health Center, line 126 | 16,049.07 (Thundermist Health Center, Schedule G, line 126, page 10 of the filing PDF) | 4,528 | ||||||||||||||||||||||||||||
| Fluticasone Propionate and Salmeterol HFAfluticasone propionate and salmeterol xinafoate45 mcg; 21 mcgaerosol, meteredPrasco Laboratories66993-0086-96Named Flutic/Salme aer 45-21 mcg by Thundermist Health Center, line 215 | 5,446.85 (Thundermist Health Center, Schedule G, line 215, page 11 of the filing PDF) | 42 | ||||||||||||||||||||||||||||
| Fluticasone Propionate and Salmeterol HFAfluticasone propionate and salmeterol xinafoate115 mcg; 21 mcgaerosol, meteredPrasco Laboratories66993-0087-96Named Flutic/Salme aer 115-21 by Thundermist Health Center, line 191 | 7,311.27 (Thundermist Health Center, Schedule G, line 191, page 11 of the filing PDF) | 45 | ||||||||||||||||||||||||||||
| Fluticasone Propionate and Salmeterol HFAfluticasone propionate and salmeterol xinafoate230 mcg; 21 mcgaerosol, meteredPrasco Laboratories66993-0088-96Named Flutic/Salme aer 230-21 by Thundermist Health Center, line 203 | 5,955.03 (Thundermist Health Center, Schedule G, line 203, page 11 of the filing PDF) | 28 | ||||||||||||||||||||||||||||
| Follistim AQfollitropin900 IU/1.08 mLinjection, solutionOrganon LLC78206-0131-01Named Follistim AQ 900 units Cartridg by Women & Infants Hospital of RI, line 141 | 46,939.24 (Women & Infants Hospital of RI, Schedule G, line 141, page 14 of the filing PDF) | 152 | ||||||||||||||||||||||||||||
| Folotynpralatrexate40 mg/2 mLinjectionAcrotech Biopharma Inc72893-0005-01Named Folotyn 40 mg VL 2 mL by Rhode Island Hospital, line 254 | 214,922.25 (Rhode Island Hospital, Schedule G, line 254, page 18 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Fosaprepitantfosaprepitant dimeglumine150 mg/5 mLinjection, powder, lyophilized, for solutionNorthStar RxLLC16714-0248-01Named fosaprepitant (Emend) 150 mg in sodium chloride 250 mL IVPB by Women & Infants Hospital of RI, line 247 | 7,358.66 (Women & Infants Hospital of RI, Schedule G, line 247, page 16 of the filing PDF) | 209 | ||||||||||||||||||||||||||||
| Fosaprepitant150 mg/5 mLinjection, powder, lyophilized, for solutionNovadoz Pharmaceuticals LLC72205-0054-01Named Fosaprepitant 150 mg SDV by Rhode Island Hospital, line 545 | 36,296.77 (Rhode Island Hospital, Schedule G, line 545, page 25 of the filing PDF) | 3,660 | ||||||||||||||||||||||||||||
| Fotivdativozanib0.89 mgcapsuleAVEO Pharmaceuticals, Inc.45629-0089-01The FDA directory lists this product, not this packageNamed MPB Fotivda 0.89 mg caps 21 by Kent County Memorial Hospital, line 178 | 42,219.70 (Kent County Memorial Hospital, Schedule G, line 178, page 15 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Fotivdativozanib0.89 mgcapsuleAVEO Pharmaceuticals, Inc.45629-0089-02Named MPB Fotivda 0.89 mg caps 21 by Kent County Memorial Hospital, line 177 | 42,752.70 (Kent County Memorial Hospital, Schedule G, line 177, page 15 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Freestyle Libre 2 Sensor MISC57599-0800-00The FDA directory does not list this code: the name is from the filingFiled by Blackstone Valley Community Health Care, line 25 | 19,095.20 (Blackstone Valley Community Health Care, Schedule G, line 25, page 8 of the filing PDF) | 100 | ||||||||||||||||||||||||||||
| Fruzaqlafruquintinib5 mgcapsuleTakeda Pharmaceuticals America, Inc.63020-0225-21Named Fruzaqla 5 mg cap 21 by Rhode Island Hospital, line 452 | 58,571.22 (Rhode Island Hospital, Schedule G, line 452, page 23 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Fulphilapegfilgrastim-jmdb6 mg/0.6 mLinjectionBiocon Biologics Inc.83257-0005-41Named Fulphila 6 mg PFS 0.6 mL by Rhode Island Hospital, line 176 | 393,619.18 (Rhode Island Hospital, Schedule G, line 176, page 16 of the filing PDF) | 637 | ||||||||||||||||||||||||||||
| Fulvestrant50 mg/mLinjectionHikma Pharmaceuticals USA Inc.00143-9022-02Named Fulvestrant 250 mg PFS 2x5 mL by Rhode Island Hospital, line 633 | 21,698.78 (Rhode Island Hospital, Schedule G, line 633, page 28 of the filing PDF) | 420 | ||||||||||||||||||||||||||||
| Furosemide10 mg/mLinjection, solutionHospira, Inc.00409-6102-10Named Furosemide 10 mg/mL SOLN by Kent County Memorial Hospital, line 366 | 5,931.54 (Kent County Memorial Hospital, Schedule G, line 366, page 20 of the filing PDF) | 1,281 | ||||||||||||||||||||||||||||
| Fycompaperampanel8 mgtabletCatalyst Pharmaceuticals, Inc.69616-0278-30Named Fycompa tab 8 mg by Wood River Health Services, Inc., line 4 | 6,066 (Wood River Health Services, Inc., Schedule G, line 4, page 8 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Gabapentin800 mgtablet, film coatedGranules Pharmaceuticals Inc.70010-0228-05Named Gabapentin tab 800 mg by Thundermist Health Center, line 208 | 5,656.05 (Thundermist Health Center, Schedule G, line 208, page 11 of the filing PDF) | 1,162 | ||||||||||||||||||||||||||||
| Gablofenbaclofen injection1,000 mcg/mLinjection, solutionPiramal Critical Care Inc66794-0156-01Named Gablofen 20 MU mcg PFS 20 mL DS by Rhode Island Hospital, line 680 | 16,709.00 (Rhode Island Hospital, Schedule G, line 680, page 29 of the filing PDF) | 40 | ||||||||||||||||||||||||||||
| Gablofenbaclofen injection2,000 mcg/mLinjection, solutionPiramal Critical Care Inc66794-0157-01Named Gablofen 2,000 mcg/mL PFS 20 mL DS by Rhode Island Hospital, line 341 | 120,840.00 (Rhode Island Hospital, Schedule G, line 341, page 20 of the filing PDF) | 120 | ||||||||||||||||||||||||||||
| Gammagard Liquidimmune globulin infusion (human)100 mg/mLinjection, solutionTakeda Pharmaceuticals America, Inc.00944-2700-04Named Gammagard 10% 5 g VL 50 mL DS by Rhode Island Hospital, line 212 | 291,195.24 (Rhode Island Hospital, Schedule G, line 212, page 17 of the filing PDF) | 711 | ||||||||||||||||||||||||||||
| Gammagard S/Dimmune globulin intravenous (human)kitTakeda Pharmaceuticals America, Inc.00944-2658-04Named Gammagard SD inj 10 g HU by Rhode Island Hospital, line 424 | 70,895.35 (Rhode Island Hospital, Schedule G, line 424, page 22 of the filing PDF) | 234 | ||||||||||||||||||||||||||||
| Ganirelix Acetate250 mcg/0.5 mLinjectionAmphastar Pharmaceuticals, Inc.00548-5001-00Named ganirelix 250 mcg/0.5 mL Syrg by Women & Infants Hospital of RI, line 216 | 12,554.61 (Women & Infants Hospital of RI, Schedule G, line 216, page 16 of the filing PDF) | 115 | ||||||||||||||||||||||||||||
| GattexteduglutidekitTakeda Pharmaceuticals America, Inc.68875-0102-01Named Gattex Ancillary 5 mg kit 30 by Rhode Island Hospital, line 142 | 561,227.62 (Rhode Island Hospital, Schedule G, line 142, page 15 of the filing PDF) | 25 | ||||||||||||||||||||||||||||
| Gavretopralsetinib100 mgcapsuleRigel Pharmaceuticals, Inc.71332-0006-60Named Gavreto 100 mg cap 60 by Rhode Island Hospital, line 229 | 247,485.01 (Rhode Island Hospital, Schedule G, line 229, page 17 of the filing PDF) | 24 | ||||||||||||||||||||||||||||
| Gemcitabinegemcitabine hydrochloride1 ginjection, powder, lyophilized, for solutionMeitheal Pharmaceuticals Inc.71288-0114-50Named Gemcitabine 1 g SDV by Rhode Island Hospital, line 458 | 56,330.79 (Rhode Island Hospital, Schedule G, line 458, page 23 of the filing PDF) | 1,743 | ||||||||||||||||||||||||||||
| Gemtesavibegron75 mgtablet, film coatedSumitomo Pharma America, Inc.73336-0075-90Named Gemtesa tab 75 mg by Women & Infants Hospital of RI, line 274 | 5,040.96 (Women & Infants Hospital of RI, Schedule G, line 274, page 17 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| GenotropinsomatropinkitPfizer Laboratories Div Pfizer Inc00013-2626-81Named Genotropin 5 mg SYG CRT 1 by Rhode Island Hospital, line 944 | 5,576.64 (Rhode Island Hospital, Schedule G, line 944, page 36 of the filing PDF) | 37 | ||||||||||||||||||||||||||||
| GenotropinsomatropinkitPfizer Laboratories Div Pfizer Inc00013-2646-81Named Genotropin 12 mg CRT by Rhode Island Hospital, line 432 | 67,269.56 (Rhode Island Hospital, Schedule G, line 432, page 22 of the filing PDF) | 88 | ||||||||||||||||||||||||||||
| GenotropinsomatropinkitPfizer Laboratories Div Pfizer Inc00013-2658-02Named Genotropin M/Q 2 mg SYG 7 by Rhode Island Hospital, line 939 | 5,680.91 (Rhode Island Hospital, Schedule G, line 939, page 36 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Glatopaglatiramer acetate20 mg/mLinjection, solutionSandoz Inc00781-3234-34Named Glatopa 20 mg PFS 30x1 mL by Rhode Island Hospital, line 904 | 6,619.38 (Rhode Island Hospital, Schedule G, line 904, page 35 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Glatopaglatiramer acetate40 mg/mLinjection, solutionSandoz Inc00781-3250-89Named Glatopa 40 mg/mL syringe by Kent County Memorial Hospital, line 297 | 12,904.71 (Kent County Memorial Hospital, Schedule G, line 297, page 18 of the filing PDF) | 27 | ||||||||||||||||||||||||||||
| Gleevecimatinib mesylate100 mgtabletNovartis Pharmaceuticals Corporation00078-0401-34Named Gleevec 100 mg tab 90 by Rhode Island Hospital, line 609 | 24,346.71 (Rhode Island Hospital, Schedule G, line 609, page 27 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Gleevecimatinib mesylate400 mgtabletNovartis Pharmaceuticals Corporation00078-0649-13Named Gleevec 400 mg tab 30 (3x10) BP by Rhode Island Hospital, line 392 | 84,672.95 (Rhode Island Hospital, Schedule G, line 392, page 21 of the filing PDF) | 22 | ||||||||||||||||||||||||||||
| Gleostinelomustine100 mgcapsule, gelatin coatedNextSource Biotechnology, LLC58181-3042-05Named Gleostine 100 mg cap 5 by Rhode Island Hospital, line 655 | 19,417.62 (Rhode Island Hospital, Schedule G, line 655, page 28 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Gliadelcarmustine7.7 mgwaferAzurity Pharmaceuticals, Inc.24338-0050-08Named Gliadel WAF 8 DS by Rhode Island Hospital, line 832 | 8,868.51 (Rhode Island Hospital, Schedule G, line 832, page 33 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| GlucagonkitFresenius Kabi USA, LLC63323-0593-03Named Glucagon HCl (Diagnostic) 1 mg SOLR by Kent County Memorial Hospital, line 328 | 8,840.87 (Kent County Memorial Hospital, Schedule G, line 328, page 19 of the filing PDF) | 81 | ||||||||||||||||||||||||||||
| Glucagon1 mg/mLinjection, powder, lyophilized, for solutionFresenius Kabi USA, LLC63323-0596-13Named Glucagon 1 mg VL 10x3 mL by Rhode Island Hospital, line 382 | 89,251.68 (Rhode Island Hospital, Schedule G, line 382, page 21 of the filing PDF) | 354 | ||||||||||||||||||||||||||||
| Glydolidocaine hydrochloride20 mg/mLjellySagent Pharmaceuticals25021-0673-76Named Glydo 2% PRSY by Women & Infants Hospital of RI, line 269 | 5,163.61 (Women & Infants Hospital of RI, Schedule G, line 269, page 17 of the filing PDF) | 1,939 | ||||||||||||||||||||||||||||
| Glydolidocaine hydrochloride20 mg/mLjellySagent Pharmaceuticals25021-0673-77Named Lidocaine 2% Glydo Jelly 10x11 mL by Rhode Island Hospital, line 844 | 8,474.95 (Rhode Island Hospital, Schedule G, line 844, page 33 of the filing PDF) | 1,718 | ||||||||||||||||||||||||||||
| Gvoke HypoPen 0.5 mg Auto-Injectorglucagon injection, solution0.5 mg/0.1 mLinjection, solutionXeris Pharmaceuticals, Inc.72065-0120-12Named Gvoke HypoPen 2-pack 0.5 mg per 0.1 mL by Rhode Island Hospital, line 882 | 7,487.98 (Rhode Island Hospital, Schedule G, line 882, page 34 of the filing PDF) | 23 | ||||||||||||||||||||||||||||
| Hadlimaadalimumab-bwwd40 mg/0.8 mLsolutionOrganon LLC78206-0184-01Named Hadlima Pushtouch 40 mg auto inj 2x0.8 mL by Rhode Island Hospital, line 878 | 7,580.85 (Rhode Island Hospital, Schedule G, line 878, page 34 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Hemgenixetranacogene dezaparvoveckitCSL Behring00053-0230-23Named Hemgenix 111-115 kg by Rhode Island Hospital, line 26 | 2,691,500.00 (Rhode Island Hospital, Schedule G, line 26, page 12 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Hemlibraemicizumab30 mg/mLinjection, solutionGenentech, Inc.50242-0920-01Named Hemlibra 30 mg SDV by Rhode Island Hospital, line 783 | 11,014.48 (Rhode Island Hospital, Schedule G, line 783, page 32 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Hemlibraemicizumab60 mg/0.4 mLinjection, solutionGenentech, Inc.50242-0921-01Named Hemlibra 60 mg SDV 0.4 mL by Rhode Island Hospital, line 33 | 2,427,512.64 (Rhode Island Hospital, Schedule G, line 33, page 12 of the filing PDF) | 119 | ||||||||||||||||||||||||||||
| Hemlibraemicizumab105 mg/0.7 mLinjection, solutionGenentech, Inc.50242-0922-01Named Hemlibra 105 mg SDV 0.7 mL by Rhode Island Hospital, line 9 | 4,336,357.33 (Rhode Island Hospital, Schedule G, line 9, page 11 of the filing PDF) | 159 | ||||||||||||||||||||||||||||
| Hemlibraemicizumab150 mg/mLinjection, solutionGenentech, Inc.50242-0923-01Named Hemlibra 150 mg SDV 1 mL by Rhode Island Hospital, line 40 | 2,147,248.82 (Rhode Island Hospital, Schedule G, line 40, page 12 of the filing PDF) | 61 | ||||||||||||||||||||||||||||
| Hemlibraemicizumab300 mg/2 mLinjection, solutionGenentech, Inc.50242-0930-01Named Hemlibra 300 mg SDV 2 mL by Rhode Island Hospital, line 53 | 1,620,840.11 (Rhode Island Hospital, Schedule G, line 53, page 12 of the filing PDF) | 44 | ||||||||||||||||||||||||||||
| Hemofil Mantihemophilic factor humankitTakeda Pharmaceuticals America, Inc.00944-3946-02Named Hemofil M NF AHF 1,501-2,000 IU in 10 mL by Rhode Island Hospital, line 472 | 50,000.50 (Rhode Island Hospital, Schedule G, line 472, page 23 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Heparin Sodium5,000 USP units/mLinjection, solutionFresenius Kabi USA, LLC63323-0262-06Named Heparin Sod 5,000 units-mL VL 25x1 mL by Rhode Island Hospital, line 956 | 5,330.92 (Rhode Island Hospital, Schedule G, line 956, page 36 of the filing PDF) | 5,808 | ||||||||||||||||||||||||||||
| Heparin Sodium5,000 USP units/100 mLinjection, solutionFresenius Kabi USA, LLC63323-0522-77Named Heparin 5% Dextrose 50 units-mL bag 24x500 mL by Rhode Island Hospital, line 837 | 8,687.20 (Rhode Island Hospital, Schedule G, line 837, page 33 of the filing PDF) | 965 | ||||||||||||||||||||||||||||
| Hernexeoszongertinib60 mgtablet, film coatedBoehringer Ingelheim Pharmaceuticals, Inc.00597-9257-86Named Hernexeos 60 mg tab 60 by Rhode Island Hospital, line 681 | 16,620.28 (Rhode Island Hospital, Schedule G, line 681, page 29 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Hizentrahuman immunoglobulin G0.2 g/mLliquidCSL Behring AG44206-0457-22Named Hizentra 2 g/10 mL PFS by Rhode Island Hospital, line 777 | 11,210.64 (Rhode Island Hospital, Schedule G, line 777, page 31 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Hizentrahuman immunoglobulin G0.2 g/mLliquidCSL Behring AG44206-0458-24Named Hizentra 4 g PFS 20 mL by Rhode Island Hospital, line 594 | 26,413.72 (Rhode Island Hospital, Schedule G, line 594, page 27 of the filing PDF) | 22 | ||||||||||||||||||||||||||||
| Humaloginsulin lispro100 IU/mLinjection, solutionEli Lilly and Company00002-7510-01Named Humalog 100 units/mL VL 10 mL by Rhode Island Hospital, line 876 | 7,607.66 (Rhode Island Hospital, Schedule G, line 876, page 34 of the filing PDF) | 182 | ||||||||||||||||||||||||||||
| Humalog KwikPeninsulin lispro200 IU/mLinjection, solutionEli Lilly and Company00002-7712-27Named Humalog Kwik pen 200 units 2x3 mL by Rhode Island Hospital, line 941 | 5,649.29 (Rhode Island Hospital, Schedule G, line 941, page 36 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Humalog KwikPen SOPN2879959, 2879759Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 22 | 20,985.38 (Blackstone Valley Community Health Care, Schedule G, line 22, page 8 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Humate-Pantihemophilic factor/von willebrand factor complex (human)kitCSL Behring GmbH63833-0615-02Named Humate-P PDS 600 RCOF VL 250 IU FVIII by Rhode Island Hospital, line 691 | 15,969.14 (Rhode Island Hospital, Schedule G, line 691, page 29 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Humate-Pantihemophilic factor/von willebrand factor complex (human)kitCSL Behring GmbH63833-0616-02Named Humate-P PDS 1,200 RCOF VL 500 IU FVIII by Rhode Island Hospital, line 602 | 25,264.47 (Rhode Island Hospital, Schedule G, line 602, page 27 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Humate-Pantihemophilic factor/von willebrand factor complex (human)kitCSL Behring GmbH63833-0617-02Named Humate-P 2,400 RCOF 1,000 IU FVIII by Rhode Island Hospital, line 415 | 75,243.51 (Rhode Island Hospital, Schedule G, line 415, page 22 of the filing PDF) | 19 | ||||||||||||||||||||||||||||
| HumatropesomatropinkitEli Lilly and Company00002-8148-01Named Humatrope 12 mg CRT by Rhode Island Hospital, line 968 | 5,116.08 (Rhode Island Hospital, Schedule G, line 968, page 36 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| HumiraadalimumabkitAbbVie Inc.00074-0124-02Named Humira 80 mg-0.8 mL PFP kit 2 by Rhode Island Hospital, line 358 | 106,105.10 (Rhode Island Hospital, Schedule G, line 358, page 20 of the filing PDF) | 22 | ||||||||||||||||||||||||||||
| HumiraadalimumabkitAbbVie Inc.00074-0124-03Named Humira 80 mg-0.8 mL PFP kit 3 by Rhode Island Hospital, line 666 | 17,863.04 (Rhode Island Hospital, Schedule G, line 666, page 29 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| HumiraadalimumabkitAbbVie Inc.00074-0616-02Named Humira CF 20 mg-0.2 mL PFS kit 2 by Rhode Island Hospital, line 394 | 83,808.22 (Rhode Island Hospital, Schedule G, line 394, page 21 of the filing PDF) | 53 | ||||||||||||||||||||||||||||
| HumiraadalimumabkitAbbVie Inc.00074-1539-03Named Humira 80 mg/0.8 mL 40 mg/0.4 mL kit 3 by Rhode Island Hospital, line 948 | 5,502.24 (Rhode Island Hospital, Schedule G, line 948, page 36 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| HumiraadalimumabkitAbbVie Inc.00074-4339-02Named Humira 40 mg-0.8 mL PFP kit 2 by Rhode Island Hospital, line 669 | 17,720.54 (Rhode Island Hospital, Schedule G, line 669, page 29 of the filing PDF) | 135 | ||||||||||||||||||||||||||||
| Humulin KwikPen SUPN2880359Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 37 | 10,027.37 (Blackstone Valley Community Health Care, Schedule G, line 37, page 8 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Hydrocortisone Acetate25 mgsuppositoryPadagis US LLC00574-7090-12Named Hydrocort AC SUP 25 mg by Thundermist Health Center, line 176 | 8,081.76 (Thundermist Health Center, Schedule G, line 176, page 11 of the filing PDF) | 33 | ||||||||||||||||||||||||||||
| Hydromorphone Hydrochloride10 mg/mLinjection, solutionHospira, Inc.00409-2634-50Named Hydromorphone HCl 500 mg SDV 50 mL by Rhode Island Hospital, line 692 | 15,768.92 (Rhode Island Hospital, Schedule G, line 692, page 29 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Hylenex Recombinanthyaluronidase150 USP units/mLinjection, solutionAntares Pharma, Inc.18657-0117-04Named Hylenex 150 USP VL 4x1 mL by Rhode Island Hospital, line 560 | 33,100.18 (Rhode Island Hospital, Schedule G, line 560, page 26 of the filing PDF) | 588 | ||||||||||||||||||||||||||||
| HyperRABrabies immune globulin (human)300 IU/mLinjection, solutionGrifols USA, LLC13533-0318-05Named HyperRAB 1,500 units/5 mL SOLN by Kent County Memorial Hospital, line 158 | 51,455.68 (Kent County Memorial Hospital, Schedule G, line 158, page 14 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Ibrancepalbociclib75 mgcapsulePfizer Laboratories Div Pfizer Inc00069-0187-21Named Ibrance 75 mg cap 21 by Rhode Island Hospital, line 319 | 141,725.26 (Rhode Island Hospital, Schedule G, line 319, page 19 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| Ibrancepalbociclib125 mgcapsulePfizer Laboratories Div Pfizer Inc00069-0189-21Named Ibrance 125 mg cap 21 by Rhode Island Hospital, line 295 | 160,787.33 (Rhode Island Hospital, Schedule G, line 295, page 19 of the filing PDF) | 17 | ||||||||||||||||||||||||||||
| Ibsrelatenapanor hydrochloride53.2 mgtabletArdelyx, Inc.73154-0050-60Named Ibsrela tab 50 mg by Wood River Health Services, Inc., line 27 | 18,513 (Wood River Health Services, Inc., Schedule G, line 27, page 9 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Ibtrozitaletrectinib272 mgcapsuleNuvation Bio Inc.84651-0200-93Named Ibtrozi 200 mg cap 90 (3x30) by Rhode Island Hospital, line 429 | 67,858.74 (Rhode Island Hospital, Schedule G, line 429, page 22 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Ibuprofen600 mgtablet, film coatedTime Cap Laboratories, Inc49483-0603-50Named Ibuprofen tab 600 mg by Thundermist Health Center, line 207 | 5,682.50 (Thundermist Health Center, Schedule G, line 207, page 11 of the filing PDF) | 2,275 | ||||||||||||||||||||||||||||
| Ibuprofen800 mgtablet, film coatedTime Cap Laboratories, Inc49483-0604-50Named Ibuprofen tab 800 mg by Thundermist Health Center, line 151 | 11,900.73 (Thundermist Health Center, Schedule G, line 151, page 10 of the filing PDF) | 3,007 | ||||||||||||||||||||||||||||
| Iclusigponatinib hydrochloride30 mgtablet, film coatedTakeda Pharmaceuticals America, Inc.63020-0533-30Named Iclusig 30 mg (30 tablets ea) by Rhode Island Hospital, line 890 | 7,228.59 (Rhode Island Hospital, Schedule G, line 890, page 34 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Iclusigponatinib hydrochloride45 mgtablet, film coatedTakeda Pharmaceuticals America, Inc.63020-0534-30Named Iclusig 45 mg (30 tablets ea) by Rhode Island Hospital, line 525 | 39,313.78 (Rhode Island Hospital, Schedule G, line 525, page 25 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Iclusigponatinib hydrochloride15 mgtablet, film coatedTakeda Pharmaceuticals America, Inc.63020-0535-30Named Iclusig 15 mg (30 tablets ea) by Rhode Island Hospital, line 489 | 45,970.26 (Rhode Island Hospital, Schedule G, line 489, page 24 of the filing PDF) | 35 | ||||||||||||||||||||||||||||
| Idelvioncoagulation factor IX recombinant humankitCSL Behring Lengnau AG69911-0867-02Named Idelvion 2,095 IU VL by Rhode Island Hospital, line 606 | 24,867.60 (Rhode Island Hospital, Schedule G, line 606, page 27 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Idhifaenasidenib mesylate50 mgtablet, film coatedCelgene Corporation59572-0705-30Named Idhifa 50 mg tab 30 by Rhode Island Hospital, line 428 | 68,749.73 (Rhode Island Hospital, Schedule G, line 428, page 22 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Imbruvicaibrutinib70 mg/mLsuspensionPharmacyclics LLC57962-0007-12Named Imbruvica 70 mg-mL sol 108 mL by Rhode Island Hospital, line 346 | 116,493.56 (Rhode Island Hospital, Schedule G, line 346, page 20 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Imbruvicaibrutinib140 mgtablet, film coatedPharmacyclics LLC57962-0014-28Named Imbruvica 140 mg tab 28 by Rhode Island Hospital, line 354 | 109,540.80 (Rhode Island Hospital, Schedule G, line 354, page 20 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Imbruvicaibrutinib280 mgtablet, film coatedPharmacyclics LLC57962-0280-28Named Imbruvica 280 mg tab 28 by Rhode Island Hospital, line 323 | 136,716.24 (Rhode Island Hospital, Schedule G, line 323, page 19 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Imdelltra (AMG757)tarlatamab-dllekitAmgen, Inc55513-0059-01Named Imdelltra 1 mg VL by Rhode Island Hospital, line 576 | 28,506.30 (Rhode Island Hospital, Schedule G, line 576, page 26 of the filing PDF) | 19 | ||||||||||||||||||||||||||||
| Imdelltra (AMG757)tarlatamab-dllekitAmgen, Inc55513-0077-01Named Imdelltra 10 mg VL by Rhode Island Hospital, line 37 | 2,276,513.40 (Rhode Island Hospital, Schedule G, line 37, page 12 of the filing PDF) | 146 | ||||||||||||||||||||||||||||
| Imjudotremelimumab25 mg/1.25 mLinjection, solutionAstraZeneca Pharmaceuticals LP00310-4505-25Named tremelimumab-actl 75 mg in sodium chloride 0.9% 50 mL chemo IVPB by Women & Infants Hospital of RI, line 147 | 44,317.86 (Women & Infants Hospital of RI, Schedule G, line 147, page 14 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Inbrijalevodopa42 mgcapsuleMerz Pharmaceuticals, LLC10144-0342-60Named Inbrija 42 mg cap 60 by Rhode Island Hospital, line 592 | 26,844.44 (Rhode Island Hospital, Schedule G, line 592, page 27 of the filing PDF) | 22 | ||||||||||||||||||||||||||||
| Indocyanine Greenindocyanine green and waterkitRenew Pharmaceuticals Limited70100-0424-02Named Indocyanine Green 25 mg SOLR by Women & Infants Hospital of RI, line 191 | 20,599.42 (Women & Infants Hospital of RI, Schedule G, line 191, page 15 of the filing PDF) | 186 | ||||||||||||||||||||||||||||
| Indomethacin50 mgsuppositoryZydus Pharmaceuticals USA Inc.70710-1852-07Named Indomethacin 50 mg SUP 30 by Rhode Island Hospital, line 556 | 34,147.77 (Rhode Island Hospital, Schedule G, line 556, page 26 of the filing PDF) | 66 | ||||||||||||||||||||||||||||
| Infliximab100 mg/10 mLinjection, powder, lyophilized, for solutionJanssen Biotech, Inc.57894-0160-01Named Infliximab 100 mg SDV 20 mL by Rhode Island Hospital, line 78 | 1,022,201.02 (Rhode Island Hospital, Schedule G, line 78, page 13 of the filing PDF) | 901 | ||||||||||||||||||||||||||||
| Infumorph 500morphine sulfate25 mg/mLinjection, solutionHikma Pharmaceuticals USA Inc.00641-6040-01Named Infumorph 25 mg/mL amp 20 mL by Rhode Island Hospital, line 580 | 27,828.39 (Rhode Island Hospital, Schedule G, line 580, page 26 of the filing PDF) | 86 | ||||||||||||||||||||||||||||
| Ingrezzavalbenazine60 mgcapsuleNeurocrine Biosciences, Inc.70370-1060-01Named Ingrezza 60 mg CAPS 30x1 EA by East Bay Community Action Program, line 5 | 100,695.99 (East Bay Community Action Program, Schedule G, line 5, page 9 of the filing PDF) | 19 | ||||||||||||||||||||||||||||
| Ingrezza Sprinklevalbenazine40 mgcapsuleNeurocrine Biosciences, Inc.70370-4040-01Named Ingrezza Sprinkle 40 mg cap 30 by Rhode Island Hospital, line 809 | 10,091.94 (Rhode Island Hospital, Schedule G, line 809, page 32 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Inlytaaxitinib1 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc00069-0145-01Named Inlyta 1 mg tab 180 by Rhode Island Hospital, line 873 | 7,627.16 (Rhode Island Hospital, Schedule G, line 873, page 34 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Inrebicfedratinib hydrochloride100 mgcapsuleCelgene Corporation59572-0720-12Named MPB Inrebic 100 mg cap 120 by Kent County Memorial Hospital, line 152 | 55,910.84 (Kent County Memorial Hospital, Schedule G, line 152, page 14 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Insulin Aspart100 IU/mLinjection, solutionNovo Nordisk Pharma, Inc.73070-0103-15Named Insulin ASPA inj Flexpen by Thundermist Health Center, line 214 | 5,448.28 (Thundermist Health Center, Schedule G, line 214, page 11 of the filing PDF) | 82 | ||||||||||||||||||||||||||||
| Insulin Lispro100 IU/mLinjection, solutionEli Lilly and Company00002-7737-01Named Insulin Lispro 100 units/mL VL 10 mL by Rhode Island Hospital, line 773 | 11,448.27 (Rhode Island Hospital, Schedule G, line 773, page 31 of the filing PDF) | 232 | ||||||||||||||||||||||||||||
| Insulin Lispro SOPN2822259Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 53 | 5,384.84 (Blackstone Valley Community Health Care, Schedule G, line 53, page 8 of the filing PDF) | 55 | ||||||||||||||||||||||||||||
| Invega Hafyerapaliperidone palmitate1,092 mg/3.5 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc50458-0611-01Named Invega Hafyera 1,092 mg PFS 3.5 mL by Rhode Island Hospital, line 386 | 87,817.69 (Rhode Island Hospital, Schedule G, line 386, page 21 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Invega Hafyerapaliperidone palmitate1,560 mg/5 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc50458-0612-01Named Invega Hafyera 1,560 mg ER PFS 5 mL by Rhode Island Hospital, line 203 | 316,164.39 (Rhode Island Hospital, Schedule G, line 203, page 16 of the filing PDF) | 25 | ||||||||||||||||||||||||||||
| Invega Sustennapaliperidone palmitate78 mg/0.5 mLinjectionJanssen Pharmaceuticals, Inc.50458-0561-01Named Invega Susten 78 mg SYG 0.50 mL by Rhode Island Hospital, line 780 | 11,127.70 (Rhode Island Hospital, Schedule G, line 780, page 32 of the filing PDF) | 26 | ||||||||||||||||||||||||||||
| Invega Trinzapaliperidone palmitate273 mg/0.88 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc50458-0606-01Named Invega Trinza 273 mg SYG 0.88 mL by Rhode Island Hospital, line 559 | 33,252.13 (Rhode Island Hospital, Schedule G, line 559, page 26 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Invokanacanagliflozin100 mgtablet, film coatedJanssen Pharmaceuticals, Inc.50458-0140-30Named Invokana 100 mg tablets by The Providence Community Health Centers, Inc, line 84 | 18,028.20 (The Providence Community Health Centers, Inc, Schedule G, line 84, page 11 of the filing PDF) | 77 | ||||||||||||||||||||||||||||
| Invokanacanagliflozin300 mgtablet, film coatedJanssen Pharmaceuticals, Inc.50458-0141-30Named Invokana 300 mg tablets by The Providence Community Health Centers, Inc, line 154 | 6,436.07 (The Providence Community Health Centers, Inc, Schedule G, line 154, page 13 of the filing PDF) | 32 | ||||||||||||||||||||||||||||
| Invokana tabs50458014030, 50458014090, 50458014130Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 16 | 29,287.20 (Blackstone Valley Community Health Care, Schedule G, line 16, page 8 of the filing PDF) | 22 | ||||||||||||||||||||||||||||
| Irbesartan300 mgtabletCamber Pharmaceuticals, Inc.31722-0731-90Named irbesartan (Avapro) 300 mg tablet by Women & Infants Hospital of RI, line 115 | 69,987.40 (Women & Infants Hospital of RI, Schedule G, line 115, page 13 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Irinotecan Hydrochloride20 mg/mLinjection, solutionApotex Corp.60505-6128-01Named Irinotecan HCl 100 mg SDV 5 mL by Rhode Island Hospital, line 825 | 9,056.07 (Rhode Island Hospital, Schedule G, line 825, page 33 of the filing PDF) | 977 | ||||||||||||||||||||||||||||
| Isentressraltegravir400 mgtablet, film coatedMerck Sharp & Dohme LLC00006-0227-61Named Isentress 400 mg tab 60 by The Miriam Hospital Ryan White Care Program, line 3 | 17,636.04 (The Miriam Hospital Ryan White Care Program, Schedule G, line 3, page 11 of the filing PDF) | 26 | ||||||||||||||||||||||||||||
| Isoniazid300 mgtabletGenus Lifesciences64950-0217-03Named Isoniazid 300 mg tab 30 by The Miriam Hospital RISE TB Clinic, line 3 | 8,523.48 (The Miriam Hospital RISE TB Clinic, Schedule G, line 3, page 10 of the filing PDF) | 591 | ||||||||||||||||||||||||||||
| Isoniazid300 mgtabletOmnivium Pharmaceuticals LLC.81665-0108-30Named Isoniazid 300 mg tab 30 by The Miriam Hospital RISE TB Clinic, line 5 | 11,366.56 (The Miriam Hospital RISE TB Clinic, Schedule G, line 5, page 10 of the filing PDF) | 235 | ||||||||||||||||||||||||||||
| Isoproterenol Hydrochloride0.2 mg/mLinjection, solutionHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.23155-0661-42Named Isoproterenol HCl 1 mg SDV 5x5 mL by Rhode Island Hospital, line 638 | 21,242.95 (Rhode Island Hospital, Schedule G, line 638, page 28 of the filing PDF) | 387 | ||||||||||||||||||||||||||||
| Isosulfan Blue10 mg/mLinjection, solutionMylan Institutional LLC67457-0220-05Named Isosulfan Blue 1% SDV 6x5 mL by Rhode Island Hospital, line 460 | 54,993.75 (Rhode Island Hospital, Schedule G, line 460, page 23 of the filing PDF) | 90 | ||||||||||||||||||||||||||||
| IstodaxromidepsinkitCelgene Corporation59572-0984-01Named Istodax 10 mg SDV kit by Rhode Island Hospital, line 222 | 270,077.93 (Rhode Island Hospital, Schedule G, line 222, page 17 of the filing PDF) | 117 | ||||||||||||||||||||||||||||
| Itovebiinavolisib9 mgtablet, film coatedGenentech, Inc.50242-0079-08Named Itovebi 9 mg tab 28 by Rhode Island Hospital, line 297 | 157,110.01 (Rhode Island Hospital, Schedule G, line 297, page 19 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Itovebiinavolisib3 mgtablet, film coatedGenentech, Inc.50242-0084-08Named Itovebi 3 mg tab 28 by Rhode Island Hospital, line 598 | 26,146.92 (Rhode Island Hospital, Schedule G, line 598, page 27 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Janumet tabs6057761Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 50 | 5,494.84 (Blackstone Valley Community Health Care, Schedule G, line 50, page 8 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Januviasitagliptin50 mgtablet, film coatedMerck Sharp & Dohme LLC00006-0112-31Named Januvia 50 mg/0.5 mL Inj by Comprehensive Community Action, Inc., line 6 | 11,307.19 (Comprehensive Community Action, Inc., Schedule G, line 6, page 8 of the filing PDF) | 61 | ||||||||||||||||||||||||||||
| Januviasitagliptin25 mgtablet, film coatedMerck Sharp & Dohme LLC00006-0221-31Named Januvia 25 mg Tablets by Comprehensive Community Action, Inc., line 13 | 6,613.34 (Comprehensive Community Action, Inc., Schedule G, line 13, page 8 of the filing PDF) | 38 | ||||||||||||||||||||||||||||
| Januviasitagliptin100 mgtablet, film coatedMerck Sharp & Dohme LLC00006-0277-54Named Januvia 100 mg tab 90 by Rhode Island Hospital, line 942 | 5,593.40 (Rhode Island Hospital, Schedule G, line 942, page 36 of the filing PDF) | 36 | ||||||||||||||||||||||||||||
| Januvia tablets00006027731, 6027754, 00006022131, 6022154, 6011231, 6011254Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 6 | 129,158.56 (Blackstone Valley Community Health Care, Schedule G, line 6, page 8 of the filing PDF) | 163 | ||||||||||||||||||||||||||||
| Jardianceempagliflozin10 mgtablet, film coatedBoehringer Ingelheim Pharmaceuticals, Inc.00597-0152-30Named Jardiance 10 mg tablets by The Providence Community Health Centers, Inc, line 90 | 15,393.41 (The Providence Community Health Centers, Inc, Schedule G, line 90, page 11 of the filing PDF) | 743 | ||||||||||||||||||||||||||||
| Jardianceempagliflozin25 mgtablet, film coatedBoehringer Ingelheim Pharmaceuticals, Inc.00597-0153-30Named Jardiance 25 mg tablets by The Providence Community Health Centers, Inc, line 95 | 14,140.92 (The Providence Community Health Centers, Inc, Schedule G, line 95, page 11 of the filing PDF) | 912 | ||||||||||||||||||||||||||||
| Jardiance597015230, 597015290, 597015330, 597015390Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 2 | 441,945.42 (Blackstone Valley Community Health Care, Schedule G, line 2, page 8 of the filing PDF) | 401 | ||||||||||||||||||||||||||||
| Jascaydnerandomilast18 mgtablet, film coatedBoehringer Ingelheim Pharmaceuticals, Inc.00597-7313-21Named Jascayd 18 mg tab 60 by Rhode Island Hospital, line 416 | 74,650.50 (Rhode Island Hospital, Schedule G, line 416, page 22 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Jaypircapirtobrutinib50 mgtablet, coatedEli Lilly and Company00002-6902-30Named Jaypirca 50 mg tab 30 by Rhode Island Hospital, line 676 | 16,843.72 (Rhode Island Hospital, Schedule G, line 676, page 29 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Jiviantihemophilic factor (recombinant) pegylated-auclkitBayer HealthCare LLC00026-3946-25Named Jivi Factor FVIII 1,999 IU VL by Rhode Island Hospital, line 269 | 192,092.20 (Rhode Island Hospital, Schedule G, line 269, page 18 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Jiviantihemophilic factor (recombinant) pegylated-auclkitBayer HealthCare LLC00026-3948-25Named Jivi Factor FVIII 3,383 IU VL by Rhode Island Hospital, line 257 | 212,773.34 (Rhode Island Hospital, Schedule G, line 257, page 18 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Jiviantihemophilic factor (recombinant) pegylated-auclkitBayer HealthCare LLC00026-3950-50Named Jivi Factor FVIII 4,110 IU VL by Rhode Island Hospital, line 315 | 145,645.32 (Rhode Island Hospital, Schedule G, line 315, page 19 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Jubbontidenosumab60 mg/mLinjectionSandoz Inc61314-0240-63Named denosumab-bbdz (Jubbonti) injection 60 mg by Women & Infants Hospital of RI, line 238 | 9,192.15 (Women & Infants Hospital of RI, Schedule G, line 238, page 16 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Kalydecoivacaftor150 mgtablet, film coatedVertex Pharmaceuticals Incorporated51167-0200-01Named Kalydeco 150 mg tab 56 by Rhode Island Hospital, line 233 | 240,067.20 (Rhode Island Hospital, Schedule G, line 233, page 17 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Kalydecoivacaftor50 mggranuleVertex Pharmaceuticals Incorporated51167-0300-01Named Kalydeco PED gran 50 mg 56 by Rhode Island Hospital, line 306 | 150,965.50 (Rhode Island Hospital, Schedule G, line 306, page 19 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Kalydecoivacaftor25 mggranuleVertex Pharmaceuticals Incorporated51167-0600-01Named Kalydeco PED gran 25 mg 56 by Rhode Island Hospital, line 634 | 21,566.50 (Rhode Island Hospital, Schedule G, line 634, page 28 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Kanjintitrastuzumab-anns420 mg/20 mLinjection, powder, lyophilized, for solutionAmgen, Inc55513-0132-01Named Kanjinti 420 mg MDV by Rhode Island Hospital, line 100 | 770,650.64 (Rhode Island Hospital, Schedule G, line 100, page 14 of the filing PDF) | 785 | ||||||||||||||||||||||||||||
| Katerziaamlodipine1 mg/mLsuspensionAzurity Pharmaceuticals, Inc.52652-5001-01Named Katerzia 1 mg/mL sus 150 mL by Rhode Island Hospital, line 745 | 13,020.52 (Rhode Island Hospital, Schedule G, line 745, page 31 of the filing PDF) | 64 | ||||||||||||||||||||||||||||
| Kcentraprothrombin, coagulation factor VII human, coagulation factor IX human, coagulation factor X human, protein C, protein S human, and waterkitCSL Behring GmbH63833-0387-02Named Kcentra 1,000 units KIT by Kent County Memorial Hospital, line 30 | 285,916.19 (Kent County Memorial Hospital, Schedule G, line 30, page 11 of the filing PDF) | 82 | ||||||||||||||||||||||||||||
| Kedrabhuman rabies virus immune globulin150 IU/mLinjection, solutionKedrion Biopharma Inc.76125-0150-10Named Kedrab 1,500 units/10 mL SOLN by Landmark Medical center, line 59 | 5,539.75 (Landmark Medical center, Schedule G, line 59, page 13 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Kengrealcangrelor50 mginjection, powder, lyophilized, for solutionChiesi USA, Inc.10122-0620-10Named Kengreal 50 mg VL 10x10 mL by Rhode Island Hospital, line 487 | 46,174.30 (Rhode Island Hospital, Schedule G, line 487, page 24 of the filing PDF) | 59 | ||||||||||||||||||||||||||||
| Kepivancepalifermin5.16 mg/1.2 mLinjection, powder, lyophilized, for solutionSwedish Orphan Biovitrum AB (publ)66658-0113-03Named Kepivance 5.16 mg VL 3 by Rhode Island Hospital, line 840 | 8,529.52 (Rhode Island Hospital, Schedule G, line 840, page 33 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Ketorolac Tromethamine15 mg/mLinjection, solutionFresenius Kabi USA, LLC63323-0161-01Named Ketorolac Trometh 15 mg-mL SDV 25x1 mL by Rhode Island Hospital, line 812 | 9,999.16 (Rhode Island Hospital, Schedule G, line 812, page 32 of the filing PDF) | 11,463 | ||||||||||||||||||||||||||||
| Ketorolac Tromethamine30 mg/mLinjection, solutionFresenius Kabi USA, LLC63323-0162-01Named Ketorolac Tromethamine 30 mg/mL SOLN by Kent County Memorial Hospital, line 382 | 5,196.11 (Kent County Memorial Hospital, Schedule G, line 382, page 20 of the filing PDF) | 5,762 | ||||||||||||||||||||||||||||
| Kevzarasarilumab150 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC00024-5920-01Named Kevzara 150 mg PFP 2x1.14 mL by Rhode Island Hospital, line 565 | 31,955.41 (Rhode Island Hospital, Schedule G, line 565, page 26 of the filing PDF) | 16 | ||||||||||||||||||||||||||||
| Kimmtraktebentafusp100 mcg/0.5 mLinjection, solution, concentrateImmunocore Commercial LLC80446-0401-01Named Kimmtrak 100 mcg SDV 0.5 mL by Rhode Island Hospital, line 93 | 876,500.75 (Rhode Island Hospital, Schedule G, line 93, page 13 of the filing PDF) | 80 | ||||||||||||||||||||||||||||
| Kineretanakinra100 mg/0.67 mLinjection, solutionSwedish Orphan Biovitrum AB (publ)66658-0234-07Named Kineret 100 mg PFS 7x0.67 mL by Rhode Island Hospital, line 583 | 27,647.34 (Rhode Island Hospital, Schedule G, line 583, page 26 of the filing PDF) | 60 | ||||||||||||||||||||||||||||
| Kinevacsincalide5 mcg/5 mLinjection, powder, lyophilized, for solutionBracco Diagnostics Inc.00270-0556-15Named Kinevac vial 5 mcg 10 by Kent County Memorial Hospital, line 365 | 5,996.20 (Kent County Memorial Hospital, Schedule G, line 365, page 20 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Kisunladonanemab-azbt17.5 mg/mLinjection, solutionEli Lilly and Company00002-9401-01Named donanemab-azbt (Kisunla) 1,400 mg in sodium chloride 0.9% 250 mL by Women & Infants Hospital of RI, line 96 | 87,670.19 (Women & Infants Hospital of RI, Schedule G, line 96, page 13 of the filing PDF) | 54 | ||||||||||||||||||||||||||||
| Konvomepomeprazole and sodium bicarbonatekitAzurity Pharmaceuticals, Inc.65628-0272-05Named Konvomep 2-84 mg-mL kit 150 mL by Rhode Island Hospital, line 687 | 16,124.40 (Rhode Island Hospital, Schedule G, line 687, page 29 of the filing PDF) | 88 | ||||||||||||||||||||||||||||
| Konvomepomeprazole and sodium bicarbonatekitAzurity Pharmaceuticals, Inc.65628-0272-10Named Konvomep 2-84 mg-mL kit 300 mL by Rhode Island Hospital, line 440 | 63,244.16 (Rhode Island Hospital, Schedule G, line 440, page 23 of the filing PDF) | 205 | ||||||||||||||||||||||||||||
| Koselugoselumetinib25 mgcapsuleAstraZeneca Pharmaceuticals LP00310-0625-60Named Koselugo 25 mg cap 60 by Rhode Island Hospital, line 562 | 33,063.87 (Rhode Island Hospital, Schedule G, line 562, page 26 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Kovaltryantihemophilic factor (recombinant)kitBayer HealthCare LLC00026-3826-50Named Kovaltry Adapter 2,142 IU VL by Rhode Island Hospital, line 760 | 12,175.16 (Rhode Island Hospital, Schedule G, line 760, page 31 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Kuvansapropterin dihydrochloride100 mgtabletBioMarin Pharmaceutical Inc.68135-0300-02Named Kuvan tab 100 mg 120 DS by Rhode Island Hospital, line 449 | 59,072.75 (Rhode Island Hospital, Schedule G, line 449, page 23 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Lantus Solostar 100 units/mL SOPN88222033, 88221905Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 4 | 173,895.41 (Blackstone Valley Community Health Care, Schedule G, line 4, page 8 of the filing PDF) | 560 | ||||||||||||||||||||||||||||
| Ledipasvir and Sofosbuvir90 mg; 400 mgtablet, film coatedAsegua Therapeutics LLC72626-2601-01Named Ledipasvir-Sofosbuvir 90-400 mg tab 28 by Rhode Island Hospital, line 744 | 13,024.00 (Rhode Island Hospital, Schedule G, line 744, page 31 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Lenalidomide20 mgcapsuleTeva Pharmaceuticals, Inc.00480-1245-21Named Lenalidomide 20 mg cap 21 DS by Rhode Island Hospital, line 718 | 14,352.56 (Rhode Island Hospital, Schedule G, line 718, page 30 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Lenvimalenvatinib4 mgcapsuleEisai Inc.62856-0712-30Named Lenvima 12 mg cap 90 by Rhode Island Hospital, line 407 | 77,309.34 (Rhode Island Hospital, Schedule G, line 407, page 22 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Leqembilecanemab100 mg/mLinjection, solutionEisai Inc.62856-0212-01Named lecanemab irmb 200 mg/2 mL INJ by Women & Infants Hospital of RI, line 151 | 40,541.16 (Women & Infants Hospital of RI, Schedule G, line 151, page 14 of the filing PDF) | 93 | ||||||||||||||||||||||||||||
| Leucovorin Calcium350 mg/17.5 mLinjection, powder, lyophilized, for solutionHikma Pharmaceuticals USA Inc.00143-9552-01Named Leucovorin Calcium 350 mg 50 mL SDV by Rhode Island Hospital, line 646 | 20,339.34 (Rhode Island Hospital, Schedule G, line 646, page 28 of the filing PDF) | 750 | ||||||||||||||||||||||||||||
| Leucovorin Calcium200 mg/20 mLinjection, powder, lyophilized, for solutionHikma Pharmaceuticals USA Inc.00143-9553-01Named Leucovorin Calcium 200 mg LYO SDV by Rhode Island Hospital, line 867 | 7,813.00 (Rhode Island Hospital, Schedule G, line 867, page 34 of the filing PDF) | 294 | ||||||||||||||||||||||||||||
| Leucovorin Calcium350 mg/17.5 mLinjection, powder, lyophilized, for solutionSagent Pharmaceuticals25021-0816-30Named Leucovorin Calcium 350 mg LYO SDV by Rhode Island Hospital, line 860 | 7,929.77 (Rhode Island Hospital, Schedule G, line 860, page 34 of the filing PDF) | 1,082 | ||||||||||||||||||||||||||||
| Leucovorin Calcium350 mg/17.5 mLinjection, powder, lyophilized, for suspensionMylan Institutional LLC67457-0530-35Named Leucovorin Calcium 350 mg SDV by Rhode Island Hospital, line 822 | 9,151.28 (Rhode Island Hospital, Schedule G, line 822, page 33 of the filing PDF) | 195 | ||||||||||||||||||||||||||||
| Leukeranchlorambucil2 mgtablet, film coatedWaylis Therapeutics LLC80725-0610-25Named Leukeran 2 mg tab 25 by Rhode Island Hospital, line 520 | 40,177.23 (Rhode Island Hospital, Schedule G, line 520, page 25 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Levalbuterol tartrate HFA inhalationlevalbuterol tartrate45 mcgaerosol, meteredActavis Pharma, Inc.00591-2927-54Named Levalbuterol HFA inh (200PF) 15 g by The Providence Community Health Centers, Inc, line 171 | 5,158.93 (The Providence Community Health Centers, Inc, Schedule G, line 171, page 13 of the filing PDF) | 175 | ||||||||||||||||||||||||||||
| Levetiracetam100 mg/mLinjection, solutionHospira, Inc.00409-1886-02Named Levetiracetam 500 mg-5 mL SDV 25x5 mL by Rhode Island Hospital, line 933 | 5,795.26 (Rhode Island Hospital, Schedule G, line 933, page 36 of the filing PDF) | 1,436 | ||||||||||||||||||||||||||||
| Lidocaine50 mg/gpatchPar Health USA, LLC00603-1880-16Named Lidocaine DIS 5% patch by Thundermist Health Center, line 149 | 12,456.93 (Thundermist Health Center, Schedule G, line 149, page 10 of the filing PDF) | 516 | ||||||||||||||||||||||||||||
| Lidocaine 4% Patchlidocaine 4%40 mg/gpatchSOLA Pharmaceuticals70512-0014-30Named Lidocaine pad 4% by Thundermist Health Center, line 146 | 12,904.10 (Thundermist Health Center, Schedule G, line 146, page 10 of the filing PDF) | 60 | ||||||||||||||||||||||||||||
| Lidocaine Hydrochloride20 mg/mLsolutionPAI Holdings, LLC dba PAI Pharma00121-4950-40Named Lidocaine HCl 2% Viscous sol 40x15 mL by Rhode Island Hospital, line 900 | 6,796.73 (Rhode Island Hospital, Schedule G, line 900, page 35 of the filing PDF) | 2,403 | ||||||||||||||||||||||||||||
| Lidocaine Hydrochloride10 mg/mLinjection, solutionHospira, Inc.00409-4276-01Named Lidocaine HCl 1% MDV 25x20 mL by Rhode Island Hospital, line 966 | 5,133.68 (Rhode Island Hospital, Schedule G, line 966, page 36 of the filing PDF) | 6,974 | ||||||||||||||||||||||||||||
| Lidocaine Hydrochloride and Epinephrine10 mg/mL; 10 mcg/mLinjection, solutionHospira, Inc.00409-0007-10Named Lidocaine-Epineph 1%-1:100K MDV 10x20 mL by Rhode Island Hospital, line 970 | 5,093.82 (Rhode Island Hospital, Schedule G, line 970, page 37 of the filing PDF) | 5,329 | ||||||||||||||||||||||||||||
| Linzess 145 mcg caps456120130Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 30 | 13,466.47 (Blackstone Valley Community Health Care, Schedule G, line 30, page 8 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Liraglutide6 mg/mLinjection, solutionTeva Pharmaceuticals, Inc.00480-7250-46Named Liraglutide inj 18 mg/3 mL by Thundermist Health Center, line 147 | 12,765.24 (Thundermist Health Center, Schedule G, line 147, page 10 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Lisdexamfetamine Dimesylate70 mgcapsuleAlvogen Inc.47781-0568-01Named Lisdexamf DIM CP 70 mg ALV 100@ by Kent County Memorial Hospital, line 363 | 6,029.76 (Kent County Memorial Hospital, Schedule G, line 363, page 20 of the filing PDF) | 16 | ||||||||||||||||||||||||||||
| Lokelmasodium zirconium cyclosilicate10 g/10 gpowder, for suspensionAstraZeneca Pharmaceuticals LP00310-1110-39Named Lokelma 10 g PKT 11 by Rhode Island Hospital, line 854 | 8,127.79 (Rhode Island Hospital, Schedule G, line 854, page 33 of the filing PDF) | 24 | ||||||||||||||||||||||||||||
| Lonsurftrifluridine and tipiracil20 mg; 8.19 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd.64842-1020-01Named Lonsurf 20 mg tab 20 by Rhode Island Hospital, line 207 | 310,459.94 (Rhode Island Hospital, Schedule G, line 207, page 16 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Lonsurftrifluridine and tipiracil15 mg; 6.14 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd.64842-1025-01Named Lonsurf 15 mg tab 20 by Rhode Island Hospital, line 575 | 29,863.33 (Rhode Island Hospital, Schedule G, line 575, page 26 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Lonsurftrifluridine and tipiracil15 mg; 6.14 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd.64842-1025-03Named MPB Lonsurf 15 mg/6.14 mg tab 60 by Kent County Memorial Hospital, line 78 | 134,817.20 (Kent County Memorial Hospital, Schedule G, line 78, page 12 of the filing PDF) | 17 | ||||||||||||||||||||||||||||
| Lorbrenalorlatinib25 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc00069-0227-01Named Lorbrena 25 mg tab 30 by Rhode Island Hospital, line 255 | 214,487.36 (Rhode Island Hospital, Schedule G, line 255, page 18 of the filing PDF) | 25 | ||||||||||||||||||||||||||||
| Lorbrenalorlatinib100 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc00069-0231-01Named Lorbrena 100 mg tab 30 by Rhode Island Hospital, line 256 | 213,731.50 (Rhode Island Hospital, Schedule G, line 256, page 18 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Lumakrassotorasib120 mgtablet, coatedAmgen, Inc55513-0488-24Named Lumakras 120 mg tab 240 by Rhode Island Hospital, line 707 | 14,966.67 (Rhode Island Hospital, Schedule G, line 707, page 30 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Lumakrassotorasib320 mgtablet, coatedAmgen, Inc55513-0504-50Named Lumakras 320 mg tab 90 by Rhode Island Hospital, line 167 | 438,465.47 (Rhode Island Hospital, Schedule G, line 167, page 15 of the filing PDF) | 39 | ||||||||||||||||||||||||||||
| Lumakrassotorasib240 mgtablet, coatedAmgen, Inc55513-0512-60Named Lumakras 240 mg tab 120 by Rhode Island Hospital, line 716 | 14,421.04 (Rhode Island Hospital, Schedule G, line 716, page 30 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Lumizymealglucosidase alfa5 mg/mLinjection, powder, for solutionGenzyme Corporation58468-0160-01Named Lumizyme 50 mg vial DS by Rhode Island Hospital, line 113 | 698,760.14 (Rhode Island Hospital, Schedule G, line 113, page 14 of the filing PDF) | 132 | ||||||||||||||||||||||||||||
| Lunsumiomosunetuzumab30 mg/30 mLconcentrateGenentech, Inc.50242-0142-01Named Lunsumio 30 mg SDV 30 mL by Rhode Island Hospital, line 197 | 324,523.30 (Rhode Island Hospital, Schedule G, line 197, page 16 of the filing PDF) | 16 | ||||||||||||||||||||||||||||
| Lunsumiomosunetuzumab1 mg/mLconcentrateGenentech, Inc.50242-0159-01Named Lunsumio 1 mg SDV 1 mL by Rhode Island Hospital, line 940 | 5,670.94 (Rhode Island Hospital, Schedule G, line 940, page 36 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Lupron Depotleuprolide acetatekitAbbVie Inc.00074-3641-03Named Lupron Depot 3.75 mg kit by Rhode Island Hospital, line 711 | 14,687.13 (Rhode Island Hospital, Schedule G, line 711, page 30 of the filing PDF) | 217 | ||||||||||||||||||||||||||||
| Lupron Depotleuprolide acetatekitAbbVie Inc.00074-3642-03Named leuprolide (1-month) (Lupron Depot) injection 7.5 mg by Women & Infants Hospital of RI, line 201 | 16,359.81 (Women & Infants Hospital of RI, Schedule G, line 201, page 15 of the filing PDF) | 179 | ||||||||||||||||||||||||||||
| Lupron Depotleuprolide acetatekitAbbVie Inc.00074-3663-03Named Lupron Depot 3 mo 11.25 mg kit by Rhode Island Hospital, line 444 | 61,228.64 (Rhode Island Hospital, Schedule G, line 444, page 23 of the filing PDF) | 61 | ||||||||||||||||||||||||||||
| Lupron Depot-PEDleuprolide acetatekitAbbVie Inc.00074-3779-03Named Lupron 3 mo 11.25 mg PE kit by Rhode Island Hospital, line 519 | 40,568.69 (Rhode Island Hospital, Schedule G, line 519, page 25 of the filing PDF) | 15 | ||||||||||||||||||||||||||||
| Lupron Depot-PEDleuprolide acetatekitAbbVie Inc.00074-9694-03Named Lupron Depot 30 mg PED kit by Rhode Island Hospital, line 466 | 53,126.97 (Rhode Island Hospital, Schedule G, line 466, page 23 of the filing PDF) | 25 | ||||||||||||||||||||||||||||
| Lutatheralutetium lu 177 dotatate10 mCi/mLinjectionAdvanced Accelerator Applications USA, Inc69488-0003-01Named Lutathera by Rhode Island Hospital, line 44 | 1,870,166.00 (Rhode Island Hospital, Schedule G, line 44, page 12 of the filing PDF) | 42 | ||||||||||||||||||||||||||||
| Lynparzaolaparib100 mgtablet, film coatedAstraZeneca Pharmaceuticals LP00310-0668-60Named Lynparza 100 mg tab 60 by Rhode Island Hospital, line 378 | 91,790.84 (Rhode Island Hospital, Schedule G, line 378, page 21 of the filing PDF) | 16 | ||||||||||||||||||||||||||||
| Lynparzaolaparib150 mgtablet, film coatedAstraZeneca Pharmaceuticals LP00310-0679-60Named Lynparza 150 mg tab 60 by Rhode Island Hospital, line 488 | 46,131.90 (Rhode Island Hospital, Schedule G, line 488, page 24 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Magnesium Sulfatemagnesium sulfate heptahydrate40 mg/mLinjection, solutionFresenius Kabi USA, LLC63323-0106-05Named Magnesium Sulfate 2 g bag 24x50 mL by Rhode Island Hospital, line 807 | 10,145.12 (Rhode Island Hospital, Schedule G, line 807, page 32 of the filing PDF) | 5,194 | ||||||||||||||||||||||||||||
| Margenzamargetuximab-cmkb25 mg/mLinjection, solution, concentrateMacroGenics, Inc74527-0022-02Named margetuximab-cmkb 250 mg /10 mL INJ by Women & Infants Hospital of RI, line 93 | 90,121.35 (Women & Infants Hospital of RI, Schedule G, line 93, page 12 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Mavyretglecaprevir and pibrentasvir20 mg; 50 mgpelletAbbVie Inc.00074-2600-28Named Mavyret 50/20 mg PEL 28 by Rhode Island Hospital, line 763 | 12,070.16 (Rhode Island Hospital, Schedule G, line 763, page 31 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Mayzentsiponimod2 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0986-15Named siponimod (Mayzent) 2 mg Tab by Kent County Memorial Hospital, line 153 | 55,654.31 (Kent County Memorial Hospital, Schedule G, line 153, page 14 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Medroxyprogesterone Acetate150 mg/mLinjection, suspensionPrasco Laboratories66993-0371-79Named medroxyPROGESTERone Acetate 150 mg/mL SUSY by Women & Infants Hospital of RI, line 254 | 6,730.84 (Women & Infants Hospital of RI, Schedule G, line 254, page 17 of the filing PDF) | 771 | ||||||||||||||||||||||||||||
| MenopurmenotropinskitFerring Pharmaceuticals Inc.55566-7501-02Named menotropins (Menopur) 75 units SolR by Women & Infants Hospital of RI, line 271 | 21,826.75 (Women & Infants Hospital of RI, Schedule G, line 271, page 17 of the filing PDF) | 347 | ||||||||||||||||||||||||||||
| Mercaptopurine20 mg/mLsuspensionHikma Pharmaceuticals USA Inc.00054-0879-49Named Mercaptopurine 2,000 mg oral sus 100 mL by Rhode Island Hospital, line 817 | 9,680.72 (Rhode Island Hospital, Schedule G, line 817, page 32 of the filing PDF) | 55 | ||||||||||||||||||||||||||||
| Mesna400 mgtablet, film coatedIngenus Pharmaceuticals, LLC50742-0354-01Named Mesna 400 mg tab 10 by Rhode Island Hospital, line 712 | 14,665.64 (Rhode Island Hospital, Schedule G, line 712, page 30 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Mesnexmesna400 mgtablet, film coatedBaxter Healthcare Company67108-3565-09Named Mesnex 400 mg tab 10 by Rhode Island Hospital, line 907 | 6,466.11 (Rhode Island Hospital, Schedule G, line 907, page 35 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Metformin Hydrochloride625 mgtabletChartwell RX, LLC62135-0681-30Named metFORMIN HCl 625 mg TABS 30x1 EA by East Bay Community Action Program, line 39 | 11,859.99 (East Bay Community Action Program, Schedule G, line 39, page 10 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Methylprednisolone acetate40 mg/mLinjection, suspensionAmneal Pharmaceuticals LLC70121-1573-05Named Methylprednisolone ACE 40 mg SDV 25x1 mL by Rhode Island Hospital, line 899 | 6,886.66 (Rhode Island Hospital, Schedule G, line 899, page 35 of the filing PDF) | 831 | ||||||||||||||||||||||||||||
| Mirabegron25 mgtablet, film coated, extended releaseLupin Pharmaceuticals, Inc.68180-0151-06Named Mirabegron 25 mg ER tablets by The Providence Community Health Centers, Inc, line 147 | 7,203.36 (The Providence Community Health Centers, Inc, Schedule G, line 147, page 13 of the filing PDF) | 37 | ||||||||||||||||||||||||||||
| Mirabegron50 mgtablet, film coated, extended releaseLupin Pharmaceuticals, Inc.68180-0152-06Named Mirabegron 50 mg ER tablets by Women & Infants Hospital of RI, line 273 | 11,169.84 (Women & Infants Hospital of RI, Schedule G, line 273, page 17 of the filing PDF) | 36 | ||||||||||||||||||||||||||||
| Mirabegron50 mgtablet, extended releaseZydus Pharmaceuticals (USA) Inc.70710-1160-03Named Mirabegron tab 50 mg ER by Thundermist Health Center, line 182 | 7,613.00 (Thundermist Health Center, Schedule G, line 182, page 11 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Mitomycin20 mg/40 mLinjection, powder, lyophilized, for solutionHikma Pharmaceuticals USA Inc.00143-9279-01Named Mitomycin 20 mg LYO VL by Rhode Island Hospital, line 964 | 5,162.05 (Rhode Island Hospital, Schedule G, line 964, page 36 of the filing PDF) | 51 | ||||||||||||||||||||||||||||
| Monjuvitafasitamab-cxix200 mg/5 mLinjection, powder, lyophilized, for solutionIncyte Corporation73535-0208-01Named Monjuvi 200 mg/5 mL SDV by Rhode Island Hospital, line 724 | 14,161.14 (Rhode Island Hospital, Schedule G, line 724, page 30 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Morphine Sulfate4 mg/mLinjection, solutionHospira, Inc.00409-1891-01Named Morphine Sulfate PF 4 mg/mL CJ LL 10x1 mL by Rhode Island Hospital, line 824 | 9,063.44 (Rhode Island Hospital, Schedule G, line 824, page 33 of the filing PDF) | 9,462 | ||||||||||||||||||||||||||||
| Motpoly XRlacosamide150 mgcapsule, extended releaseAucta Pharmaceuticals, Inc.73289-0064-02Named Motpoly XR 150 mg ER cap 60 by Rhode Island Hospital, line 927 | 5,922.17 (Rhode Island Hospital, Schedule G, line 927, page 35 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Mounjaro2147180, 2150680,2148480Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 9 | 44,721.96 (Blackstone Valley Community Health Care, Schedule G, line 9, page 8 of the filing PDF) | 43 | ||||||||||||||||||||||||||||
| Mycophenolic Acid360 mgtablet, delayed releaseAccord Healthcare Inc.16729-0189-29Named Mycophenolic Acid 360 mg DR tab 120 by Rhode Island Hospital, line 853 | 8,146.98 (Rhode Island Hospital, Schedule G, line 853, page 33 of the filing PDF) | 973 | ||||||||||||||||||||||||||||
| Myfembreerelugolix, estradiol hemihydrate, and norethindrone acetate40 mg; 1 mg; 0.5 mgtablet, film coatedSumitomo Pharma America, Inc72974-0415-01Named Myfembree TB 40/1/0.5 mg 28 by Kent County Memorial Hospital, line 358 | 6,210.60 (Kent County Memorial Hospital, Schedule G, line 358, page 19 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Myforticmycophenolic acid180 mgtablet, delayed releaseNovartis Pharmaceuticals Corporation00078-0385-66Named Myfortic 180 mg DR tab 120 by Rhode Island Hospital, line 726 | 14,078.97 (Rhode Island Hospital, Schedule G, line 726, page 30 of the filing PDF) | 51 | ||||||||||||||||||||||||||||
| Myforticmycophenolic acid360 mgtablet, delayed releaseNovartis Pharmaceuticals Corporation00078-0386-66Named Myfortic 360 mg DR tab 120 by Rhode Island Hospital, line 578 | 27,975.77 (Rhode Island Hospital, Schedule G, line 578, page 26 of the filing PDF) | 73 | ||||||||||||||||||||||||||||
| Myrbetriq 50 mg TB24469260230Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 48 | 6,147.28 (Blackstone Valley Community Health Care, Schedule G, line 48, page 8 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Myxredlininsulin human1 IU/mLinjection, solutionBaxter Healthcare Corporation00338-0126-12Named Myxredlin Sod Chl 0.9% bag 12x100 mL by Rhode Island Hospital, line 962 | 5,186.23 (Rhode Island Hospital, Schedule G, line 962, page 36 of the filing PDF) | 486 | ||||||||||||||||||||||||||||
| Naloxone Hydrochloride4 mg/0.1 mLspray, meteredTeva Pharmaceuticals, Inc.00480-3478-68Named Naloxone HCl spr 4 mg by Thundermist Health Center, line 226 | 5,190.30 (Thundermist Health Center, Schedule G, line 226, page 12 of the filing PDF) | 174 | ||||||||||||||||||||||||||||
| Naltrexone Hydrochloride50 mgtablet, film coatedSun Pharmaceutical Industries, Inc.47335-0326-88Named Naltrexone tab 50 mg by Thundermist Health Center, line 140 | 14,017.99 (Thundermist Health Center, Schedule G, line 140, page 10 of the filing PDF) | 776 | ||||||||||||||||||||||||||||
| Nerlynxneratinib40 mgtabletPuma Biotechnology, Inc.70437-0240-18Named MPB Nerlynx 40 mg tab 180 by Kent County Memorial Hospital, line 233 | 24,551.76 (Kent County Memorial Hospital, Schedule G, line 233, page 16 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Nerlynxneratinib40 mgtabletPuma Biotechnology, Inc.70437-0240-33Named MPB Nerlynx 40 mg TB 133 by Kent County Memorial Hospital, line 238 | 24,044.36 (Kent County Memorial Hospital, Schedule G, line 238, page 16 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Neupogenfilgrastim300 mcg/mLinjection, solutionAmgen, Inc55513-0530-10Named Neupogen 300 mcg SDV 10x1 mL by Rhode Island Hospital, line 541 | 37,090.95 (Rhode Island Hospital, Schedule G, line 541, page 25 of the filing PDF) | 37 | ||||||||||||||||||||||||||||
| Neupogenfilgrastim480 mcg/1.6 mLinjection, solutionAmgen, Inc55513-0546-10Named Neupogen 480 mcg SDV 10x1.6 mL by Rhode Island Hospital, line 802 | 10,340.25 (Rhode Island Hospital, Schedule G, line 802, page 32 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Nexplanonetonogestrel68 mgimplantOrganon LLC78206-0145-01Named Nexplanon IMP 68 mg by Rhode Island Hospital, line 573 | 30,220.63 (Rhode Island Hospital, Schedule G, line 573, page 26 of the filing PDF) | 55 | ||||||||||||||||||||||||||||
| Nexviazymeavalglucosidase alfa-ngpt100 mg/10 mLinjection, powder, lyophilized, for solutionGenzyme Corporation58468-0426-01Named Nexviazyme 100 mg/10 mL by Rhode Island Hospital, line 71 | 1,112,966.55 (Rhode Island Hospital, Schedule G, line 71, page 13 of the filing PDF) | 465 | ||||||||||||||||||||||||||||
| Ngenlasomatrogon-ghla60 mg/1.2 mLinjection, solutionPfizer Laboratories Div Pfizer Inc00069-0520-02Named Ngenla 60 mg PFP 1.2 mL by Rhode Island Hospital, line 852 | 8,183.15 (Rhode Island Hospital, Schedule G, line 852, page 33 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Nicotinenicotine polacrilex4 mggum, chewingRugby Laboratories00536-3405-01Named Nicotine POL gum 4 mg by Thundermist Health Center, line 178 | 7,959.55 (Thundermist Health Center, Schedule G, line 178, page 11 of the filing PDF) | 229 | ||||||||||||||||||||||||||||
| Nicotine14 mg/24 hourspatchRugby Laboratories00536-5895-88Named Nicotine TD DIS 14 mg/24H by Thundermist Health Center, line 173 | 8,279.59 (Thundermist Health Center, Schedule G, line 173, page 11 of the filing PDF) | 339 | ||||||||||||||||||||||||||||
| Nicotine21 mg/24 hourspatchRugby Laboratories00536-5896-88Named Nicotine TD DIS 21 mg/24H by Thundermist Health Center, line 155 | 11,518.32 (Thundermist Health Center, Schedule G, line 155, page 10 of the filing PDF) | 491 | ||||||||||||||||||||||||||||
| Nilotinib150 mgcapsuleApotex Corp.60505-3801-02Named Nilotinib 150 mg cap 112 (4x28) BP by Rhode Island Hospital, line 501 | 43,939.70 (Rhode Island Hospital, Schedule G, line 501, page 24 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| Ninlaroixazomib2.3 mgcapsuleTakeda Pharmaceuticals America, Inc.63020-0230-02Named Ninlaro 2.3 mg cap 3 (1x3) by Rhode Island Hospital, line 841 | 8,519.32 (Rhode Island Hospital, Schedule G, line 841, page 33 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Ninlaroixazomib3 mgcapsuleTakeda Pharmaceuticals America, Inc.63020-0390-02Named Ninlaro 3 mg cap 1x3 by Rhode Island Hospital, line 839 | 8,560.60 (Rhode Island Hospital, Schedule G, line 839, page 33 of the filing PDF) | 15 | ||||||||||||||||||||||||||||
| Ninlaroixazomib4 mgcapsuleTakeda Pharmaceuticals America, Inc.63020-0400-02Named Ninlaro 4 mg cap 1x3 by Rhode Island Hospital, line 506 | 42,737.11 (Rhode Island Hospital, Schedule G, line 506, page 24 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Norditropinsomatropin10 mg/1.5 mLinjection, solutionNovo Nordisk00169-7705-21Named Norditropin Flex Pro 10 mg PFP 1.5 mL by Rhode Island Hospital, line 174 | 409,237.93 (Rhode Island Hospital, Schedule G, line 174, page 16 of the filing PDF) | 754 | ||||||||||||||||||||||||||||
| Norditropinsomatropin15 mg/1.5 mLinjection, solutionNovo Nordisk00169-7708-21Named Norditropin Flex Pro 15 mg PFP 1.5 mL by Rhode Island Hospital, line 402 | 79,614.12 (Rhode Island Hospital, Schedule G, line 402, page 22 of the filing PDF) | 565 | ||||||||||||||||||||||||||||
| Norelgestromin and Ethinyl Estradiol150 mcg/mg; 35 mcg/mgpatchZydus Pharmaceuticals USA Inc.70710-1190-03Named Norelge/ETHI DIS 150/35 by Thundermist Health Center, line 114 | 19,063.19 (Thundermist Health Center, Schedule G, line 114, page 10 of the filing PDF) | 294 | ||||||||||||||||||||||||||||
| Norepinephrinenorepinephrine bitartrate32 mcg/mLsolutionLong Grove Pharmaceuticals, LLC81298-9655-03Named Norepinephrine 8 mg bag 10x250 mL by Rhode Island Hospital, line 566 | 31,751.09 (Rhode Island Hospital, Schedule G, line 566, page 26 of the filing PDF) | 1,320 | ||||||||||||||||||||||||||||
| Norepinephrine Bitartrate8 mg/250 mLinjection, solutionBaxter Healthcare Corporation00338-0108-20Named Norepinephrine-Dext 8 mg-5% bag 20x250 mL by Rhode Island Hospital, line 885 | 7,414.68 (Rhode Island Hospital, Schedule G, line 885, page 34 of the filing PDF) | 1,002 | ||||||||||||||||||||||||||||
| Norethindrone0.35 mgtabletGlenmark Pharmaceuticals Inc., USA68462-0305-29Named norethindrone (Micronor) 0.35 mg tablet by Women & Infants Hospital of RI, line 237 | 9,254.88 (Women & Infants Hospital of RI, Schedule G, line 237, page 16 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Novolog Flexpen 100 units/mL SOPN169633910Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 46 | 6,656.14 (Blackstone Valley Community Health Care, Schedule G, line 46, page 8 of the filing PDF) | 23 | ||||||||||||||||||||||||||||
| Nucalamepolizumab100 mg/mLinjection, powder, for solutionGlaxoSmithKline LLC00173-0881-01Named mepolizumab (Nucala) injection 300 mg by Women & Infants Hospital of RI, line 21 | 509,609.60 (Women & Infants Hospital of RI, Schedule G, line 21, page 11 of the filing PDF) | 192 | ||||||||||||||||||||||||||||
| Nulojixbelatacept250 mginjection, powder, lyophilized, for solutionE.R. Squibb & Sons, L.L.C.00003-0371-13Named Nulojix 250 mg VL by Rhode Island Hospital, line 136 | 603,531.00 (Rhode Island Hospital, Schedule G, line 136, page 15 of the filing PDF) | 609 | ||||||||||||||||||||||||||||
| Nuplazidpimavanserin tartrate34 mgcapsuleAcadia Pharmaceuticals Inc.63090-0340-30Named Nuplazid 34 mg cap 30 by Rhode Island Hospital, line 695 | 15,593.80 (Rhode Island Hospital, Schedule G, line 695, page 29 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| NuvaRingetonogestrel and ethinyl estradiol0.12 mg/day; 0.015 mg/dayinsert, extended releaseAdvanz Pharma (US) Corp.59212-0146-03Named NuvaRing MIS by Thundermist Health Center, line 198 | 6,248.06 (Thundermist Health Center, Schedule G, line 198, page 11 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Nuzyraomadacycline150 mgtablet, film coatedParatek Pharmaceuticals, Inc.71715-0002-27Named Nuzyra 150 mg tab 30 by Rhode Island Hospital, line 574 | 29,898.95 (Rhode Island Hospital, Schedule G, line 574, page 26 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Nyvepriapegfilgrastim-apgf6 mg/0.6 mLinjection, solutionPfizer Laboratories Div Pfizer Inc00069-0324-01Named Nyvepria 6 mg PFS 0.6 mL by Rhode Island Hospital, line 781 | 11,100.81 (Rhode Island Hospital, Schedule G, line 781, page 32 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Odomzosonidegib200 mgcapsuleSun Pharmaceutical Industries, Inc.47335-0303-83Named Odomzo 200 mg cap 30 by Rhode Island Hospital, line 603 | 25,192.86 (Rhode Island Hospital, Schedule G, line 603, page 27 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Ogsiveonirogacestat100 mgtablet, film coatedSpringWorks Therapeutics, Inc.82448-0100-14Named Ogsiveo 100 mg tab 14 by Rhode Island Hospital, line 192 | 333,104.44 (Rhode Island Hospital, Schedule G, line 192, page 16 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Ogsiveonirogacestat150 mgtablet, film coatedSpringWorks Therapeutics, Inc.82448-0150-14Named Ogsiveo 150 mg tab 14 by Rhode Island Hospital, line 124 | 646,562.96 (Rhode Island Hospital, Schedule G, line 124, page 14 of the filing PDF) | 34 | ||||||||||||||||||||||||||||
| Ojjaaramomelotinib150 mgtabletGlaxoSmithKline LLC81864-0102-30Named momelotinib 150 mg Tab by Kent County Memorial Hospital, line 254 | 20,974.86 (Kent County Memorial Hospital, Schedule G, line 254, page 17 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Ojjaaramomelotinib100 mgtabletGlaxoSmithKline LLC81864-0103-30Named momelotinib (Ojjaara) 100 mg Tab by Kent County Memorial Hospital, line 99 | 103,634.09 (Kent County Memorial Hospital, Schedule G, line 99, page 13 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Olanzapine10 mg/2 mLinjection, powder, for solutionCamber Pharmaceuticals, Inc.31722-0308-01Named Olanzapine 10 mg SDV by Rhode Island Hospital, line 946 | 5,532.71 (Rhode Island Hospital, Schedule G, line 946, page 36 of the filing PDF) | 690 | ||||||||||||||||||||||||||||
| Olumiantbaricitinib4 mgtablet, film coatedEli Lilly and Company00002-4479-30Named Olumiant 4 mg tab 30 by Rhode Island Hospital, line 324 | 135,871.39 (Rhode Island Hospital, Schedule G, line 324, page 20 of the filing PDF) | 33 | ||||||||||||||||||||||||||||
| Omnitropesomatropin10 mg/1.5 mLinjection, solutionSandoz Inc00781-3004-07Named Omnitrope 10 mg /1.5 mL CRT by Rhode Island Hospital, line 645 | 20,644.41 (Rhode Island Hospital, Schedule G, line 645, page 28 of the filing PDF) | 65 | ||||||||||||||||||||||||||||
| Omvohmirikizumab-mrkzkitEli Lilly and Company00002-7717-11Named Omvoh 200 mg-2 mL-100 mg-mL PFP 2 by Rhode Island Hospital, line 617 | 22,984.91 (Rhode Island Hospital, Schedule G, line 617, page 27 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Omvohmirikizumab-mrkz100 mg/mLinjection, solutionEli Lilly and Company00002-8011-27Named Omvoh 100 mg PFP 2x1 mL by Rhode Island Hospital, line 513 | 41,461.16 (Rhode Island Hospital, Schedule G, line 513, page 24 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Ondansetron2 mg/mLinjection, solutionHospira, Inc.00409-4755-03Named Ondansetron HCl 4 mg/2 mL SOLN by Women & Infants Hospital of RI, line 160 | 36,921.82 (Women & Infants Hospital of RI, Schedule G, line 160, page 14 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Ondansetron2 mg/mLinjectionHikma Pharmaceuticals USA Inc.00641-6078-25Named Ondansetron 4 mg SDV 25x2 mL by Rhode Island Hospital, line 753 | 12,626.71 (Rhode Island Hospital, Schedule G, line 753, page 31 of the filing PDF) | 29,437 | ||||||||||||||||||||||||||||
| Ondansetron4 mg/5 mLsolutionAmerican Health Packaging60687-0252-86Named Ondansetron 4 mg oral sol 30x5 mL by Rhode Island Hospital, line 649 | 19,960.52 (Rhode Island Hospital, Schedule G, line 649, page 28 of the filing PDF) | 1,796 | ||||||||||||||||||||||||||||
| Onuregazacitidine300 mgtablet, film coatedCelgene Corporation59572-0740-07Named Onureg 300 mg tab 7 by Rhode Island Hospital, line 251 | 221,268.53 (Rhode Island Hospital, Schedule G, line 251, page 18 of the filing PDF) | 17 | ||||||||||||||||||||||||||||
| Onyda XRclonidine hydrochloride0.1 mg/mLsuspension, extended releaseNextWave Pharmaceuticals, Inc24478-0148-03Named Onyda XR 0.1 mg ER sus 30 mL by Rhode Island Hospital, line 805 | 10,223.55 (Rhode Island Hospital, Schedule G, line 805, page 32 of the filing PDF) | 25 | ||||||||||||||||||||||||||||
| Opdivonivolumab10 mg/mLinjectionE.R. Squibb & Sons, L.L.C.00003-3756-14Named Opdivo 120 mg/12 mL SOLN by Landmark Medical center, line 52 | 8,555.11 (Landmark Medical center, Schedule G, line 52, page 12 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Opdivo Qvantignivolumab and hyaluronidase-nvhy120 mg/mL; 2,000 units/mLinjection, solutionE.R. Squibb & Sons, L.L.C.00003-6120-01Named nivolumab-hyaluronidase-nvhy 600 mg-10,000 units/5 mL Soln 600 mg by Women & Infants Hospital of RI, line 190 | 16,668.96 (Women & Infants Hospital of RI, Schedule G, line 190, page 15 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Oraceadoxycycline40 mgcapsuleGalderma Laboratories, L.P.00299-3822-30Named Oracea cap 40 mg by Thundermist Health Center, line 218 | 5,405.19 (Thundermist Health Center, Schedule G, line 218, page 11 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Orenciaabatacept50 mg/0.4 mLinjection, solutionE.R. Squibb & Sons, L.L.C.00003-2814-11Named Orencia 50 mg/0.4 mL SYG 4 by Rhode Island Hospital, line 590 | 26,884.40 (Rhode Island Hospital, Schedule G, line 590, page 27 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Orilissaelagolix150 mgtablet, film coatedAbbVie Inc.00074-0038-28Named Orilissa tab 150 mg by Thundermist Health Center, line 184 | 7,541.81 (Thundermist Health Center, Schedule G, line 184, page 11 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Orkambilumacaftor and ivacaftor75 mg; 94 mggranuleVertex Pharmaceuticals Incorporated51167-0122-01Named Orkambi 75/94 mg pack 56 by Rhode Island Hospital, line 457 | 56,639.43 (Rhode Island Hospital, Schedule G, line 457, page 23 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Oseltamivir Phosphateoseltamivir75 mgcapsuleAmneal Pharmaceuticals LLC60219-1266-01Named Oseltamivir cap 75 mg by Thundermist Health Center, line 152 | 11,827.11 (Thundermist Health Center, Schedule G, line 152, page 10 of the filing PDF) | 559 | ||||||||||||||||||||||||||||
| OtezlaapremilastkitAmgen, Inc55513-0369-55Named Otezla 28 day Starter pack by The Providence Community Health Centers, Inc, line 169 | 5,259.32 (The Providence Community Health Centers, Inc, Schedule G, line 169, page 13 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Otulfiustekinumab-aauz45 mg/0.5 mLinjection, solutionFresenius Kabi USA, LLC65219-0824-01Named Otulfi 45 mg PFS 0.5 mL by Rhode Island Hospital, line 865 | 7,817.95 (Rhode Island Hospital, Schedule G, line 865, page 34 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Otulfiustekinumab-aauz90 mg/mLinjection, solutionFresenius Kabi USA, LLC65219-0826-26Named Otulfi 90 mg PFS 1 mL by Rhode Island Hospital, line 347 | 114,967.76 (Rhode Island Hospital, Schedule G, line 347, page 20 of the filing PDF) | 57 | ||||||||||||||||||||||||||||
| Oxaliplatin5 mg/mLinjection, solutionApotex Corp.60505-6132-06Named Oxaliplatin 50 mg SDV 10 mL by Rhode Island Hospital, line 697 | 15,529.19 (Rhode Island Hospital, Schedule G, line 697, page 29 of the filing PDF) | 1,741 | ||||||||||||||||||||||||||||
| Ozempic169418113, 169413013, 169477212Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 1 | 508,090.64 (Blackstone Valley Community Health Care, Schedule G, line 1, page 8 of the filing PDF) | 583 | ||||||||||||||||||||||||||||
| Paclitaxel100 mg/20 mLinjection, powder, lyophilized, for suspensionSandoz Inc00781-3531-91Named PACLitaxel Protein-Bound Part 100 mg SUSR by Landmark Medical center, line 36 | 24,388.82 (Landmark Medical center, Schedule G, line 36, page 12 of the filing PDF) | 20 | ||||||||||||||||||||||||||||
| Paclitaxel6 mg/mLinjection, solutionSagent Pharmaceuticals25021-0255-50Named Paclitaxel 300 mg MDV 50 mL by Rhode Island Hospital, line 748 | 12,768.41 (Rhode Island Hospital, Schedule G, line 748, page 31 of the filing PDF) | 1,303 | ||||||||||||||||||||||||||||
| Paclitaxel6 mg/mLinjection, solutionHospira, Inc.61703-0342-50Named PACLItaxel 300 mg/50 mL MDV by Women & Infants Hospital of RI, line 199 | 16,774.57 (Women & Infants Hospital of RI, Schedule G, line 199, page 15 of the filing PDF) | 1,960 | ||||||||||||||||||||||||||||
| Paclitaxel6 mg/mLinjection, solutionFresenius Kabi USA, LLC63323-0763-50Named PACLitaxel (Taxol) 102 mg in sodium chloride 0.9% 250 mL IVPB by Women & Infants Hospital of RI, line 248 | 7,357.15 (Women & Infants Hospital of RI, Schedule G, line 248, page 17 of the filing PDF) | 133 | ||||||||||||||||||||||||||||
| Palonosetron0.05 mg/mLinjection, solutionBluePoint Laboratories68001-0355-25Named Palonosetron HCl 0.25 mg SDV 5 mL by Rhode Island Hospital, line 902 | 6,717.94 (Rhode Island Hospital, Schedule G, line 902, page 35 of the filing PDF) | 1,248 | ||||||||||||||||||||||||||||
| Palonosetron Hydrochloride0.25 mg/5 mLinjection, solutionMeitheal Pharmaceuticals Inc.71288-0409-05Named Palonosetron HCl 0.25 mg SDV 5 mL by Rhode Island Hospital, line 931 | 5,815.34 (Rhode Island Hospital, Schedule G, line 931, page 35 of the filing PDF) | 2,083 | ||||||||||||||||||||||||||||
| Palynziqpegvaliase-pqpz20 mg/mLinjection, solutionBioMarin Pharmaceutical Inc.68135-0673-45Named Palynziq PFS 20 mg/mL 10 DS by Rhode Island Hospital, line 456 | 56,801.94 (Rhode Island Hospital, Schedule G, line 456, page 23 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Pancreazepancrelipase lipase, pancrelipase amylase, and pancrelipase protease21,000 USP units; 83,900 USP units; 54,700 USP unitscapsule, delayed releaseVivus LLC62541-0405-10Named Pancreaze CP 21,000 units 100 DR by Rhode Island Hospital, line 866 | 7,816.44 (Rhode Island Hospital, Schedule G, line 866, page 34 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Pancreazepancrelipase lipase, pancrelipase amylase, and pancrelipase protease37,000 USP units; 149,900 USP units; 97,300 USP unitscapsule, delayed releaseVivus LLC62541-0406-10Named Pancreaze 37,000 units DR cap 100 by Rhode Island Hospital, line 477 | 48,790.56 (Rhode Island Hospital, Schedule G, line 477, page 24 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| ParaGard T 380Acopper313.4 mgintrauterine deviceCooperSurgical, Inc.59365-5129-01Named IUD supplied - ParaGard by Thundermist Health Center, line 235 | 13,222.88 (Thundermist Health Center, Schedule G, line 235, page 12 of the filing PDF) | 44 | ||||||||||||||||||||||||||||
| Parsabivetelcalcetide2.5 mg/0.5 mLinjection, solutionAmgen, Inc55513-0740-10Named Parsabiv 2.5 mg SDV 10x0.5 mL by Rhode Island Hospital, line 302 | 152,266.09 (Rhode Island Hospital, Schedule G, line 302, page 19 of the filing PDF) | 1,140 | ||||||||||||||||||||||||||||
| Parsabivetelcalcetide5 mg/mLinjection, solutionAmgen, Inc55513-0741-10Named Parsabiv 5 mg SDV 10x1 mL by Rhode Island Hospital, line 199 | 323,210.42 (Rhode Island Hospital, Schedule G, line 199, page 16 of the filing PDF) | 2,145 | ||||||||||||||||||||||||||||
| Paxlovidnirmatrelvir and ritonavirkitPfizer Laboratories Div Pfizer Inc00069-5317-20Named Paxlovid tab 150-100 by Wood River Health Services, Inc., line 9 | 6,480 (Wood River Health Services, Inc., Schedule G, line 9, page 8 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Paxlovid standard dose 300/100 mg T00069-5045-30, 00069-5321-30Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 23 | 20,688.72 (Blackstone Valley Community Health Care, Schedule G, line 23, page 8 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| Pegasyspeginterferon alfa-2a180 mcg/mLinjection, solutionpharmaand GmbH82154-0449-01Named Pegasys 180 mcg VL 1 mL by Rhode Island Hospital, line 850 | 8,260.08 (Rhode Island Hospital, Schedule G, line 850, page 33 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Pemetrexedpemetrexed disodium500 mg/50 mLinjection, powder, lyophilized, for solutionMeitheal Pharmaceuticals Inc.71288-0167-50Named Pemetrexed 500 mg LYO pwd SDV by Rhode Island Hospital, line 512 | 41,562.28 (Rhode Island Hospital, Schedule G, line 512, page 24 of the filing PDF) | 1,057 | ||||||||||||||||||||||||||||
| Pentam 300pentamidine isethionate300 mg/3 mLinjection, powder, lyophilized, for solutionFresenius Kabi USA, LLC63323-0113-10Named Pentam Lyophz 300 mg SDV 10x15 mL by Rhode Island Hospital, line 846 | 8,340.36 (Rhode Island Hospital, Schedule G, line 846, page 33 of the filing PDF) | 184 | ||||||||||||||||||||||||||||
| Perjetapertuzumab30 mg/mLinjection, solution, concentrateGenentech, Inc.50242-0145-01Named Perjeta 420 mg SDV 14 mL by Rhode Island Hospital, line 54 | 1,585,692.18 (Rhode Island Hospital, Schedule G, line 54, page 12 of the filing PDF) | 286 | ||||||||||||||||||||||||||||
| Pertzyepancrelipase24,000 USP units; 90,750 USP units; 86,250 USP unitscapsule, delayed releaseDigestive Care, Inc.59767-0024-01Named Pertzye DR cap 24000USP UN 80 by Rhode Island Hospital, line 567 | 31,194.24 (Rhode Island Hospital, Schedule G, line 567, page 26 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Pertzyepancrelipase24,000 USP units; 90,750 USP units; 86,250 USP unitscapsule, delayed releaseDigestive Care, Inc.59767-0024-02Named Pertzye 24 MU DR cap 200 by Rhode Island Hospital, line 404 | 79,152.40 (Rhode Island Hospital, Schedule G, line 404, page 22 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Phenobarbital Sodium130 mg/mLinjectionHikma Pharmaceuticals USA Inc.00641-0477-25Named PHENobarbital Sodium 130 mg/mL SOLN by Kent County Memorial Hospital, line 357 | 6,281.50 (Kent County Memorial Hospital, Schedule G, line 357, page 19 of the filing PDF) | 96 | ||||||||||||||||||||||||||||
| Phenobarbital Sodium130 mg/mLinjectionCameron Pharmaceuticals42494-0416-25Named Phenobarbital 130 mg VL 25x1 mL by Rhode Island Hospital, line 630 | 21,950.00 (Rhode Island Hospital, Schedule G, line 630, page 28 of the filing PDF) | 252 | ||||||||||||||||||||||||||||
| Phenobarbital Sodium130 mg/mLinjectionBPI Labs LLC54288-0137-10Named PHENobarbital Sodium 130 mg/mL SOLN by Kent County Memorial Hospital, line 371 | 5,679.52 (Kent County Memorial Hospital, Schedule G, line 371, page 20 of the filing PDF) | 42 | ||||||||||||||||||||||||||||
| Phenylephrine Hydrochloride25 mg/mLsolution/ dropsLifestar Pharma LLC70756-0629-25Named Phenylephrine HCl 2.5% O/S 2 mL by Rhode Island Hospital, line 517 | 40,935.21 (Rhode Island Hospital, Schedule G, line 517, page 25 of the filing PDF) | 2,617 | ||||||||||||||||||||||||||||
| Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf1,200 mg/15 mL; 600 mg/15 mL; 30,000 units/15 mLinjection, solutionGenentech, Inc.50242-0245-01Named Phesgo 1,200 mg-600 mg SDV 15 mL by Rhode Island Hospital, line 494 | 45,000.00 (Rhode Island Hospital, Schedule G, line 494, page 24 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Pifeltrodoravirine100 mgtablet, film coatedMerck Sharp & Dohme LLC00006-3069-01Named Pifeltro 100 mg tab 30 by The Miriam Hospital Ryan White Care Program, line 4 | 160,213.45 (The Miriam Hospital Ryan White Care Program, Schedule G, line 4, page 11 of the filing PDF) | 120 | ||||||||||||||||||||||||||||
| Pluvicto69488-0010-61The FDA directory does not list this code: the name is from the filingFiled by Rhode Island Hospital, line 12 | 3,559,810.00 (Rhode Island Hospital, Schedule G, line 12, page 11 of the filing PDF) | 103 | ||||||||||||||||||||||||||||
| Pomalystpomalidomide1 mgcapsuleCelgene Corporation59572-0501-21Named Pomalyst DS 1 mg cap 21 by Rhode Island Hospital, line 296 | 159,677.74 (Rhode Island Hospital, Schedule G, line 296, page 19 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Pomalystpomalidomide4 mgcapsuleCelgene Corporation59572-0504-21Named Pomalyst DS 4 mg cap 21 by Rhode Island Hospital, line 156 | 498,136.96 (Rhode Island Hospital, Schedule G, line 156, page 15 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Potassium Chloride7.46 g/1,000 mLinjection, solutionBaxter Healthcare Corporation00338-0709-48Named Pot Chl 10 mEq P-B 24x100 mL by Rhode Island Hospital, line 961 | 5,200.63 (Rhode Island Hospital, Schedule G, line 961, page 36 of the filing PDF) | 2,430 | ||||||||||||||||||||||||||||
| Poteligeomogamulizumab-kpkc4 mg/mLinjectionKyowa Kirin, Inc.42747-0761-01Named Poteligeo inj 20 mg/5 mL by Rhode Island Hospital, line 108 | 734,698.82 (Rhode Island Hospital, Schedule G, line 108, page 14 of the filing PDF) | 150 | ||||||||||||||||||||||||||||
| Praxbindidarucizumab50 mg/mLinjectionBoehringer Ingelheim Pharmaceuticals, Inc.00597-0197-05Named Praxbind 2.5 g SDV 2x50 mL by Rhode Island Hospital, line 798 | 10,589.01 (Rhode Island Hospital, Schedule G, line 798, page 32 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Prednisolone Acetate10 mg/mLsuspension/ dropsSandoz Inc61314-0637-05Named Prednisolone Acetate 1% OPH DRP 5 mL by Rhode Island Hospital, line 650 | 19,736.90 (Rhode Island Hospital, Schedule G, line 650, page 28 of the filing PDF) | 1,465 | ||||||||||||||||||||||||||||
| Priftinrifapentine150 mgtablet, film coatedsanofi-aventis U.S. LLC00088-2102-24Named Priftin 150 mg tab 3x8 BP by The Miriam Hospital RISE TB Clinic, line 1 | 14,359.62 (The Miriam Hospital RISE TB Clinic, Schedule G, line 1, page 10 of the filing PDF) | 312 | ||||||||||||||||||||||||||||
| Procriterythropoietin10,000 IU/mLinjection, solutionJanssen Products, LP59676-0310-01Named Procrit 10 MU SDV 6x1 mL by Rhode Island Hospital, line 626 | 22,099.56 (Rhode Island Hospital, Schedule G, line 626, page 27 of the filing PDF) | 173 | ||||||||||||||||||||||||||||
| Procriterythropoietin20,000 IU/mLinjection, solutionJanssen Products, LP59676-0320-04Named Procrit 20M UN/mL MDV 4x1 mL by Rhode Island Hospital, line 607 | 24,740.30 (Rhode Island Hospital, Schedule G, line 607, page 27 of the filing PDF) | 127 | ||||||||||||||||||||||||||||
| Procriterythropoietin40,000 IU/mLinjection, solutionJanssen Products, LP59676-0340-01Named Procrit 40 MU SDV 4x1 mL by Rhode Island Hospital, line 282 | 175,216.41 (Rhode Island Hospital, Schedule G, line 282, page 18 of the filing PDF) | 512 | ||||||||||||||||||||||||||||
| Prograftacrolimus1 mgcapsule, gelatin coatedAstellas Pharma US, Inc.00469-0617-73Named Prograf 1 mg cap 100 by Rhode Island Hospital, line 581 | 27,802.81 (Rhode Island Hospital, Schedule G, line 581, page 26 of the filing PDF) | 112 | ||||||||||||||||||||||||||||
| Prolastin-C Liquidalpha1-proteinase inhibitor (human)1,000 mg/20 mLinjection, solutionGrifols USA, LLC13533-0705-01Named Prolastin-C inj 1,000 mg by Rhode Island Hospital, line 181 | 379,334.73 (Rhode Island Hospital, Schedule G, line 181, page 16 of the filing PDF) | 1,027 | ||||||||||||||||||||||||||||
| Promactaeltrombopag olamine12.5 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0684-15Named Promacta 12.5 mg tab 30 by Rhode Island Hospital, line 702 | 15,312.15 (Rhode Island Hospital, Schedule G, line 702, page 29 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Promactaeltrombopag olamine25 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-0685-15Named Promacta 25 mg tab 30 by Rhode Island Hospital, line 291 | 166,617.34 (Rhode Island Hospital, Schedule G, line 291, page 19 of the filing PDF) | 132 | ||||||||||||||||||||||||||||
| Promactaeltrombopag olamine25 mgpowder, for suspensionNovartis Pharmaceuticals Corporation00078-0697-61Named Promacta 25 mg pak 30 by Rhode Island Hospital, line 368 | 97,643.06 (Rhode Island Hospital, Schedule G, line 368, page 21 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| Proparacaine Hydrochloride5 mg/mLsolution/ dropsBausch & Lomb Incorporated24208-0730-06Named Proparacaine HCl 0.5% O/S 15 mL by Rhode Island Hospital, line 710 | 14,697.74 (Rhode Island Hospital, Schedule G, line 710, page 30 of the filing PDF) | 1,653 | ||||||||||||||||||||||||||||
| Propofol10 mg/mLinjection, emulsionHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.23155-0345-42Named Propofol 500 mg EML VL 20x50 mL by Rhode Island Hospital, line 896 | 7,117.96 (Rhode Island Hospital, Schedule G, line 896, page 35 of the filing PDF) | 7,332 | ||||||||||||||||||||||||||||
| Protamine Sulfate10 mg/mLinjection, solutionFresenius Kabi USA, LLC63323-0229-05Named Protamine Sulfate 10 mg-mL VL 25x5 mL by Rhode Island Hospital, line 827 | 9,005.34 (Rhode Island Hospital, Schedule G, line 827, page 33 of the filing PDF) | 1,914 | ||||||||||||||||||||||||||||
| Provocholine Inhalation Solutionmethacholine chloride inhalation solutionkitMethapharm Inc.64281-0110-06Named Provocholine KIT by Kent County Memorial Hospital, line 321 | 9,490.61 (Kent County Memorial Hospital, Schedule G, line 321, page 18 of the filing PDF) | 75 | ||||||||||||||||||||||||||||
| Prucalopride1 mgtabletANI Pharmaceuticals, Inc.70954-0596-10Named Prucalopride 1 mg tab 30 by Rhode Island Hospital, line 894 | 7,152.01 (Rhode Island Hospital, Schedule G, line 894, page 35 of the filing PDF) | 23 | ||||||||||||||||||||||||||||
| Pulmozymedornase alfa1 mg/mLsolutionGenentech, Inc.50242-0100-40Named Pulmozyme amp 30x2.5 mL by Rhode Island Hospital, line 250 | 222,670.96 (Rhode Island Hospital, Schedule G, line 250, page 18 of the filing PDF) | 428 | ||||||||||||||||||||||||||||
| Purixan20 mg/mLsuspensionNova Laboratories, Ltd62484-0020-02Named Purixan 2,000 mg 100 mL EA by Rhode Island Hospital, line 958 | 5,302.26 (Rhode Island Hospital, Schedule G, line 958, page 36 of the filing PDF) | 28 | ||||||||||||||||||||||||||||
| Qalsodytofersen100 mg/15 mLinjectionBiogen Inc.64406-0109-01Named Qalsody sol 100/15 mL by Rhode Island Hospital, line 179 | 385,600.09 (Rhode Island Hospital, Schedule G, line 179, page 16 of the filing PDF) | 214 | ||||||||||||||||||||||||||||
| Qbrelislisinopril1 mg/mLsolutionAzurity Pharmaceuticals, Inc.52652-3001-01Named Qbrelis 1 mg/mL sol 150 mL by Rhode Island Hospital, line 917 | 6,218.43 (Rhode Island Hospital, Schedule G, line 917, page 35 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Qelbreeviloxazine hydrochloride200 mgcapsule, extended releaseSupernus Pharmaceuticals, Inc17772-0133-30Named Qelbree 200 mg CP24 30x1 EA by East Bay Community Action Program, line 58 | 6,561.54 (East Bay Community Action Program, Schedule G, line 58, page 11 of the filing PDF) | 15 | ||||||||||||||||||||||||||||
| Qinlockripretinib50 mgtabletDeciphera Pharmaceuticals, LLC73207-0101-30Named Qinlock 50 mg tab 90 by Rhode Island Hospital, line 166 | 439,745.13 (Rhode Island Hospital, Schedule G, line 166, page 15 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| QutenzacapsaicinkitAveritas Pharma Inc72512-0930-01Named MPB Qutenza 8% 179 mg patch 4 by Kent County Memorial Hospital, line 376 | 5,457.25 (Kent County Memorial Hospital, Schedule G, line 376, page 20 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Radicava ORSedaravonekitShionogi Inc.70510-2321-02Named Radicava ORS 105 mg/5 mL sus kit 2x35 mL by Rhode Island Hospital, line 721 | 14,276.88 (Rhode Island Hospital, Schedule G, line 721, page 30 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Rasuvomethotrexate15 mg/0.3 mLinjection, solutionMedexus Pharma Inc.59137-0520-04Named Rasuvo auto 15 mg inj 4x0.3 mL by Rhode Island Hospital, line 728 | 13,763.23 (Rhode Island Hospital, Schedule G, line 728, page 30 of the filing PDF) | 64 | ||||||||||||||||||||||||||||
| Rasuvomethotrexate20 mg/0.4 mLinjection, solutionMedexus Pharma Inc.59137-0530-04Named Rasuvo auto 20 mg inj 4x0.4 mL by Rhode Island Hospital, line 641 | 20,943.21 (Rhode Island Hospital, Schedule G, line 641, page 28 of the filing PDF) | 90 | ||||||||||||||||||||||||||||
| Rasuvomethotrexate25 mg/0.5 mLinjection, solutionMedexus Pharma Inc.59137-0540-04Named Rasuvo auto inj 4 25 mg/0.50 mL by Rhode Island Hospital, line 737 | 13,376.68 (Rhode Island Hospital, Schedule G, line 737, page 30 of the filing PDF) | 64 | ||||||||||||||||||||||||||||
| Recothromthrombin topical recombinantkitBaxter Healthcare Corporation00338-0322-01Named Recothrom 5,000 IU kit by Rhode Island Hospital, line 393 | 84,269.15 (Rhode Island Hospital, Schedule G, line 393, page 21 of the filing PDF) | 1,194 | ||||||||||||||||||||||||||||
| Repathaevolocumab140 mg/mLinjection, solutionAmgen USA Inc.72511-0501-01Named Repatha 140 mg PFS 1 mL L/F by Rhode Island Hospital, line 936 | 5,762.48 (Rhode Island Hospital, Schedule G, line 936, page 36 of the filing PDF) | 27 | ||||||||||||||||||||||||||||
| Retevmoselpercatinib160 mgtablet, coatedEli Lilly and Company00002-5562-60Named Retevmo 160 mg tab 60 by Rhode Island Hospital, line 674 | 17,377.55 (Rhode Island Hospital, Schedule G, line 674, page 29 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Retevmoselpercatinib80 mgtablet, coatedEli Lilly and Company00002-6082-60Named Retevmo 80 mg tab 60 by Rhode Island Hospital, line 552 | 34,755.12 (Rhode Island Hospital, Schedule G, line 552, page 26 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Revlimidlenalidomide5 mgcapsuleCelgene Corporation59572-0405-00Named Revlimid DS 5 mg cap 100 by Rhode Island Hospital, line 735 | 13,528.44 (Rhode Island Hospital, Schedule G, line 735, page 30 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Revlimidlenalidomide10 mgcapsuleCelgene Corporation59572-0410-00Named Revlimid DS 10 mg cap 100 by Rhode Island Hospital, line 919 | 6,119.76 (Rhode Island Hospital, Schedule G, line 919, page 35 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Revlimidlenalidomide15 mgcapsuleCelgene Corporation59572-0415-21Named Revlimid DS 15 mg cap 21 by Rhode Island Hospital, line 830 | 8,894.66 (Rhode Island Hospital, Schedule G, line 830, page 33 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Revlimidlenalidomide25 mgcapsuleCelgene Corporation59572-0425-21Named Revlimid DS 25 mg cap 21 by Rhode Island Hospital, line 928 | 5,879.71 (Rhode Island Hospital, Schedule G, line 928, page 35 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Rexultibrexpiprazole0.25 mgtabletOtsuka America Pharmaceutical, Inc.59148-0035-13Named Rexulti tab 0.25 mg by Thundermist Health Center, line 196 | 6,400.40 (Thundermist Health Center, Schedule G, line 196, page 11 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Rexultibrexpiprazole4 mgtabletOtsuka America Pharmaceutical, Inc.59148-0040-13Named Rexulti tab 4 mg by Thundermist Health Center, line 116 | 18,362.48 (Thundermist Health Center, Schedule G, line 116, page 10 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| RhoGAM Ultra-Filtered PLUShuman Rho(D) immune globulin300 mcginjection, solutionKedrion Biopharma Inc00562-7805-05Named Rho Immune Globuilin (RH by Thundermist Health Center, line 237 | 10,454.07 (Thundermist Health Center, Schedule G, line 237, page 12 of the filing PDF) | 33 | ||||||||||||||||||||||||||||
| Rifabutin150 mgcapsuleMylan Pharmaceuticals Inc.59762-1350-01Named Rifabutin 150 mg cap 100 by The Miriam Hospital RISE TB Clinic, line 2 | 5,118.47 (The Miriam Hospital RISE TB Clinic, Schedule G, line 2, page 10 of the filing PDF) | 23 | ||||||||||||||||||||||||||||
| Rifampin300 mgcapsuleLupin Pharmaceuticals, Inc.68180-0659-07Named Rifampin 300 mg 60 caps by The Miriam Hospital RISE TB Clinic, line 4 | 9,849.05 (The Miriam Hospital RISE TB Clinic, Schedule G, line 4, page 10 of the filing PDF) | 992 | ||||||||||||||||||||||||||||
| Risperdal ConstarisperidonekitJanssen Pharmaceuticals, Inc.50458-0307-11Named Risperdal Con 37.5 mg ER SYG 2 mL kit by Rhode Island Hospital, line 703 | 15,190.22 (Rhode Island Hospital, Schedule G, line 703, page 29 of the filing PDF) | 31 | ||||||||||||||||||||||||||||
| RisperidonekitTeva Pharmaceuticals, Inc.00480-1232-08Named risperiDONE Microspheres ER 25 mg SRER 1x1 EA by East Bay Community Action Program, line 50 | 8,229.60 (East Bay Community Action Program, Schedule G, line 50, page 10 of the filing PDF) | 26 | ||||||||||||||||||||||||||||
| RisperidonekitTeva Pharmaceuticals, Inc.00480-1342-08Named Risperidone 37.5 mg ER inj sus kit by Rhode Island Hospital, line 813 | 9,916.00 (Rhode Island Hospital, Schedule G, line 813, page 32 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Rituxanrituximab10 mg/mLinjection, solutionGenentech, Inc.50242-0051-21Named Rituxan 100 mg SDV 10 mL by Rhode Island Hospital, line 623 | 22,274.16 (Rhode Island Hospital, Schedule G, line 623, page 27 of the filing PDF) | 19 | ||||||||||||||||||||||||||||
| Rocuronium Bromide10 mg/mLinjection, solutionHospira, Inc.00409-3189-10Named Rocuronium Bromide 50 mg/5 mL SOLN by Women & Infants Hospital of RI, line 253 | 6,900.63 (Women & Infants Hospital of RI, Schedule G, line 253, page 17 of the filing PDF) | 3,798 | ||||||||||||||||||||||||||||
| Rukobiafostemsavir tromethamine600 mgtablet, film coated, extended releaseViiV Healthcare Company49702-0250-18Named Rukobia 600 mg tab 60 by The Miriam Hospital Ryan White Care Program, line 22 | 176,538.43 (The Miriam Hospital Ryan White Care Program, Schedule G, line 22, page 12 of the filing PDF) | 26 | ||||||||||||||||||||||||||||
| Rybelsus 14 mg tabs169431430Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 39 | 9,126.35 (Blackstone Valley Community Health Care, Schedule G, line 39, page 8 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Rydapt25 mgcapsule, liquid filledNovartis Pharmaceuticals Corporation00078-0698-19Named midostaurin (Rydapt) 25 mg cap by Kent County Memorial Hospital, line 70 | 149,632.24 (Kent County Memorial Hospital, Schedule G, line 70, page 12 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Rydapt25 mgcapsule, liquid filledNovartis Pharmaceuticals Corporation00078-0698-99Named Rydapt 25 mg SGC 56 (2x28) by Rhode Island Hospital, line 910 | 6,399.25 (Rhode Island Hospital, Schedule G, line 910, page 35 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Rylazeasparaginase erwinia chrysanthemi (recombinant)-rywn20 mg/mLinjectionJazz Pharmaceuticals, Inc.68727-0900-03Named Rylaze 10 mg SDV 3x0.5 mL by Rhode Island Hospital, line 182 | 371,404.08 (Rhode Island Hospital, Schedule G, line 182, page 16 of the filing PDF) | 36 | ||||||||||||||||||||||||||||
| Rytarycarbidopa and levodopa95 mg; 23.75 mgcapsule, extended releaseAmneal Pharmaceuticals LLC64896-0661-01Named Rytary 23.75 mg/95 mg cap 100 by Rhode Island Hospital, line 847 | 8,329.88 (Rhode Island Hospital, Schedule G, line 847, page 33 of the filing PDF) | 20 | ||||||||||||||||||||||||||||
| Rytarycarbidopa and levodopa145 mg; 36.25 mgcapsule, extended releaseAmneal Pharmaceuticals LLC64896-0662-01Named Rytary 36.25 mg/145 mg cap 100 by Rhode Island Hospital, line 700 | 15,418.64 (Rhode Island Hospital, Schedule G, line 700, page 29 of the filing PDF) | 40 | ||||||||||||||||||||||||||||
| Rytarycarbidopa and levodopa195 mg; 48.75 mgcapsule, extended releaseAmneal Pharmaceuticals LLC64896-0663-01Named Rytary 48.75 mg/195 mg cap 100 by Rhode Island Hospital, line 755 | 12,412.74 (Rhode Island Hospital, Schedule G, line 755, page 31 of the filing PDF) | 25 | ||||||||||||||||||||||||||||
| Ryteloimetelstat sodium188 mginjection, powder, lyophilized, for solutionGeron Corporation82959-0111-01Named Rytelo 188 mg SDV by Rhode Island Hospital, line 134 | 614,217.57 (Rhode Island Hospital, Schedule G, line 134, page 15 of the filing PDF) | 31 | ||||||||||||||||||||||||||||
| Ryteloimetelstat sodium47 mginjection, powder, lyophilized, for solutionGeron Corporation82959-0112-01Named Rytelo 47 mg SDV by Rhode Island Hospital, line 510 | 41,648.06 (Rhode Island Hospital, Schedule G, line 510, page 24 of the filing PDF) | 24 | ||||||||||||||||||||||||||||
| Sacubitril and Valsartan24 mg; 26 mgtablet, film coatedAlembic Pharmaceuticals Inc.62332-0556-60Named Sacubitril-Valsartan 24-26 mg tab 60 by Rhode Island Hospital, line 969 | 5,101.40 (Rhode Island Hospital, Schedule G, line 969, page 36 of the filing PDF) | 83 | ||||||||||||||||||||||||||||
| Sandostatin LAR Depotoctreotide acetatekitNovartis Pharmaceuticals Corporation00078-0811-81Named Sandostatin LAR Depot 10 mg VL by Rhode Island Hospital, line 461 | 54,533.04 (Rhode Island Hospital, Schedule G, line 461, page 23 of the filing PDF) | 42 | ||||||||||||||||||||||||||||
| Sapropterin Dihydrochloride100 mgtabletPar Health USA, LLC49884-0720-08Named Sapropterin Dihcl 100 mg tab 120 by Rhode Island Hospital, line 571 | 30,591.35 (Rhode Island Hospital, Schedule G, line 571, page 26 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Scemblixasciminib20 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-1091-20Named Scemblix 20 mg tab 60 by Rhode Island Hospital, line 204 | 315,129.03 (Rhode Island Hospital, Schedule G, line 204, page 16 of the filing PDF) | 22 | ||||||||||||||||||||||||||||
| Sevelamer Carbonate800 mgtablet, film coatedAmneal Pharmaceuticals LLC65162-0058-27Named Sevelamer Carbonate 800 mg tab 270 by Rhode Island Hospital, line 848 | 8,296.13 (Rhode Island Hospital, Schedule G, line 848, page 33 of the filing PDF) | 334 | ||||||||||||||||||||||||||||
| Sikloshydroxyurea1,000 mgtablet, film coatedMedunik71770-0120-30Named Siklos 1,000 mg tab 30 by Rhode Island Hospital, line 629 | 21,987.15 (Rhode Island Hospital, Schedule G, line 629, page 28 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Simulectbasiliximab20 mg/5 mLinjection, powder, for solutionNovartis Pharmaceuticals Corporation00078-0331-84Named Simulect 20 mg SDV by Rhode Island Hospital, line 627 | 22,085.21 (Rhode Island Hospital, Schedule G, line 627, page 27 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Sincalide5 mcg/5 mLinjection, powder, lyophilized, for solutionFosun Pharma USA Inc72266-0248-05Named Sincalide 5 mcg SOLR by Kent County Memorial Hospital, line 356 | 6,336.67 (Kent County Memorial Hospital, Schedule G, line 356, page 19 of the filing PDF) | 98 | ||||||||||||||||||||||||||||
| Sirolimus1 mgtablet, film coatedGlenmark Pharmaceuticals Inc., USA68462-0683-01Named Sirolimus 1 mg tab 100 by Rhode Island Hospital, line 898 | 6,892.88 (Rhode Island Hospital, Schedule G, line 898, page 35 of the filing PDF) | 208 | ||||||||||||||||||||||||||||
| Sivextrotedizolid phosphate200 mgtablet, film coatedMerck Sharp & Dohme LLC67919-0041-04Named Sivextro tab 200 mg 30 by Kent County Memorial Hospital, line 285 | 14,261.32 (Kent County Memorial Hospital, Schedule G, line 285, page 17 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Skylalevonorgestrel13.5 mgintrauterine deviceBayer HealthCare Pharmaceuticals Inc.50419-0422-01Named IUD supplied - Skyla by Thundermist Health Center, line 236 | 6,068.28 (Thundermist Health Center, Schedule G, line 236, page 12 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Skytrofalonapegsomatropin-tcgd4.3 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc.73362-0005-01Named Skytrofa 4.3 mg HGH 1x4 BX by Rhode Island Hospital, line 601 | 25,414.69 (Rhode Island Hospital, Schedule G, line 601, page 27 of the filing PDF) | 23 | ||||||||||||||||||||||||||||
| Skytrofalonapegsomatropin-tcgd5.2 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc.73362-0006-01Named Skytrofa 5.2 mg HGH 1x4BX by Rhode Island Hospital, line 738 | 13,284.82 (Rhode Island Hospital, Schedule G, line 738, page 30 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Skytrofalonapegsomatropin-tcgd7.6 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc.73362-0008-01Named Skytrofa 7.6 mg HGH 1x4BX by Rhode Island Hospital, line 564 | 32,179.04 (Rhode Island Hospital, Schedule G, line 564, page 26 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Skytrofalonapegsomatropin-tcgd9.1 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc.73362-0009-01Named Skytrofa 9.1 mg HGH 1x4BX by Rhode Island Hospital, line 413 | 75,539.72 (Rhode Island Hospital, Schedule G, line 413, page 22 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Skytrofalonapegsomatropin-tcgd11 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc.73362-0010-01Named Skytrofa 11 mg HGH 1x4BX by Rhode Island Hospital, line 471 | 50,360.19 (Rhode Island Hospital, Schedule G, line 471, page 23 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Skytrofalonapegsomatropin-tcgd13.3 mginjection, powder, lyophilized, for solutionAscendis Pharma Endocrinology, Inc.73362-0011-01Named Skytrofa 13.3 mg HGH-6XNDL/4XSD cartridge by Rhode Island Hospital, line 611 | 24,095.27 (Rhode Island Hospital, Schedule G, line 611, page 27 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Sodium Chloride9 g/1,000 mLinjection, solutionBaxter Healthcare Corporation00338-0049-02Named F/S Sodium Chloride 0.9% 250 mL by Women & Infants Hospital of RI, line 197 | 17,112.09 (Women & Infants Hospital of RI, Schedule G, line 197, page 15 of the filing PDF) | 2,631 | ||||||||||||||||||||||||||||
| Sodium Ferric Gluconate Complex in Sucrose12.5 mg/mLinjectionHikma Pharmaceuticals USA Inc.00143-9570-10Named Sodium Ferric 62.5 mg 10x5 mL SDV by Rhode Island Hospital, line 658 | 19,237.57 (Rhode Island Hospital, Schedule G, line 658, page 28 of the filing PDF) | 1,191 | ||||||||||||||||||||||||||||
| Sogroyasomapacitan-beco6.7 mg/mLinjection, solutionNovo Nordisk00169-2030-11Named Sogroya 10 mg PFP 1.5 mL by Rhode Island Hospital, line 905 | 6,573.71 (Rhode Island Hospital, Schedule G, line 905, page 35 of the filing PDF) | 15 | ||||||||||||||||||||||||||||
| Sogroyasomapacitan-beco3.3 mg/mLinjection, solutionNovo Nordisk00169-2035-11Named Sogroya 5 mg PFP 1.5 mL by Rhode Island Hospital, line 913 | 6,338.42 (Rhode Island Hospital, Schedule G, line 913, page 35 of the filing PDF) | 28 | ||||||||||||||||||||||||||||
| Sogroyasomapacitan-beco10 mg/mLinjection, solutionNovo Nordisk00169-2037-11Named Sogroya 15 mg PFP 1.5 mL by Rhode Island Hospital, line 479 | 47,913.60 (Rhode Island Hospital, Schedule G, line 479, page 24 of the filing PDF) | 34 | ||||||||||||||||||||||||||||
| Solu-Medrolmethylprednisolone sodium succinate125 mg/2 mLinjection, powder, for solutionPharmacia & Upjohn Company LLC00009-0047-22Named Solu Medrol 125 mg AOV 25x2 mL by Rhode Island Hospital, line 893 | 7,157.98 (Rhode Island Hospital, Schedule G, line 893, page 34 of the filing PDF) | 3,670 | ||||||||||||||||||||||||||||
| Somatuline Depotlanreotide acetate60 mg/0.2 mLinjectionIpsen Biopharmaceuticals, Inc.15054-1060-04Named Somatuline Depot 60 mg PFS 0.2 mL by Rhode Island Hospital, line 677 | 16,760.97 (Rhode Island Hospital, Schedule G, line 677, page 29 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Somatuline Depotlanreotide acetate90 mg/0.3 mLinjectionIpsen Biopharmaceuticals, Inc.15054-1090-04Named Somatuline Depot 90 mg PFS 0.3 mL by Rhode Island Hospital, line 815 | 9,730.89 (Rhode Island Hospital, Schedule G, line 815, page 32 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Spevigospesolimab-sbzo60 mg/mLinjectionBoehringer Ingelheim Pharmaceuticals, Inc.00597-0035-10Named MPB Spevigo 450 mg/7.5 mL SDV 2 by Women & Infants Hospital of RI, line 106 | 80,380.34 (Women & Infants Hospital of RI, Schedule G, line 106, page 13 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Spevigospesolimab-sbzo150 mginjectionBoehringer Ingelheim Pharmaceuticals, Inc.00597-0620-20Named Spevigo 150 mg PFS 2x1 mL by Rhode Island Hospital, line 331 | 132,987.70 (Rhode Island Hospital, Schedule G, line 331, page 20 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Spinosad9 mg/mLsuspensionParaPRO LLC52246-0570-04Named Spinosad sus 0.9% by Thundermist Health Center, line 205 | 5,789.97 (Thundermist Health Center, Schedule G, line 205, page 11 of the filing PDF) | 30 | ||||||||||||||||||||||||||||
| Spinrazanusinersen2.4 mg/mLinjection, solutionBiogen Inc.64406-0058-01Named Spinraza inj 12 mg/5 mL by Rhode Island Hospital, line 123 | 647,624.74 (Rhode Island Hospital, Schedule G, line 123, page 14 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Spironolactone100 mgtabletAmneal Pharmaceuticals of New York LLC53746-0515-01Named spironolactone (Aldactone) 100 mg tablet by Women & Infants Hospital of RI, line 233 | 9,710.18 (Women & Infants Hospital of RI, Schedule G, line 233, page 16 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Spryceldasatinib100 mgtabletE.R. Squibb & Sons, L.L.C.00003-0852-22Named Sprycel 100 mg tab 30 by Rhode Island Hospital, line 372 | 94,497.86 (Rhode Island Hospital, Schedule G, line 372, page 21 of the filing PDF) | 114 | ||||||||||||||||||||||||||||
| Spryceldasatinib80 mgtabletE.R. Squibb & Sons, L.L.C.00003-0855-22Named Sprycel 80 mg tab 30 by Rhode Island Hospital, line 720 | 14,306.93 (Rhode Island Hospital, Schedule G, line 720, page 30 of the filing PDF) | 29 | ||||||||||||||||||||||||||||
| Stribildelvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate150 mg; 150 mg; 200 mg; 300 mgtablet, film coatedGilead Sciences, Inc.61958-1201-01Named Stribild tab 30 by The Miriam Hospital Ryan White Care Program, line 30 | 14,378.72 (The Miriam Hospital Ryan White Care Program, Schedule G, line 30, page 12 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Strong Iodine Solution700 mg/mL; 1,400 mg/mLsolution/ dropsSafecor Health, LLC48433-0230-15Named iodine 5%-10% topical 14 mL SOLN by Women & Infants Hospital of RI, line 251 | 6,928.69 (Women & Infants Hospital of RI, Schedule G, line 251, page 17 of the filing PDF) | 239 | ||||||||||||||||||||||||||||
| Sunitinib Malate12.5 mgcapsuleMylan Pharmaceuticals Inc.00378-6678-28Named Sunitinib Malate 12.5 mg cap 28 by Rhode Island Hospital, line 924 | 6,016.48 (Rhode Island Hospital, Schedule G, line 924, page 35 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Sunitinib Malate50 mgcapsuleMylan Pharmaceuticals Inc.00378-6680-28Named Sunitinib Malate 50 mg cap 28 by Rhode Island Hospital, line 951 | 5,468.56 (Rhode Island Hospital, Schedule G, line 951, page 36 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Sunlencalenacapavir sodium300 mgtablet, film coatedGilead Sciences, Inc.61958-3001-01Named Sunlenca 300 mg tab 4 by The Miriam Hospital Ryan White Care Program, line 37 | 14,995.50 (The Miriam Hospital Ryan White Care Program, Schedule G, line 37, page 12 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Sunlencalenacapavir sodium300 mgtablet, film coatedGilead Sciences, Inc.61958-3001-03Named Sunlenca 300 mg tab 4 by The Miriam Hospital Ryan White Care Program, line 38 | 22,462.05 (The Miriam Hospital Ryan White Care Program, Schedule G, line 38, page 12 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Sunlencalenacapavir sodiumkitGilead Sciences, Inc.61958-3002-01Named Sunlenca 463.5 mg 2x1.5 mL SDV kit by The Miriam Hospital Ryan White Care Program, line 39 | 147,928.14 (The Miriam Hospital Ryan White Care Program, Schedule G, line 39, page 12 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Sunlencalenacapavir sodiumkitGilead Sciences, Inc.61958-3005-01Named Sunlenca 463.5 mg 2x1.5 mL SDV kit by The Miriam Hospital Ryan White Care Program, line 40 | 326,052.88 (The Miriam Hospital Ryan White Care Program, Schedule G, line 40, page 12 of the filing PDF) | 23 | ||||||||||||||||||||||||||||
| Sunosisolriamfetol150 mgtablet, film coatedAxsome Therapeutics, Inc.81968-0351-01Named solriamfetoL (Sunosi) 150 mg Tab by Kent County Memorial Hospital, line 338 | 7,521.47 (Kent County Memorial Hospital, Schedule G, line 338, page 19 of the filing PDF) | 40 | ||||||||||||||||||||||||||||
| Supprelin LAhistrelin acetate50 mgimplantEndo USA, Inc.67979-0002-01Named Supprelin LA 50 mg kit DS by Rhode Island Hospital, line 125 | 645,411.87 (Rhode Island Hospital, Schedule G, line 125, page 14 of the filing PDF) | 42 | ||||||||||||||||||||||||||||
| Sylvantsiltuximab400 mginjection, powder, for solutionRecordati Rare Diseases, Inc.73090-0421-01Named Sylvant 400 mg SOLR by Landmark Medical center, line 15 | 95,644.92 (Landmark Medical center, Schedule G, line 15, page 11 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Symbicortbudesonide and formoterol fumarate dihydrate80 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP00186-0372-20Named Symbicort 120 80-4.5 mcg inh 10.2 g by Rhode Island Hospital, line 960 | 5,230.37 (Rhode Island Hospital, Schedule G, line 960, page 36 of the filing PDF) | 114 | ||||||||||||||||||||||||||||
| Symbicortbudesonide and formoterol fumarate dihydrate80 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP00186-0372-28Named Symbicort INS 80/ 4.5 mcg inh 6.9 g by Rhode Island Hospital, line 971 | 5,051.20 (Rhode Island Hospital, Schedule G, line 971, page 37 of the filing PDF) | 168 | ||||||||||||||||||||||||||||
| Symbicort 160-4.5 mcg/ACT aero186037020Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 35 | 10,897.99 (Blackstone Valley Community Health Care, Schedule G, line 35, page 8 of the filing PDF) | 29 | ||||||||||||||||||||||||||||
| Synagis 100 mg-mL SDV66658-0231-01The FDA directory does not list this code: the name is from the filingFiled by Rhode Island Hospital, line 729 | 13,751.68 (Rhode Island Hospital, Schedule G, line 729, page 30 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Syndrosdronabinol5 mg/mLsolutionBenuvia Operations, LLC78613-0201-30Named Syndros 5 mg/mL sol 30 mL by The Miriam Hospital Ryan White Care Program, line 43 | 44,915.20 (The Miriam Hospital Ryan White Care Program, Schedule G, line 43, page 12 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Tacrolimus1 mgcapsuleDr. Reddy's Laboratories Limited55111-0526-01Named Tacrolimus 1 mg cap 100 by Rhode Island Hospital, line 762 | 12,121.07 (Rhode Island Hospital, Schedule G, line 762, page 31 of the filing PDF) | 991 | ||||||||||||||||||||||||||||
| Tafinlardabrafenib50 mgcapsuleNovartis Pharmaceuticals Corporation00078-0682-66Named Tafinlar 50 mg cap 120 by Rhode Island Hospital, line 389 | 86,038.73 (Rhode Island Hospital, Schedule G, line 389, page 21 of the filing PDF) | 19 | ||||||||||||||||||||||||||||
| Taltzixekizumab80 mg/mLinjection, solutionEli Lilly and Company00002-1445-09Named Taltz 80 mg/mL auto inj 3x1 mL by Rhode Island Hospital, line 480 | 47,549.17 (Rhode Island Hospital, Schedule G, line 480, page 24 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Taltzixekizumab80 mg/mLinjection, solutionEli Lilly and Company00002-1445-27Named Taltz 80 mg/mL auto inj 2x1 mL by Rhode Island Hospital, line 217 | 279,623.07 (Rhode Island Hospital, Schedule G, line 217, page 17 of the filing PDF) | 45 | ||||||||||||||||||||||||||||
| Talveytalquetamab-tgvs3 mg/1.5 mLinjectionJanssen Biotech, Inc.57894-0469-01Named Talvey 3 mg SDV 1.5 mL by Rhode Island Hospital, line 771 | 11,515.91 (Rhode Island Hospital, Schedule G, line 771, page 31 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Talzennatalazoparib0.35 mgcapsule, liquid filledPfizer Laboratories Div Pfizer Inc00069-0454-30Named Talzenna 0.35 mg SGC 30 by Rhode Island Hospital, line 727 | 13,952.08 (Rhode Island Hospital, Schedule G, line 727, page 30 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Talzennatalazoparib0.5 mgcapsule, liquid filledPfizer Laboratories Div Pfizer Inc00069-0546-30Named Talzenna 0.5 mg SGC 30 by Rhode Island Hospital, line 194 | 332,051.43 (Rhode Island Hospital, Schedule G, line 194, page 16 of the filing PDF) | 24 | ||||||||||||||||||||||||||||
| Talzennatalazoparib0.5 mgcapsulePfizer Laboratories Div Pfizer Inc00069-1501-30Named Talzenna 0.5 mg cap 30 by Rhode Island Hospital, line 398 | 81,422.52 (Rhode Island Hospital, Schedule G, line 398, page 21 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Tasimelteon20 mgcapsule, gelatin coatedTeva Pharmaceuticals, Inc.00480-4490-56Named Tasimelteon 20 mg cap 30 by Rhode Island Hospital, line 943 | 5,584.56 (Rhode Island Hospital, Schedule G, line 943, page 36 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Tavalissefostamatinib150 mgtabletRigel Pharmaceuticals, Inc.71332-0002-01Named MPB Tavalisse 150 mg tab 60 by Kent County Memorial Hospital, line 111 | 91,402.43 (Kent County Memorial Hospital, Schedule G, line 111, page 13 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Tavneosavacopan10 mgcapsuleChemoCentryx, Inc.73556-0168-01Named Tavneos 10 mg cap 180 by Rhode Island Hospital, line 446 | 60,668.31 (Rhode Island Hospital, Schedule G, line 446, page 23 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Tecvayliteclistamab-cqyv10 mg/mLinjectionJanssen Biotech, Inc.57894-0449-01Named Tecvayli 30 mg SDV 3 mL SD by Rhode Island Hospital, line 589 | 27,004.02 (Rhode Island Hospital, Schedule G, line 589, page 26 of the filing PDF) | 32 | ||||||||||||||||||||||||||||
| Tecvayliteclistamab-cqyv90 mg/mLinjectionJanssen Biotech, Inc.57894-0450-01Named Tecvayli 153 mg SDV 1.7 mL SD by Rhode Island Hospital, line 50 | 1,671,022.98 (Rhode Island Hospital, Schedule G, line 50, page 12 of the filing PDF) | 311 | ||||||||||||||||||||||||||||
| Temsirolimustemsirolimus injectionkitAlmaject, Inc.72611-0785-02Named Temsirolimus 25 mg-mL SDV kit by Rhode Island Hospital, line 636 | 21,348.75 (Rhode Island Hospital, Schedule G, line 636, page 28 of the filing PDF) | 27 | ||||||||||||||||||||||||||||
| Tepmetkotepotinib hydrochloride225 mgtabletEMD Serono, Inc.44087-5000-03Named MPB Tepmetko 225 mg tab 30 DS by Kent County Memorial Hospital, line 53 | 198,564.10 (Kent County Memorial Hospital, Schedule G, line 53, page 11 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| Tepmetkotepotinib hydrochloride225 mgtabletEMD Serono, Inc.44087-5000-06Named Tepmetko 225 mg tab 60 (6x10) DS by Rhode Island Hospital, line 286 | 170,527.29 (Rhode Island Hospital, Schedule G, line 286, page 19 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Teriparatide250 mcg/mLinjection, solutionPrasco Laboratories66993-0495-28Named Teriparatide 560 mcg PFP 2.24 mL by Rhode Island Hospital, line 886 | 7,355.63 (Rhode Island Hospital, Schedule G, line 886, page 34 of the filing PDF) | 26 | ||||||||||||||||||||||||||||
| Testopeltestosterone75 mgpelletEndo USA, Inc.66887-0004-10Named Testopel 75 mg PEL 10 DS by Rhode Island Hospital, line 514 | 41,389.70 (Rhode Island Hospital, Schedule G, line 514, page 25 of the filing PDF) | 57 | ||||||||||||||||||||||||||||
| Testosterone Cypionate200 mg/mLinjectionHikma Pharmaceuticals USA Inc.00143-9659-01Named Testost Cyp inj 200 mg/mL by Thundermist Health Center, line 71 | 40,328.91 (Thundermist Health Center, Schedule G, line 71, page 9 of the filing PDF) | 1,786 | ||||||||||||||||||||||||||||
| Tetracaine Hydrochloride5 mg/mLsolutionAlcon Laboratories, Inc.00065-0741-14Named Tetracaine HCl 0.5% O/S 12x4 mL by Rhode Island Hospital, line 593 | 26,784.98 (Rhode Island Hospital, Schedule G, line 593, page 27 of the filing PDF) | 2,340 | ||||||||||||||||||||||||||||
| Tetracycline HCl 500 mg caps23155076701, 60219152301, 62135026601Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 49 | 5,961.90 (Blackstone Valley Community Health Care, Schedule G, line 49, page 8 of the filing PDF) | 49 | ||||||||||||||||||||||||||||
| Thiaminethiamine hydrochloride100 mg/mLinjection, solutionFresenius Kabi USA, LLC63323-0013-02Named Thiamine 200 mg MDV 25x2 mL by Rhode Island Hospital, line 973 | 5,000.61 (Rhode Island Hospital, Schedule G, line 973, page 37 of the filing PDF) | 670 | ||||||||||||||||||||||||||||
| Thyrogenthyrotropin alfa0.9 mg/mLinjection, powder, lyophilized, for solutionGenzyme Corporation58468-0030-02Named Thyrogen VL 2 DS by Rhode Island Hospital, line 568 | 31,066.54 (Rhode Island Hospital, Schedule G, line 568, page 26 of the filing PDF) | 90 | ||||||||||||||||||||||||||||
| Tiopronin300 mgtablet, delayed releasePar Health USA, LLC00254-3035-09Named Tiopronin 300 mg DR tab 90 by Rhode Island Hospital, line 554 | 34,307.54 (Rhode Island Hospital, Schedule G, line 554, page 26 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Tivdaktisotumab vedotin40 mg/4 mLinjection, powder, for solutionSeagen Inc.51144-0003-01Named tisotumab vedotin (Tivdak) 130 mg in sodium chloride 0.9% 100 mL chemo IVPB by Women & Infants Hospital of RI, line 66 | 137,803.12 (Women & Infants Hospital of RI, Schedule G, line 66, page 12 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| TOBI Podhalertobramycin28 mgcapsuleViatris Specialty LLC49502-0401-24Named TOBI Podhaler 28 mg cap 4x56 by Rhode Island Hospital, line 439 | 63,444.78 (Rhode Island Hospital, Schedule G, line 439, page 23 of the filing PDF) | 15 | ||||||||||||||||||||||||||||
| Toujeoinsulin glargine300 units/mLinjection, solutionSanofi-Aventis U.S. LLC00024-5869-03Named Toujeo Solo inj 300/mL by Thundermist Health Center, line 144 | 13,464.71 (Thundermist Health Center, Schedule G, line 144, page 10 of the filing PDF) | 132 | ||||||||||||||||||||||||||||
| Toujeo Solostar 300 units/mL SOPN24586903Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 34 | 10,898.55 (Blackstone Valley Community Health Care, Schedule G, line 34, page 8 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Tradjentalinagliptin5 mgtablet, film coatedBoehringer Ingelheim Pharmaceuticals, Inc.00597-0140-30Named Tradjenta 5 mg tablets by The Providence Community Health Centers, Inc, line 166 | 5,562.13 (The Providence Community Health Centers, Inc, Schedule G, line 166, page 13 of the filing PDF) | 171 | ||||||||||||||||||||||||||||
| Tradjenta 5 mg tabs597014030, 597014090Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 15 | 33,445.99 (Blackstone Valley Community Health Care, Schedule G, line 15, page 8 of the filing PDF) | 37 | ||||||||||||||||||||||||||||
| Tranexamic Acid100 mg/mLinjection, solutionEugia US LLC55150-0188-10Named Tranexamic Acid 1,000 mg/10 mL SOLN by Women & Infants Hospital of RI, line 178 | 26,317.88 (Women & Infants Hospital of RI, Schedule G, line 178, page 15 of the filing PDF) | 224 | ||||||||||||||||||||||||||||
| Trelegy Ellipta 100-62.5-25 AEPB173088710Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 27 | 16,154.66 (Blackstone Valley Community Health Care, Schedule G, line 27, page 8 of the filing PDF) | 17 | ||||||||||||||||||||||||||||
| Trelstartriptorelin pamoatekitVerity Pharmaceuticals Inc.74676-5902-01Named Trelstar Mixject 3.75 mg SUSR by Women & Infants Hospital of RI, line 180 | 25,030.80 (Women & Infants Hospital of RI, Schedule G, line 180, page 15 of the filing PDF) | 134 | ||||||||||||||||||||||||||||
| Trelstartriptorelin pamoatekitVerity Pharmaceuticals Inc.74676-5904-01Named triptorelin (Trelstar Mixject) intramuscular injection 11.25 mg by Women & Infants Hospital of RI, line 230 | 10,049.29 (Women & Infants Hospital of RI, Schedule G, line 230, page 16 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Tremfyaguselkumab100 mg/mLinjectionJanssen Biotech, Inc.57894-0640-06Named Tremfya 100 mg PFP 1 mL by Rhode Island Hospital, line 619 | 22,638.83 (Rhode Island Hospital, Schedule G, line 619, page 27 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Tremfyaguselkumab200 mg/2 mLinjectionJanssen Biotech, Inc.57894-0651-22Named Tremfya 200 mg PFS 2 mL by Rhode Island Hospital, line 709 | 14,713.92 (Rhode Island Hospital, Schedule G, line 709, page 30 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Trettencoagulation factor XIII A-subunit (recombinant)kitNovo Nordisk00169-7013-01Named Tretten 2,496 IU SDV by Rhode Island Hospital, line 61 | 1,341,015.12 (Rhode Island Hospital, Schedule G, line 61, page 13 of the filing PDF) | 26 | ||||||||||||||||||||||||||||
| Triamcinolone Acetonide40 mg/mLinjection, suspensionAmneal Pharmaceuticals LLC70121-1049-05Named Triamcinolone Acetonide 10 mg by Thundermist Health Center, line 238 | 6,929.60 (Thundermist Health Center, Schedule G, line 238, page 12 of the filing PDF) | 122 | ||||||||||||||||||||||||||||
| Trikaftaelexacaftor, tezacaftor, and ivacaftorkitVertex Pharmaceuticals Incorporated51167-0106-02Named Trikafta 75 mg tab 4x21 by Rhode Island Hospital, line 131 | 625,428.50 (Rhode Island Hospital, Schedule G, line 131, page 14 of the filing PDF) | 45 | ||||||||||||||||||||||||||||
| Trikaftaelexacaftor, tezacaftor, and ivacaftorkitVertex Pharmaceuticals Incorporated51167-0331-01Named Trikafta 150 mg tab 4x21 by Rhode Island Hospital, line 6 | 5,721,598.74 (Rhode Island Hospital, Schedule G, line 6, page 11 of the filing PDF) | 364 | ||||||||||||||||||||||||||||
| Trikaftaelexacaftor, tezacaftor, and ivacaftorkitVertex Pharmaceuticals Incorporated51167-0445-01Named Trikafta 80/40/60 oral by Rhode Island Hospital, line 221 | 272,625.48 (Rhode Island Hospital, Schedule G, line 221, page 17 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Trikaftaelexacaftor, tezacaftor, and ivacaftorkitVertex Pharmaceuticals Incorporated51167-0446-01Named Trikafta 100/50/75 oral by Rhode Island Hospital, line 289 | 168,661.68 (Rhode Island Hospital, Schedule G, line 289, page 19 of the filing PDF) | 7 | ||||||||||||||||||||||||||||
| Trintellixvortioxetine10 mgtablet, film coatedTakeda Pharmaceuticals America, Inc.64764-0730-30Named Trintellix tab 10 mg by Thundermist Health Center, line 216 | 5,417.93 (Thundermist Health Center, Schedule G, line 216, page 11 of the filing PDF) | 79 | ||||||||||||||||||||||||||||
| TriptodurtriptorelinkitAzurity Pharmaceuticals, Inc.24338-0150-20Named Triptodur 22.5 mg kit by Rhode Island Hospital, line 569 | 30,704.70 (Rhode Island Hospital, Schedule G, line 569, page 26 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Trokendi XRtopiramate100 mgcapsule, extended releaseSupernus Pharmaceuticals, Inc.17772-0103-30Named Trokendi XR 100 mg Cp24 by Women & Infants Hospital of RI, line 133 | 54,513.07 (Women & Infants Hospital of RI, Schedule G, line 133, page 13 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Tropicamide10 mg/mLsolution/ dropsSomerset Therapeutics, LLC70069-0121-01Named Tropicamide 1% O/S 15 mL by Rhode Island Hospital, line 796 | 10,641.04 (Rhode Island Hospital, Schedule G, line 796, page 32 of the filing PDF) | 1,785 | ||||||||||||||||||||||||||||
| Trulicity00002-1434-80, 2143380, 2223680, 2318280Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 3 | 208,081.14 (Blackstone Valley Community Health Care, Schedule G, line 3, page 8 of the filing PDF) | 198 | ||||||||||||||||||||||||||||
| Tyennetocilizumab-aazg80 mg/4 mLinjection, solution, concentrateFresenius Kabi USA, LLC65219-0590-04Named Tyenne 80 mg SDV 4 mL by Rhode Island Hospital, line 356 | 108,897.87 (Rhode Island Hospital, Schedule G, line 356, page 20 of the filing PDF) | 307 | ||||||||||||||||||||||||||||
| Tyennetocilizumab-aazg200 mg/10 mLinjection, solution, concentrateFresenius Kabi USA, LLC65219-0592-10Named Tyenne 200 mg SDV 10 mL by Rhode Island Hospital, line 395 | 83,733.79 (Rhode Island Hospital, Schedule G, line 395, page 21 of the filing PDF) | 99 | ||||||||||||||||||||||||||||
| Tyennetocilizumab-aazg400 mg/20 mLinjection, solution, concentrateFresenius Kabi USA, LLC65219-0594-20Named Tyenne 400 mg SDV 20 mL by Rhode Island Hospital, line 290 | 168,535.44 (Rhode Island Hospital, Schedule G, line 290, page 19 of the filing PDF) | 123 | ||||||||||||||||||||||||||||
| Tzieldteplizumab-mzwv1 mg/mLinjectionProvention Bio, Inc.73650-0316-14The FDA directory lists this product, not this packageNamed Tzield inj 2 mg/2 mL by Rhode Island Hospital, line 304 | 151,638.56 (Rhode Island Hospital, Schedule G, line 304, page 19 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Ubrelvy 50 mg tabs23649810Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 41 | 8,792.47 (Blackstone Valley Community Health Care, Schedule G, line 41, page 8 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Udenycapegfilgrastim-cbqv6 mg/0.6 mLinjection, solutionCoherus Oncology, Inc.70114-0101-01Named Udenyca 6 mg PFS 0.6 mL by Rhode Island Hospital, line 270 | 191,458.63 (Rhode Island Hospital, Schedule G, line 270, page 18 of the filing PDF) | 292 | ||||||||||||||||||||||||||||
| Umeclidinium and Vilanterol Elliptaumeclidinium bromide and vilanterol trifenatate62.5 mcg; 25 mcgpowderPrasco Laboratories66993-0134-97Named Umeclid/VILA inh 62.5-25 by Thundermist Health Center, line 93 | 27,492.29 (Thundermist Health Center, Schedule G, line 93, page 9 of the filing PDF) | 108 | ||||||||||||||||||||||||||||
| Uzedyrisperidone100 mg/0.28 mLinjection, suspension, extended releaseTeva Pharmaceuticals USA, Inc.51759-0520-10Named Uzedy 100 mg/0.28 mL SUSY 0.28x1 mL by East Bay Community Action Program, line 40 | 11,730.29 (East Bay Community Action Program, Schedule G, line 40, page 10 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Uzedyrisperidone250 mg/0.7 mLinjection, suspension, extended releaseTeva Pharmaceuticals USA, Inc.51759-0960-10Named Uzedy 250 mg ER PFS 0.7 mL by Rhode Island Hospital, line 950 | 5,477.90 (Rhode Island Hospital, Schedule G, line 950, page 36 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Valganciclovir450 mgtablet, film coatedCamber Pharmaceuticals, Inc.31722-0832-60Named Valganciclovir 450 mg tab 60 by Rhode Island Hospital, line 911 | 6,374.35 (Rhode Island Hospital, Schedule G, line 911, page 35 of the filing PDF) | 132 | ||||||||||||||||||||||||||||
| Valtocodiazepam10 mg/0.1 mLsprayNeurelis, Inc72252-0510-02Named Valtoco 10 mg nasal SPY 2 BP by Rhode Island Hospital, line 614 | 23,514.54 (Rhode Island Hospital, Schedule G, line 614, page 27 of the filing PDF) | 33 | ||||||||||||||||||||||||||||
| Valtocodiazepam7.5 mg/0.1 mLsprayNeurelis, Inc72252-0515-04Named Valtoco 15 mg nasal SPY 2 (2x7.5 mg) BP by Rhode Island Hospital, line 722 | 14,251.52 (Rhode Island Hospital, Schedule G, line 722, page 30 of the filing PDF) | 28 | ||||||||||||||||||||||||||||
| Valtocodiazepam10 mg/0.1 mLsprayNeurelis, Inc72252-0520-10Named Valtoco 20 mg nasal SPY 5 (5x20 mg) BP by Rhode Island Hospital, line 538 | 37,600.84 (Rhode Island Hospital, Schedule G, line 538, page 25 of the filing PDF) | 32 | ||||||||||||||||||||||||||||
| Vancomycin2 g/400 mLinjection, solutionXellia Pharmaceuticals USA LLC70594-0044-02Named Vancomycin HCl 2,000 mg/400 mL SOLN by Kent County Memorial Hospital, line 353 | 6,662.42 (Kent County Memorial Hospital, Schedule G, line 353, page 19 of the filing PDF) | 419 | ||||||||||||||||||||||||||||
| Vancomycin Hydrochloride1 g/200 mLinjection, solutionBaxter Healthcare Corporation00338-3583-01Named Vancomycin-Sod 1 g bag 6x200 mL DS by Rhode Island Hospital, line 863 | 7,886.19 (Rhode Island Hospital, Schedule G, line 863, page 34 of the filing PDF) | 952 | ||||||||||||||||||||||||||||
| Vancomycin Hydrochloride1.25 g/25 mLinjection, powder, lyophilized, for solutionMylan Institutional LLC67457-0823-99Named Vancomycin HCl 1.25 g SOLR by Women & Infants Hospital of RI, line 267 | 5,483.22 (Women & Infants Hospital of RI, Schedule G, line 267, page 17 of the filing PDF) | 20 | ||||||||||||||||||||||||||||
| Vanflytaquizartinib17.7 mgtablet, film coatedDaiichi Sankyo Inc.65597-0504-04Named Vanflyta 17.7 mg tab 14 by Rhode Island Hospital, line 448 | 59,738.62 (Rhode Island Hospital, Schedule G, line 448, page 23 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Vasostrictvasopressin0.2 USP units/mLinjectionPar Health USA, LLC42023-0237-10Named Vasostrict 20 units SDV 10x100 mL by Rhode Island Hospital, line 972 | 5,049.88 (Rhode Island Hospital, Schedule G, line 972, page 37 of the filing PDF) | 168 | ||||||||||||||||||||||||||||
| Vectibixpanitumumab400 mg/20 mLsolutionAmgen, Inc55513-0956-01Named panitumumab (Vectibix) 500 mg in sodium chloride 0.9% 75 mL IVPB by Women & Infants Hospital of RI, line 65 | 143,534.50 (Women & Infants Hospital of RI, Schedule G, line 65, page 12 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| Venclextavenetoclax50 mgtablet, film coatedAbbVie Inc.00074-0566-07Named Venclexta 50 mg tab 7 Wallet by Rhode Island Hospital, line 881 | 7,532.55 (Rhode Island Hospital, Schedule G, line 881, page 34 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Venclextavenetoclax100 mgtablet, film coatedAbbVie Inc.00074-0576-11Named Venclexta 1 X 100 mg tab by Rhode Island Hospital, line 374 | 92,698.62 (Rhode Island Hospital, Schedule G, line 374, page 21 of the filing PDF) | 45 | ||||||||||||||||||||||||||||
| Venclextavenetoclax100 mgtablet, film coatedAbbVie Inc.00074-0576-30Named Venclexta 100 mg tab 28 by Rhode Island Hospital, line 146 | 545,313.00 (Rhode Island Hospital, Schedule G, line 146, page 15 of the filing PDF) | 85 | ||||||||||||||||||||||||||||
| VenclextavenetoclaxkitAbbVie Inc.00074-0579-28Named Venclexta Starter pack by Rhode Island Hospital, line 572 | 30,306.72 (Rhode Island Hospital, Schedule G, line 572, page 26 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Ventolin HFAalbuterol sulfate90 mcgaerosol, meteredGlaxoSmithKline LLC00173-0682-24Named Ventolin HFA 108 (90 Base) mcg/ACT AERS by Kent County Memorial Hospital, line 354 | 6,423.57 (Kent County Memorial Hospital, Schedule G, line 354, page 19 of the filing PDF) | 1,024 | ||||||||||||||||||||||||||||
| Verzenioabemaciclib200 mgtabletEli Lilly and Company00002-6216-54Named Verzenio 200 mg tablet by Kent County Memorial Hospital, line 192 | 37,386.50 (Kent County Memorial Hospital, Schedule G, line 192, page 15 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Viagra tabs69422030, 58151042893, 69421030Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 12 | 37,293.10 (Blackstone Valley Community Health Care, Schedule G, line 12, page 8 of the filing PDF) | 28 | ||||||||||||||||||||||||||||
| Viberzieluxadoline75 mgtablet, film coatedAllergan, Inc.61874-0075-60Named eluxadoline (Viberzi) 75 mg Tab by Women & Infants Hospital of RI, line 260 | 6,255.12 (Women & Infants Hospital of RI, Schedule G, line 260, page 17 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Viberzieluxadoline100 mgtablet, film coatedAllergan, Inc.61874-0100-60Named Viberzi tab 100 mg by Thundermist Health Center, line 142 | 13,880.85 (Thundermist Health Center, Schedule G, line 142, page 10 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| Victoza 18 mg/3 mL SOPN169406012, 169406013Not grouped: the code is not filed as one 11-digit codeFiled by Blackstone Valley Community Health Care, line 29 | 13,926.86 (Blackstone Valley Community Health Care, Schedule G, line 29, page 8 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Vigabatrin50 mg/mLpowder, for solutionDr. Reddy's Laboratories Inc.43598-0697-50Named DR Vigabatrin 500 mg pwd50 by Rhode Island Hospital, line 912 | 6,345.92 (Rhode Island Hospital, Schedule G, line 912, page 35 of the filing PDF) | 24 | ||||||||||||||||||||||||||||
| Vijoicealpelisib50 mggranuleNovartis Pharmaceuticals Corporation00078-1175-51Named Vijoice 50 mg PKT 28 by Rhode Island Hospital, line 659 | 18,864.65 (Rhode Island Hospital, Schedule G, line 659, page 28 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Vinblastine Sulfate1 mg/mLinjectionFresenius Kabi USA, LLC63323-0278-10Named Vinblastine 10 mg MDV 10 mL by Rhode Island Hospital, line 949 | 5,492.66 (Rhode Island Hospital, Schedule G, line 949, page 36 of the filing PDF) | 141 | ||||||||||||||||||||||||||||
| Vonvendivon willebrand factor (recombinant)kitTakeda Pharmaceuticals America, Inc.00944-7551-02Named Vonvendi 765 IU VL 5 mL by Rhode Island Hospital, line 750 | 12,703.07 (Rhode Island Hospital, Schedule G, line 750, page 31 of the filing PDF) | 14 | ||||||||||||||||||||||||||||
| Vonvendivon willebrand factor (recombinant)kitTakeda Pharmaceuticals America, Inc.00944-7553-02Named Vonvendi 1,320 IU VL 10 mL by Rhode Island Hospital, line 653 | 19,453.50 (Rhode Island Hospital, Schedule G, line 653, page 28 of the filing PDF) | 16 | ||||||||||||||||||||||||||||
| Voqueznavonoprazan fumarate13.36 mgtabletPhathom Pharmaceuticals Inc.81520-0100-30Named Voquezna tab 10 mg by Thundermist Health Center, line 200 | 5,980.99 (Thundermist Health Center, Schedule G, line 200, page 11 of the filing PDF) | 16 | ||||||||||||||||||||||||||||
| Voranigovorasidenib40 mgtablet, film coatedServier Pharmaceuticals LLC72694-0728-40Named Voranigo 40 mg tab 30 by Rhode Island Hospital, line 121 | 663,429.10 (Rhode Island Hospital, Schedule G, line 121, page 14 of the filing PDF) | 27 | ||||||||||||||||||||||||||||
| Voranigovorasidenib10 mgtablet, film coatedServier Pharmaceuticals LLC72694-0879-10Named Voranigo 10 mg tab 30 by Rhode Island Hospital, line 129 | 632,925.04 (Rhode Island Hospital, Schedule G, line 129, page 14 of the filing PDF) | 21 | ||||||||||||||||||||||||||||
| Votrientpazopanib hydrochloride200 mgtablet, film coatedNovartis Pharmaceuticals Corporation00078-1077-66Named Votrient 200 mg tab 120 by Rhode Island Hospital, line 314 | 146,121.03 (Rhode Island Hospital, Schedule G, line 314, page 19 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Vprivvelaglucerase alfa2.5 mg/mLinjection, powder, lyophilized, for solutionTakeda Pharmaceuticals America, Inc.54092-0701-04Named Vpriv 400 units SDV by Rhode Island Hospital, line 334 | 128,637.43 (Rhode Island Hospital, Schedule G, line 334, page 20 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Vyloyzolbetuximab20 mg/mLinjection, powder, for suspensionAstellas Pharma US, Inc.00469-3425-10Named Vyloy 100 mg SDV by Rhode Island Hospital, line 292 | 163,453.43 (Rhode Island Hospital, Schedule G, line 292, page 19 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Vyndaqeltafamidis meglumine20 mgcapsule, liquid filledPfizer Laboratories Div Pfizer Inc00069-1975-40Named Vyndaqel 20 mg caps 4x30 by Rhode Island Hospital, line 24 | 2,882,319.72 (Rhode Island Hospital, Schedule G, line 24, page 12 of the filing PDF) | 169 | ||||||||||||||||||||||||||||
| Vyondys 53golodirsen50 mg/mLinjectionSarepta Therapeutics, Inc.60923-0465-02Named Vyondys 53 100 mg/2 mL SDV by Rhode Island Hospital, line 89 | 909,585.61 (Rhode Island Hospital, Schedule G, line 89, page 13 of the filing PDF) | 37 | ||||||||||||||||||||||||||||
| Vyvgartefgartigimod alfa20 mg/mLinjectionargenx US73475-3041-05Named Vyvgart 400 mg SDV 20 mL DS by Rhode Island Hospital, line 175 | 394,761.90 (Rhode Island Hospital, Schedule G, line 175, page 16 of the filing PDF) | 45 | ||||||||||||||||||||||||||||
| Vyvgart Hytruloefgartigimod alfa and hyaluronidase (human recombinant)180 mg/mL; 2,000 units/mLinjection, solutionargenx US73475-3102-03Named efgartigimod alfa-hyaluronidase qvfc 1,008 mg-11,200 units / 5.6 mL INJ by Women & Infants Hospital of RI, line 183 | 24,285.80 (Women & Infants Hospital of RI, Schedule G, line 183, page 15 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Walgreens (see separate tab)see separate tabNot grouped: the code is not filed as one 11-digit codeFiled by WellOne Primary Medical and Dental Care (A), line 1 | 273,031 (WellOne Primary Medical and Dental Care (A), Schedule G, line 1, page 8 of the filing PDF) | 2,536 | ||||||||||||||||||||||||||||
| Weliregbelzutifan40 mgtablet, film coatedMerck Sharp & Dohme LLC00006-5331-01Named Welireg 40 mg tab 90 by Rhode Island Hospital, line 148 | 541,540.74 (Rhode Island Hospital, Schedule G, line 148, page 15 of the filing PDF) | 28 | ||||||||||||||||||||||||||||
| Wellpartner (see separate tab)see separate tabNot grouped: the code is not filed as one 11-digit codeFiled by WellOne Primary Medical and Dental Care (A), line 2 | 3,379,842 (WellOne Primary Medical and Dental Care (A), Schedule G, line 2, page 8 of the filing PDF) | 15,194 | ||||||||||||||||||||||||||||
| Winrevairsotatercept-csrkkitMerck Sharp & Dohme LLC00006-5087-01Named Winrevair 90 mg pwd kit 2 by Rhode Island Hospital, line 620 | 22,491.26 (Rhode Island Hospital, Schedule G, line 620, page 27 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Winrevairsotatercept-csrkkitMerck Sharp & Dohme LLC00006-5088-01Named Winrevair 120 mg pwd kit 2 by Rhode Island Hospital, line 434 | 67,238.58 (Rhode Island Hospital, Schedule G, line 434, page 22 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Winrevairsotatercept-csrkkitMerck Sharp & Dohme LLC00006-5091-01Named Winrevair 60 mg pwd kit by Rhode Island Hospital, line 366 | 101,147.24 (Rhode Island Hospital, Schedule G, line 366, page 21 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Xareltorivaroxaban20 mgtablet, film coatedJanssen Pharmaceuticals, Inc.50458-0579-90Named Xarelto 20 mg tabs by Blackstone Valley Community Health Care, line 11 | 39,623.52 (Blackstone Valley Community Health Care, Schedule G, line 11, page 8 of the filing PDF) | 42 | ||||||||||||||||||||||||||||
| Xcopricenobamate25 mgtablet, film coatedSK Life Science, Inc.71699-0025-30Named Xcopri tab 25 mg by East Bay Community Action Program, line 38 | 11,937.04 (East Bay Community Action Program, Schedule G, line 38, page 10 of the filing PDF) | 6 | ||||||||||||||||||||||||||||
| Xcopricenobamate50 mgtablet, film coatedSK Life Science, Inc.71699-0050-30Named Xcopri tab 50 mg by East Bay Community Action Program, line 43 | 10,906.05 (East Bay Community Action Program, Schedule G, line 43, page 10 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| XeominincobotulinumtoxinA100 USP unitsinjection, powder, lyophilized, for solutionMerz Pharmaceuticals, LLC00259-1610-01Named Xeomin DS 100 units SDV 1 by Rhode Island Hospital, line 782 | 11,050.15 (Rhode Island Hospital, Schedule G, line 782, page 32 of the filing PDF) | 17 | ||||||||||||||||||||||||||||
| Xiaflexcollagenase clostridium histolyticumkitEndo USA, Inc.66887-0003-01Named Xiaflex 0.9 mg SDV DS by Rhode Island Hospital, line 746 | 12,906.72 (Rhode Island Hospital, Schedule G, line 746, page 31 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Xolair PFSomalizumab75 mg/0.5 mLinjection, solutionGenentech, Inc.50242-0214-01The FDA directory lists this product, not this packageNamed Xolair 75 mg PFS 0.5 mL by Rhode Island Hospital, line 678 | 16,736.30 (Rhode Island Hospital, Schedule G, line 678, page 29 of the filing PDF) | 54 | ||||||||||||||||||||||||||||
| Xospatagilteritinib40 mgtabletAstellas Pharma US, Inc.00469-1425-90Named Xospata 40 mg tab 90 by Rhode Island Hospital, line 234 | 239,577.56 (Rhode Island Hospital, Schedule G, line 234, page 17 of the filing PDF) | 10 | ||||||||||||||||||||||||||||
| Xpovioselinexor40 mgtablet, film coatedKaryopharm Therapeutics Inc.72237-0102-07Named Xpovio 40 mg once wkly tab (40 mg x 4) by Rhode Island Hospital, line 509 | 41,964.44 (Rhode Island Hospital, Schedule G, line 509, page 24 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Xpovioselinexor50 mgtablet, film coatedKaryopharm Therapeutics Inc.72237-0103-05Named Xpovio 100 mg once wkly tab (50 mg x 8) BP by Rhode Island Hospital, line 652 | 19,541.13 (Rhode Island Hospital, Schedule G, line 652, page 28 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Xpovioselinexor60 mgtablet, film coatedKaryopharm Therapeutics Inc.72237-0104-01Named Xpovio 60 mg once wkly tab (60 mg x 4) BP by Rhode Island Hospital, line 283 | 174,760.63 (Rhode Island Hospital, Schedule G, line 283, page 18 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Xpovioselinexor10 mgtablet, film coatedKaryopharm Therapeutics Inc.72237-0106-01Named Xpovio 40 mg once wkly tab (10 mg x 16) by Rhode Island Hospital, line 470 | 50,363.37 (Rhode Island Hospital, Schedule G, line 470, page 23 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Xromihydroxyurea100 mg/mLsolutionNova Laboratories, Ltd.62484-0015-05Named Xromi 100 mg-mL oral sol 148 mL by Rhode Island Hospital, line 360 | 105,520.68 (Rhode Island Hospital, Schedule G, line 360, page 20 of the filing PDF) | 160 | ||||||||||||||||||||||||||||
| Xulanenorelgestromin and ethinyl estradiol150 mcg/day; 35 mcg/daypatchMylan Pharmaceuticals Inc.00378-3340-53Named Xulane Patches by The Providence Community Health Centers, Inc, line 127 | 9,865.58 (The Providence Community Health Centers, Inc, Schedule G, line 127, page 12 of the filing PDF) | 65 | ||||||||||||||||||||||||||||
| Xynthaantihemophilic factor (recombinant)kitWyeth BioPharma Division of Wyeth Pharmaceuticals LLC58394-0016-03Named Xyntha PDS 3,040 IU Solofuse kit SYG by Rhode Island Hospital, line 916 | 6,300.00 (Rhode Island Hospital, Schedule G, line 916, page 35 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Xyostedtestosterone enanthate100 mg/0.5 mLinjectionAntares Pharma, Inc.54436-0200-04Named Xyosted inj 100/0.5 by Thundermist Health Center, line 188 | 7,317.90 (Thundermist Health Center, Schedule G, line 188, page 11 of the filing PDF) | 24 | ||||||||||||||||||||||||||||
| Xyostedtestosterone enanthate50 mg/0.5 mLinjectionAntares Pharma, Inc.54436-0250-04Named Xyosted inj 50/0.5 mL by Thundermist Health Center, line 186 | 7,436.54 (Thundermist Health Center, Schedule G, line 186, page 11 of the filing PDF) | 25 | ||||||||||||||||||||||||||||
| Yervoyipilimumab5 mg/mLinjectionE.R. Squibb & Sons, L.L.C.00003-2328-22Named ipilimumab 330 mg in sodium chloride 0.9% 250 mL IVPB by Women & Infants Hospital of RI, line 81 | 102,988.48 (Women & Infants Hospital of RI, Schedule G, line 81, page 12 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Yesintekustekinumab90 mg/mLinjection, solutionBiocon Biologics Inc.83257-0025-41Named Yesintek 90 mg PFS 1 mL by Rhode Island Hospital, line 747 | 12,786.45 (Rhode Island Hospital, Schedule G, line 747, page 31 of the filing PDF) | 46 | ||||||||||||||||||||||||||||
| Yeztugolenacapavir sodium300 mgtablet, film coatedGilead Sciences, Inc.61958-3401-01Named Yeztugo 300 mg tab 4 by The Miriam Hospital Immunology Center, line 11 | 19,841.58 (The Miriam Hospital Immunology Center, Schedule G, line 11, page 10 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Yonsaabiraterone acetate125 mgtabletSun Pharmaceutical Industries, Inc.47335-0401-81Named Yonsa 125 mg tab 120 by Rhode Island Hospital, line 468 | 52,737.55 (Rhode Island Hospital, Schedule G, line 468, page 23 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Yuflymaadalimumab-aatykitCELLTRION USA, Inc.72606-0030-10Named Yuflyma 40 mg-0.4 mL auto inj kit 2 by Rhode Island Hospital, line 768 | 11,627.66 (Rhode Island Hospital, Schedule G, line 768, page 31 of the filing PDF) | 32 | ||||||||||||||||||||||||||||
| Yupelrirevefenacin175 mcg/3 mLsolutionViatris Specialty LLC49502-0806-93Named Yupelri Inhal sol175 mcg/3 mL 30 by Kent County Memorial Hospital, line 326 | 9,110.93 (Kent County Memorial Hospital, Schedule G, line 326, page 19 of the filing PDF) | 32 | ||||||||||||||||||||||||||||
| Yusimryadalimumab-aqvh40 mg/0.8 mLinjection, solutionCoherus BioSciences Inc70114-0220-02Named Yusimry 40 mg PFP 2x0.8 mL by Rhode Island Hospital, line 954 | 5,410.14 (Rhode Island Hospital, Schedule G, line 954, page 36 of the filing PDF) | 0 | ||||||||||||||||||||||||||||
| Yuvafemestradiol10 mcgtabletAmneal Pharmaceuticals LLC65162-0226-21Named Yuvafem tab 10 mcg by Thundermist Health Center, line 222 | 5,311.12 (Thundermist Health Center, Schedule G, line 222, page 12 of the filing PDF) | 133 | ||||||||||||||||||||||||||||
| Zafemynorelgestromin and ethinyl estradiol150 mcg/day; 35 mcg/daypatchAmneal Pharmaceuticals LLC65162-0358-03Named Zafemy Patches by The Providence Community Health Centers, Inc, line 93 | 14,520.29 (The Providence Community Health Centers, Inc, Schedule G, line 93, page 11 of the filing PDF) | 146 | ||||||||||||||||||||||||||||
| Zarxiofilgrastim-sndz300 mcg/0.5 mLinjection, solutionSandoz Inc.61314-0318-10Named Zarxio 300 mcg PFS 10x0.5 mL by Rhode Island Hospital, line 591 | 26,852.04 (Rhode Island Hospital, Schedule G, line 591, page 27 of the filing PDF) | 205 | ||||||||||||||||||||||||||||
| Zavzpretzavegepant10 mg/0.1 mLsprayPfizer Laboratories Div Pfizer Inc00069-3500-02Named Zavzpret spr 10 mg by Wood River Health Services, Inc., line 1 | 5,355 (Wood River Health Services, Inc., Schedule G, line 1, page 8 of the filing PDF) | 8 | ||||||||||||||||||||||||||||
| Zemplarparicalcitol5 mcg/mLinjection, solutionAbbVie Inc.00074-1658-01Named Zemplar 5 mcg FTV 25x1 mL by Rhode Island Hospital, line 908 | 6,419.10 (Rhode Island Hospital, Schedule G, line 908, page 35 of the filing PDF) | 537 | ||||||||||||||||||||||||||||
| Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase10,000 USP units; 32,000 USP units; 42,000 USP unitscapsule, delayed releaseAimmune Therapeutics, Inc.73562-0110-01Named Zenpep 10,000 units DR cap 100 by Rhode Island Hospital, line 682 | 16,541.05 (Rhode Island Hospital, Schedule G, line 682, page 29 of the filing PDF) | 18 | ||||||||||||||||||||||||||||
| Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase20,000 USP units; 63,000 USP units; 84,000 USP unitscapsule, delayed releaseAimmune Therapeutics, Inc.73562-0112-01Named Zenpep 20,000 units DR cap 100 by Rhode Island Hospital, line 383 | 89,060.62 (Rhode Island Hospital, Schedule G, line 383, page 21 of the filing PDF) | 33 | ||||||||||||||||||||||||||||
| Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase25,000 USP units; 79,000 USP units; 105,000 USP unitscapsule, delayed releaseAimmune Therapeutics, Inc.73562-0116-01Named Zenpep 25,000 units DR cap 100 by Rhode Island Hospital, line 469 | 50,468.18 (Rhode Island Hospital, Schedule G, line 469, page 23 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Zerbaxaceftolozane and tazobactam1 g/10 mL; 0.5 g/10 mLinjection, powder, lyophilized, for solutionMerck Sharp & Dohme LLC67919-0030-01Named Zerbaxa 1.5 (1-0.5) GM SOLR by Kent County Memorial Hospital, line 278 | 15,272.11 (Kent County Memorial Hospital, Schedule G, line 278, page 17 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Zoledronic Acid0.04 mg/mLinjection, solutionSagent Pharmaceuticals25021-0826-82Named Zoledronic 4 mg bag 1x100 mL by Rhode Island Hospital, line 756 | 12,318.46 (Rhode Island Hospital, Schedule G, line 756, page 31 of the filing PDF) | 915 | ||||||||||||||||||||||||||||
| Zoledronic Acid0.05 mg/mLinjection, solutionSagent Pharmaceuticals25021-0830-82Named zoledronic acid (Reclast) IVPB 5 mg by Women & Infants Hospital of RI, line 227 | 10,522.84 (Women & Infants Hospital of RI, Schedule G, line 227, page 16 of the filing PDF) | 95 | ||||||||||||||||||||||||||||
| Zoledronic Acid5 mg/100 mLinjection, solutionMeitheal Pharmaceuticals Inc.71288-0806-51Named Zoledronic Acid 5 mg sol 100 mL by Rhode Island Hospital, line 690 | 15,969.73 (Rhode Island Hospital, Schedule G, line 690, page 29 of the filing PDF) | 681 | ||||||||||||||||||||||||||||
| Zolinzavorinostat100 mgcapsuleMerck Sharp & Dohme LLC00006-0568-40Named Zolinza DS 100 mg cap 120 by Rhode Island Hospital, line 529 | 38,881.31 (Rhode Island Hospital, Schedule G, line 529, page 25 of the filing PDF) | 12 | ||||||||||||||||||||||||||||
| Zonisadezonisamide100 mg/5 mLsuspensionAzurity Pharmaceuticals, Inc.52652-8001-01Named Zonisade 20 mg/mL sus 150 mL by Rhode Island Hospital, line 597 | 26,260.28 (Rhode Island Hospital, Schedule G, line 597, page 27 of the filing PDF) | 51 | ||||||||||||||||||||||||||||
| Zoryveroflumilast1.5 mg/gcreamArcutis Biotherapeutics, Inc.80610-0115-60Named Zoryve 0.15% cream 60 g by The Providence Community Health Centers, Inc, line 170 | 5,258.79 (The Providence Community Health Centers, Inc, Schedule G, line 170, page 13 of the filing PDF) | 9 | ||||||||||||||||||||||||||||
| Zoryveroflumilast3 mg/gcreamArcutis Biotherapeutics, Inc.80610-0130-60Named Zoryve crm 0.3% 60 g by Kent County Memorial Hospital, line 342 | 7,330.84 (Kent County Memorial Hospital, Schedule G, line 342, page 19 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
| Zoryveroflumilast3 mg/gaerosol, foamArcutis Biotherapeutics, Inc.80610-0430-60Named Zoryve 0.3% topical foam 60 g by The Providence Community Health Centers, Inc, line 78 | 19,220.86 (The Providence Community Health Centers, Inc, Schedule G, line 78, page 11 of the filing PDF) | 32 | ||||||||||||||||||||||||||||
| Zosynpiperacillin sodium and tazobactam sodium4 g/100 mL; 0.5 g/100 mLinjection, solutionBaxter Healthcare Corporation00338-9638-12Named Zosyn 4.5 g bag 12x100 mL DS by Rhode Island Hospital, line 500 | 43,967.31 (Rhode Island Hospital, Schedule G, line 500, page 24 of the filing PDF) | 4,544 | ||||||||||||||||||||||||||||
| Zubsolvbuprenorphine hydrochloride and naloxone hydrochloride2.9 mg; 0.71 mgtablet, orally disintegratingOrexo US, Inc.54123-0929-30Named Zubsolv SUB 2.9-0.71 by Thundermist Health Center, line 228 | 5,124.55 (Thundermist Health Center, Schedule G, line 228, page 12 of the filing PDF) | 19 | ||||||||||||||||||||||||||||
| Zubsolvbuprenorphine hydrochloride and naloxone hydrochloride5.7 mg; 1.4 mgtablet, orally disintegratingOrexo US, Inc.54123-0957-30Named Zubsolv SUB 5.7-1.4 by Thundermist Health Center, line 132 | 15,448.97 (Thundermist Health Center, Schedule G, line 132, page 10 of the filing PDF) | 56 | ||||||||||||||||||||||||||||
| Zydeligidelalisib150 mgtablet, film coatedGilead Sciences, Inc.61958-1702-01Named Zydelig 150 mg tab 60 by Rhode Island Hospital, line 534 | 38,152.86 (Rhode Island Hospital, Schedule G, line 534, page 25 of the filing PDF) | fewer than 6 (the count is not shown) | ||||||||||||||||||||||||||||
| Zymfentrainfliximab-dyybkitCELLTRION USA Inc.72606-0025-01Named Zymfentra 120 mg auto inj kit by Rhode Island Hospital, line 455 | 57,673.58 (Rhode Island Hospital, Schedule G, line 455, page 23 of the filing PDF) | 31 | ||||||||||||||||||||||||||||
| Zymfentrainfliximab-dyybkitCELLTRION USA Inc.72606-0025-02Named Zymfentra 120 mg-mL PFP kit 2 by Rhode Island Hospital, line 684 | 16,411.42 (Rhode Island Hospital, Schedule G, line 684, page 29 of the filing PDF) | 11 | ||||||||||||||||||||||||||||
| Zynlontaloncastuximab tesirine10 mg/2 mLinjection, powder, lyophilized, for solutionADC Therapeutics America, Inc.79952-0110-01Named Zynlonta 10 mg VL DS by Rhode Island Hospital, line 149 | 516,744.67 (Rhode Island Hospital, Schedule G, line 149, page 15 of the filing PDF) | 42 | ||||||||||||||||||||||||||||
| Zynyzretifanlimab-dlwr25 mg/mLinjectionIncyte Corporation50881-0006-03Named Zynyz 500 mg SDV 20 mL by Rhode Island Hospital, line 305 | 151,115.99 (Rhode Island Hospital, Schedule G, line 305, page 19 of the filing PDF) | 19 | ||||||||||||||||||||||||||||
| (no name printed)secukinumab (Cosentyx UnoReady Pen) 300 mg/2 mL PnIj00078107068Not grouped: the code is not filed as one 11-digit codeFiled by Kent County Memorial Hospital, line 129 | 71,121.33 (Kent County Memorial Hospital, Schedule G, line 129, page 13 of the filing PDF) | 29 | ||||||||||||||||||||||||||||
| (no name printed)adalimumab-adbm (Cyltezo,CF, Pen) 40 mg/0.8 mL PnKt 00597037597Not grouped: the code is not filed as one 11-digit codeFiled by Kent County Memorial Hospital, line 307 | 11,159.72 (Kent County Memorial Hospital, Schedule G, line 307, page 18 of the filing PDF) | 13 | ||||||||||||||||||||||||||||
No drug matches. | ||||||||||||||||||||||||||||||
How this page is put together
- Grouping
- Rows are put together when each one’s NDC cell is filed as one 11-digit code, written as eleven digits or with dashes as 5-4-2. Nothing is guessed. A shorter code is not padded with zeros and a cell that lists several codes is not split: those 41 rows stay on their own, with the cell as filed.
- Name shown
- Filers write one drug’s name in different ways. Where the U.S. Food and Drug Administration’s National Drug Code Directory lists a code, the name shown is the FDA’s, and the line under it gives the listed ingredient, strength, form and labeler (the firm named on the label). The directory, as downloaded on 11 November 2026, lists 1,262 of the 1,271 codes on this page; for 4 of them it lists the product but not that package. These names are the FDA’s. No filer wrote them, and each filer’s own wording is kept beside them, in the rows under the drug and in the download. The directory’s firms type their listings in different ways, so on this page its capitals, strengths and unit names are written one way (“.5 mg/1” is shown as “0.5 mg”). The download gives every field exactly as the directory lists it.
- Name when not listed
- For the 9 codes the directory does not list, and for a row that is not grouped, the name shown is the one filed most often; when names are filed equally often, the shortest.
- Filers’ names
- Filers type drug names in many ways, so a filer’s name is written one way on this page: capitals, spaces, unit names such as mg and mL, a zero before a decimal point, and commas in long numbers. No word is changed, spelled out or left out, and shorthand stays as the filer typed it. The filing and the download keep each name as typed, and a search here reads both.
- Amounts
- A figure with a dotted line under it is as filed and links to its page of the filing. A figure without one was added by this site from the rows under it. The filings describe the Schedule G amounts in more than one way, and some filers write whole dollars. Figures are written here with commas between thousands, and an amount filed with one decimal place is written with two; the filing and the download keep each figure as typed. Methods says more.
- Claims
- A count of 1 to 5 is not shown on this site or in its data files. Where a filer’s count is left out, the added figure covers the other filers and reads “at least”. Methods, section 9, says how.
- Rows under $5,000
- A filing can close Schedule G with one row for all its drugs under $5,000, and it prints a total. Those rows are on each filer’s own drug page and are not part of this page.
- Download
- drug-rows-ri-2025.csv has one line per row as filed, with the filer, the page of the filing and a link to it. Two fields are this site’s:
ndc_11, the code the row is grouped by (blank for a row on its own), andgroup_name, the name filed most often for that code. Eight fields that beginfda_carry the FDA directory’s listing for the code, with the day of the copy that listed it, and are blank when it lists none. Data: CC BY 4.0.
The 14 filings
- Blackstone Valley Community Health Care54 rows
- Comprehensive Community Action, Inc.19 rows
- East Bay Community Action Program70 rows
- Kent County Memorial Hospital387 rows
- Landmark Medical center58 rows
- Rhode Island Hospital973 rows
- The Miriam Hospital Immunology Center13 rows
- The Miriam Hospital RISE TB Clinic5 rows
- The Miriam Hospital Ryan White Care Program43 rows
- The Providence Community Health Centers, Inc172 rows
- Thundermist Health Center238 rows
- WellOne Primary Medical and Dental Care (A)2 rows
- Women & Infants Hospital of RI274 rows
- Wood River Health Services, Inc.56 rows